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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these 
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and 
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
carbaryl by members of my staff and the valuable constructive comments by 
the Review Consultants on Carbaryl, by the ad hoc committees of the Society 
for Occupational and Environmental Health and the American Medical 
Association, and by Robert B. O'Connor, M.D., NIOSH consultant in 
occupational medicine. The NIOSH recommendations for standards are not
v
necessarily a consensus of all the consultants and professional societies 
that reviewed this criteria document on carbaryl. Lists of the NIOSH 
Review Committee members and of the Review Consultants appear on the 
following pages.
Ql tkVL.tl)
John F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
vi
The Division of Criteria Documentation and Standards 
Development, National Institute for Occupational Safety and 
Health, had primary responsibility for development of the 
criteria and recommended standard for carbaryl. The 
Division review staff for this document consisted of Howard 
L. McMartin, M.D., and Keith H. Jacobson, Ph.D., with Clara
H. Williams, Ph.D. (consultant).
Stanford Research Institute developed the basic information 
for consideration by NIOSH staff and consultants under 
contract No. CDC-99-74-31. Gamil Debbas, Ph.D. had NIOSH 
program responsibility and served as criteria manager.
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I. RECOMMENDATIONS FOR A CARBARYL STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to carbaryl in the workplace be 
controlled by adherence to the following sections. The standard is 
designed to protect the health and safety of employees for up to a 10-hour 
work shift, 40-hour workweek, over a working lifetime. Compliance with all 
sections of the standard should therefore prevent adverse effects of 
carbaryl on the health and safety of employees. The recommended standard 
Is measurable by techniques that are valid, reproducible, and available to 
industry and government agencies. Sufficient technology exists to permit 
compliance with the recommended standard. The criteria and standard will 
be subject to review and revision as necessary.
The criteria and the recommended standard apply to any manufacturing, 
formulating, or applying operation in which carbaryl is produced, packaged, 
processed, mixed, blended, handled, or used, or where employees are 
otherwise potentially exposed. "Carbaryl" is the generic name for the 1- 
naphthyl ester of N-methylcarbamic acid or 1-naphthyl N-methylcarbamate. 
"Action level" is defined as one-half the recommended time-weighted average 
(TWA) environmental exposure limit for carbaryl. "Occupational exposure to 
carbaryl" is defined as exposure to airborne carbaryl at concentrations 
greater than the action level. Exposure to carbaryl at concentrations less 
than or equal to the action level shall not require adherence to the 
recommended standard, except for Sections 3, 4(a,b), and 7(b). If
employees are potentially exposed to other chemicals, such as pesticide 
vehicles, diluents, or emulsifiers or other pesticides, provisions of any
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applicable standards for such chemicals shall also be followed.
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to carbaryl shall be controlled so that no 
employee is exposed to carbaryl at concentrations greater than 5 mg/cu m in 
air determined as a TWA concentration for up to a 10-hour work shift, 40- 
hour workweek.
(b) Sampling and Analysis
Procedures for sampling and analysis of environmental samples shall 
be as provided in Appendices I and II, or by any methods shown to be at 
least equivalent in accuracy, precision, and sensitivity to the methods 
specified.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to 
workers subject to occupational exposure to carbaryl.
Physicians responsible for workers who may be occupationally exposed 
to carbaryl shall be familiar with the Information contained in Appendix 
III which describes the suggested treatment of intoxication by this 
compound.
(a) Medical examinations shall Include:
(1) An initial or interim work history.
(2) A comprehensive initial or interim medical history to 
Include at least any history of frequent headaches, dizziness, tightness in
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the chest, dimness of vision, and difficulty in focusing eyes.
(3) A physical examination which shall be directed toward 
at least the cardiorespiratory system, central nervous system (CNS), 
vision, and kidneys. A complete urinalysis including microscopic 
examination shall be performed.
(4) Those workers with a history of glaucoma, 
cardiovascular disease, hepatic disease, renal disease, central nervous 
system (CNS) abnormalities, and those using anticholinergic drugs shall be 
counseled about working in jobs involving exposure to carbaryl. Workers 
shall be advised that a review of the available scientific data warrants 
consideration of possible effects of carbaryl on the reproductive system. 
Initial information based on experimental animal studies indicates possible 
effects on the developing fetus, as well as on other reproductive processes 
in both men and women. Female workers shall be further informed that the 
status of present toxicologic information does not necessarily indicate the 
need for avoiding exposure to carbaryl during pregnancy but suggests that 
appropriate steps be taken to minimize exposure wherever possible. In 
addition, nursing mothers who may be exposed to carbaryl shall be Informed 
of the possibility that the baby may ingest the compound from the maternal 
milk and shall be counseled to minimize exposure in the workplace.
(5) Initial medical examinations shall be made available to 
all workers within 60 days of the promulgation of a standard based on these 
recommendations.
(6) Periodic examinations shall be made available on a 
yearly basis or at some other interval determined by the responsible 
physician.
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(7) At the time of the preplacement examination, it Is 
recommended that a preexposure baseline erythrocyte cholinesterase activity 
be determined.
(8) A judgment of the worker’s physical ability to use 
negative or positive pressure respirators.
(b) Emergency first-aid services shall be established, under the 
direction of the responsible physician, to provide care to any worker 
acutely intoxicated by carbaryl (See Appendix III).
(c) Appropriate medical services and surveillance shall be
provided to any worker with adverse health effects from exposure to 
carbaryl.
(d) Pertinent medical records shall be maintained for all workers 
occupationally exposed to carbaryl for at least 5 years after termination 
of employment. These records shall be available to the designated medical 
representatives of the Secretary of Health, Education, and Welfare, of the 
Secretary of Labor, of the employee or former employee, and of the 
employer.
Section 3 - Labeling and Posting
(a) Labeling
Containers of carbaryl shall bear the following label in addition to, 





HARMFUL IF INHALED, SWALLOWED, OR LEFT ON THE SKIN
NO SMOKING
Avoid breathing dust or spray mist.
Avoid contact with eyes, skin, and clothing.
Wash hands and face thoroughly before eating.
Wear long-sleeved work clothes.
Shower or bathe and change into clean clothing after work.
First Aid: On skin contact with carbary1, wash with soap and water. On
eye contact, flush eyes with copious amounts of water. If inhaled or 
swallowed, consult a physician.
Note to Physician: Carbaryl is a moderate, reversible Cholinesterase
inhibitor. Atropine sulfate is the antidote. Do not use pralidoxime 
chloride (2-PAM).
(b) Posting
The following sign shall be posted in a readily visible location at 
or near entrances to manufacturing and formulating areas containing 
carbaryl, and at other areas in which there is a risk of exposure:
CARBARYL
CAUTION!
HARMFUL IF INHALED, SWALLOWED, OR LEFT ON THE SKIN
NO SMOKING
Avoid breathing dust or spray mist.
Avoid contact with eyes, skin, and clothing.
Wash hands and face thoroughly before eating.
Wear long-sleeved work clothes.
Shower or bathe and change into clean clothing after work.
First Aid: On skin contact with carbaryl, wash with soap and water. On
eye contact, flush eyes with copious amounts of water. If inhaled or 
swallowed, consult a physician.
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Warning signs shall be printed in English and in the predominant 
language of non-English-reading employees, if any, unless employers use 
equally effective means to ensure that non-English-reading employees know 
the hazards associated with carbaryl and the areas in which there is 
exposure to carbaryl. Employers shall ensure that illiterate employees 
also know these hazards and the locations of these areas.
Section 4 - Personal Protective Equipment and Clothing
(a) Protective Clothing
Any employee whose work involves likely exposure of the skin to 
carbaryl or carbaryl formulations, eg, mixing or formulating, shall wear 
full-body coveralls or the equivalent, impervious gloves, ie, highly 
resistant to the penetration of carbaryl, impervious footwear, and, when 
there is danger of carbaryl coming in contact with the eyes, goggles or a 
face shield. Any employee engaged in field application of carbaryl shall 
be provided with, and required to wear, the following protective clothing 
and equipment: goggles, full-body coveralls, impervious footwear, and a
protective head covering. Employees working as flaggers in the aerial 
application of carbaryl shall be provided with, and required to wear, full- 
body coveralls or waterproof rainsuits, protective head coverings, 
impervious gloves and impervious footwear.
(b) Eye Protection
Safety goggles and face shields, when required, shall conform to 29 
CFR 1910.133.
(c) Respiratory Protection
Engineering controls shall be used when necessary to maintain
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airborne carbaryl concentrations below the recommended workplace 
environmental limit. Compliance with the workplace environmental limit by 
the use of respirators is allowed only when airborne carbaryl 
concentrations are in excess of the workplace environmental limit because 
required engineering controls are being installed or tested, when 
nonroutine maintenance or repair is being accomplished, or during 
emergencies. When a respirator is thus permitted, it shall be selected and 
used in accordance with the following requirements:
(1) To determine the type of respirator to be used, the 
employer shall measure, when possible, the workplace air concentration of 
carbaryl Initially and thereafter whenever process, worksite, climate, ot 
control changes occur that are likely to increase the carbaryl 
concentrations. This requirement does not apply when only air-supplied 
positive pressure respirators are used. The employer shall ensure that no 
employee Is exposed to carbaryl in excess of the recommended TWA 
environmental limit because of Improper respirator selection, fit, use, or 
maintenance.
(2) Any employee applying carbaryl by aircraft shall be 
provided with, and required to carry in the aircraft, a respirator as 
specified in Table 1-1.
(3) Employees working as flaggers shall wear appropriate 
respirators as specified in Table 1-1 when exposure to an airborne carbaryl 
concentration above that specified in Section 1 is likely to occur. 
Respirators may also be worn during the time necessary to Install or test 
the required engineering controls, for nonroutine operations at 
concentrations in excess of the recommended TWA environmental limit
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resulting from maintenance or repair activities, or during emergencies when 
air concentrations of carbaryl may exceed the recommended TWA environmental 
limit.
(4) The employer shall establish and enforce a respiratory 
protective program meeting the requirements of 29 CFR 1910.134.
(5) The employer shall provide and ensure employee use of 
respirators approved under the provisions of 30 CFR 11 and in accordance 
with Table 1-1, except during all agricultural applications of carbaryl in 
which the dust- or spray-applicator nozzle is directed upward when a chin- 
style respirator equipped with a full-face gas mask pesticide filter and 
canister shall be provided regardless of the environmental carbaryl 
concentration.
(6) Respirators specified for use in higher concentrations 
of carbaryl may be used in atmospheres of lower concentrations.
(7) The employer shall ensure that respirators are clean 
and adequately maintained and that employees are instructed on the use of 
respirators assigned to them.
(8) Canisters shall be discarded and replaced with fresh 
canisters in accord with the manufacturer's recommendations or if the odor 
of the insecticide breaks through. Unused canisters shall be discarded and 
replaced when seals are broken, after 3 years if seals are unbroken, or as 





50 mg/cu m (1) Any supplied-air respirator*
or less (2) Any self-contained breathing 
apparatus*
250 mg/cu m (1) Any supplied-air respirator with a
or less full facepiece, helmet, or hood
(2) Any self-contained breathing apparatus
with full facepiece
625 mg/cu m Type C supplied-air respirator operated in
or less pressure-demand or other positive pressure 
or continuous-flow mode
Greater than (1) Self-contained breathing apparatus
625 mg/cu m, or with full facepiece operated in pressure-
entry into and demand or other positive pressure mode
exit from unknown (2) Combination respirator which includes
concentrations Type C supplied-air respirator with full 
facepiece operated in pressure-demand mode 
and auxiliary self-contained breathing 
apparatus operated in pressure-demand 
or other positive pressure mode
Firefighting Self-contained breathing apparatus with 
full facepiece operated in pressure-demand 
or other positive pressure mode
Emergency escape (1) Any gas mask providing protection 
against organic vapors and particulates**
(2) Any escape self-contained breathing 
apparatus
*If eye Irritation occurs, a full facepiece respirator must be worn. 
**Including pesticide respirators meeting the requirements of this class
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Section 5 - Informing Employees of Hazards from Carbaryl
At the beginning of their employment in a carbaryl area, workers 
shall be informed of the hazards, relevant symptoms of overexposure, 
appropriate emergency procedures, and proper conditions and precautions for 
safety. The information shall be kept on file and shall be readily 
accessible to the worker at all places of employment where occupational 
exposure to carbaryl is likely.
Employers shall institute a continuing educational program to ensure 
that all workers have current knowledge of job hazards, proper maintenance 
procedures, and cleanup methods, and that they know how to use respiratory 
protective equipment and protective clothing correctly. Employees should 
be informed of the possible additive effects from taking anticholinesterase 
medication.
Information as required shall be recorded on the "Material Safety 
Data Sheet" shown in Appendix IV, or on a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Emergency Procedures
Emergency procedures shall be formulated In advance for all work 
areas where a reasonable potential for emergencies exists, and employees 
shall be instructed in their Implementation.
(1) Procedures shall Include prearranged plans for 
obtaining emergency medical care and for necessary transportation of 
injured workers.
(2) Approved eye, skin, and respiratory protection as
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specified in Section 4 shall be used by personnel essential to emergency 
operations.
(3) Employees not essential to emergency operations shall
be evacuated from exposure areas during emergencies. Perimeters of areas 
of hazardous exposures shall be delineated, posted, and secured.
(4) Personnel who have to shut off sources of carbaryl,
clean up spills, and repair leaks shall be properly trained in such 
procedures and adequately protected against the attendant hazards.
(b) Engineering Controls
Engineering controls, such as process enclosure or local exhaust 
ventilation, shall be used when necessary to prevent airborne 
concentrations of carbaryl from exceeding the recommended TWA environmental 
limit. Ventilation systems shall be designed to prevent the accumulation 
or recirculation of carbaryl in the workplace and to remove carbaryl 
effectively from the breathing zones of exposed employees. Exhaust 
ventilation systems discharging to outside air must conform with applicable 
local, state, and federal air pollution regulations. Ventilation systems 
shall undergo regular preventive maintenance and cleaning to ensure maximum 
effectiveness, which shall be verified by periodic airflow measurements.
(c) Disposal
(1) Work areas, fixtures, equipment, etc, contaminated by 
carbaryl spills shall be cleaned promptly. Liquid carbaryl on floors shall 
be blotted with absorbing clay which, in turn, shall be removed with a 
sweeping compound. Dry forms of carbaryl shall be removed by vacuum 
cleaning, followed by thorough scrubbing of the exposed surfaces.
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(2) Disposal of waste material shall conform to local, 
state, and federal regulations to prevent the exposure of humans and 
animals as well as the pollution of air and water.
(d) Agricultural Practice
(1) In work areas, including those related to agricultural 
application where dermal or eye contact with carbaryl may occur, the 
employer shall make readily available to the employees water, soap or 
detergent, towels, and extra personal protective equipment, including 
respirators and clothing as specified in Section 4.
(2) During agricultural use of carbaryl sprays or dusts, 
all individuals involved shall have available for use as necessary 
protective clothing (gloves, coveralls, head coverings, footwear) and shall 
use respiratory protective devices, safety goggles, and face shields as 
stated in Section 4.
Section 7 - Sanitation Practices
(a) Employees working in areas where carbaryl is manufactured,
processed, handled, or stored shall wash their hands before eating, 
drinking, smoking, or using restroom facilities during the work shift.
(b) No food or beverages shall be stored, prepared, or consumed in
areas where carbaryl is manufactured, processed, handled, or stored.
(c) Contaminated clothing shall be removed before entering areas
where food or beverages are consumed.
(d) Smoking shall be prohibited In areas where carbaryl is 
manufactured, processed, handled, or stored in unsealed containers.
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(e) Employees should shower or bathe and change clothing after the
workday.
Section 8 - Monitoring and Recordkeeping Requirements
Workers are not considered to have occupational exposure to carbaryl 
if airborne concentrations, as determined by an industrial hygiene survey 
conducted within 6 months of the promulgation of this recommended standard, 
do not exceed half the recommended TWA environmental limit, ie, action 
level. Surveys shall be repeated at least once every year and within 30 
days after any process change likely to Increase the airborne concentration 
of carbaryl. Records of these surveys, including the basis for concluding 
that airborne concentrations of carbaryl are at or below the action level, 
shall be maintained. If the survey indicates that airborne concentrations 
of carbaryl exceed the action level, then the following requirements apply:
(a) Personal Monitoring
(1) A program of personal monitoring shall be instituted to 
identify and measure, or permit calculation of, the exposure of all 
employees who are occupationally exposed to carbaryl. Interim monitoring 
of employee exposure to airborne concentrations of carbaryl shall be 
conducted at least every 6 months. If monitoring shows an employee's 
exposure to be above the recommended TWA environmental limit, the exposure 
of that employee shall be measured at least once every 30 days, control 
measures shall be initiated, and the employee shall be notified of the 
exposure and the control measures being implemented to correct the 
situation. Such monitoring shall continue until two consecutive samplings, 
at least a week apart, Indicate that employee exposure no longer exceeds
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the recommended TWA environmental limit specified in Section 1(a). Semi­
annual monitoring may then be resumed.
(2) In all personal monitoring, samples of airborne
carbaryl shall be collected which, when analyzed, will provide an accurate 
representation of the concentration of carbaryl in the air which the worker 
breathes.
(3) For each TWA determination, a sufficient number of 
samples shall be taken to characterize each employee's exposure during each 
work shift. Variations in work and production schedules shall be 
considered in deciding when samples are to be collected. The number of 
representative TWA determinations for an operation or process shall be 
based on the variations in location and jobs of employees in relation to 
that operation or process.
(b) Recordkeeping Procedures
Records shall be maintained for 5 years and shall Include 
sampling and analytical methods, types of respiratory protective devices 
used, and TWA concentrations found. All employees shall have access to 
data on their environmental exposures. These records shall be available to 
the designated representatives of the Secretary of Labor and of the 
Secretary of Health, Education, and Welfare. Pertinent records of required 
medical examinations shall be maintained for at least 5 years after the 
worker's employment has ended, and shall be available to the designated 
medical representatives of the Secretary of Labor, of the Secretary of 




This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to carbaryl. The criteria document fulfills 
the responsibility of the Secretary of Health, Education, and Welfare, 
under Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health of employees from exposure to hazardous chemical and 
physical agents. Criteria and this recommended standard should enable 
management and labor to develop better engineering controls resulting in 
more healthful work practices and should not be used as a final goal.
These criteria for a standard for carbaryl are part of a continuing 
series being developed by NIOSH. The proposed standard applies only to the 
processing, manufacture, or use of carbaryl, or other workplace exposure to 
carbaryl, as applicable under the Occupational Safety and Health Act of 
1970. The standard was not designed for the population-at-large, and any 
extrapolation beyond occupational exposures is not warranted. It is 
Intended to (1) protect against development of systemic and local effects,
(2) be measurable by techniques that are valid, reproducible, and available
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to industry and government agencies, and (3) be attainable with existing 
technology.
Carbaryl is an organic compound used as an insecticide. The 
principal acute hazards from worker overexposure to carbaryl are the 
effects of inhibition of the enzyme acetylcholinesterase. This inhibition 
produces symptoms such as headache, nausea, vomiting, abdominal cramps, and 
dimness of vision. Effects of prolonged exposure, if any, are not well 
understood. Research is needed in the following areas: (1) air sampling 
and analysis for carbaryl; (2) further investigation to clarify possible 
mutagenic, carcinogenic, and teratogenic effects of carbaryl; and (3) 
effects of long-term exposure to carbaryl on neuromuscular, CNS, 
reproductive, and renal functions.
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III. BIOLOGIC EFFECTS OF EXPOSURE
The carbamate insecticides, one of which is carbaryl, and the 
organophosphate insecticides as well, exert their insecticidal action by 
Inhibiting cholinesterase enzymes. [1] This inhibition is the primary 
mechanism by which these insecticides cause toxicity in mammals. The 
cholinesterase enzymes hydrolyze acetylcholine and other choline esters; 
consequently, their inhibition leads to the accumulation of endogenous 
acetylcholine and other choline esters. Probably, most of the biologic 
effects of anticholinesterase agents, including carbaryl, are due to the 
inhibition of acetylcholinesterase which leads to the accumulation of 
endogenous acetylcholine, the principal choline ester that has demonstrated 
physiologic significance in humans.
Physiologically, acetylcholine is a chemical mediator of nerve 
impulses. [2 (pp 404-76)] It transmits nerve impulses to the heart and 
other parasympathetically innervated structures such as the muscles and 
glands of the gastrointestinal tract, including the salivary glands, the 
glands and muscles of the bronchial and urogenital systems, the sphincter 
muscle of the iris, and the ciliary muscle of the lens of the eye. A few 
postganglionic sympathetic fibers, such as those to the exocrine sweat 
glands, also release acetylcholine. In addition, acetylcholine has a 
neurotransmitter function at the termination of the preganglionic fibers on 
the neurons of the ganglia of both the sympathetic and parasympathetic 
parts of the autonomic nervous system and at the neuromuscular junction of
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the peripheral nerves and skeletal muscles. Also, a role for acetylcholine 
as a transmitter in synapses in the CNS has been suggested. The inhibition 
of cholinesterase allows acetylcholine to accumulate at these sites and 
thereby leads to overstimulation of these innervated organs.
Based on the ability of horse serum to hydrolyze acetylcholine and 
butyrylcholine, Stedman et al, [3] in 1932, suggested the term "choline- 
esterase" to name the enzyme present in serum. Two principal types of 
enzymes that hydrolyze choline esters have been identified in humans as 
acetylcholinesterase, or true cholinesterase, and butyrylcholinesterase, 
variously referred to as pseudo-, serum, or plasma cholinesterase. [2 (pp 
404-76)] Acetylcholinesterase catalyzes the breakdown of acetylcholine 
into acetic acid and choline. Acetylcholinesterase is found at nerve 
synaptic junctions, at the neuromuscular junction, in erythrocytes, and in 
other tissues. Plasma cholinesterase is present in various types of glial 
and satellite cells of the central and peripheral nervous systems, 
respectively, as well as in plasma, liver, and other organs. Its 
physiologic function is unknown; inhibition of plasma cholinesterase at 
most sites produces no apparent functional changes. Lehmann and Liddell
[4] speculated that the function of plasma cholinesterase may be to 
hydrolyze those choline esters that inhibit acetylcholinesteras. These 
include propionylcholine and butyrylcholine, which can be formed in vitro 
by enzyme systems responsible for the synthesis of acetylcholine and by 
bacterial action in the gut. Occasionally, humans have atypical or 
deficient plasma cholinesterases, discovered through an investigation of 
abnormal responses to the muscle relaxant succinylcholine, which appear to 
be genetically controlled variants having differing abilities to hydrolyze
18
acetylcholine and related compounds. [2 (p 585)]
O'Brien [5] discussed several theories on the mechanism of 
Cholinesterase inhibition by carbamates including carbaryl. One theory 
which the author proposed after a critical review of the literature on 
carbamates is briefly described. Carbamates react with Cholinesterase in a 
way similar to the reaction between organophosphates and Cholinesterase. 
An immediate and direct reaction takes place between the carbamate and 
Cholinesterase, resulting in the formation of a reversible enzyme-inhibitor 
complex. Second, in the case of carbaryl, carbamylation of the enzyme 
occurs with the release of 1-naphthol. Third, hydrolysis (decarbamylation) 
of the carbamylated enzyme occurs with regeneration of the original enzyme. 
The rate at which this step proceeds it* a major determinant of the rate at 
which the inactive enzyme is regenerated or restored to function. With the 
organophosphate insecticides, the third stage is extremely slow, whereas 
for the carbamate insecticides, eg, carbaryl, it is relatively rapid with a 
calculated half-life of 40 minutes for decarbamylation of the enzyme. In 
addition, if at any stage of the reaction the concentration of the 
carbamate is reduced, eg, by dilution, the carbamylated enzyme recovers 
activity by dissociation of the enzyme-inhibitor complex and by hydrolysis 
of the carbamylated enzyme. Thus, the carbamylated enzyme can be readily 
and rapidly regenerated and restored to function following inhibition. 
Therefore, one may assume that inhibition of circulating Cholinesterase may 
not be as readily apparent following exposure to carbaryl as with other 
Cholinesterase inhibitors. This assumption is also supported by the 
discovery of the ability of a component of human serum albumin to 
metabolize carbaryl to 1-naphthol, [6] and by the fact that most methods
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for determination of cholinesterase activity require dilution of the 
enzyme-substrate complex, thus accelerating the dissociation. 17] The 
method most frequently used for the measurement of cholinesterase activity, 
except in carbamate inhibition, is that of Michel. [8] Using 800 "healthy" 
blood donors, Rider et al [9] established normal limits of 0.56-0.95 and 
0.38-1.39 delta pH/hour for erythrocyte and plasma activities,
respectively, by the electrometric method. [8] The donors were men and
women between 18 and 60 years of age. Carbaryl differs further from many
anticholinesterase agents in that its metabolic changes result in
deactivation, [10] while some of the organophosphate insecticides (the 
thiophosphates) require metabolic activation to produce an effect. [5]
Extent of Exposure
Carbaryl (C12H1102N) is known chemically as 1-naphthyl N-methyl-
carbamate. Table XIII-1 presents the more important physical properties of 
carbaryl. [11,12,13 (sec 16), HH Moorefield, written communication,
February 1976] It is sold in the United States under the trade name Sevin 
and Table XIII-2 [14] lists its trade names and synonyms.
Carbaryl can be produced by reacting 1-naphthol and methyl
isocyanate. [15] Also, phosgene and 1-naphthol can be combined to produce 
naphthyl chlorofornate which reacts with methylamine to produce carbaryl. 
As the exact sequence of the domestic carbaryl-manufacturing process is not 
known, it has been suggested that the first production method is probably 
used. [16]
Total carbaryl production in the United States was estimated to
be about 50 million pounds for each of the years 1967 and 1970, [16,17]
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45 million pounds in 1971, [18] and 53 million pounds in 1972. [19] Of the 
total produced in 1972, approximately 28 million pounds were exported. 
About 25 million pounds were used in the United States, 19 million for 
agricultural purposes, 3.5 million in homes and gardens, 1.5 million by 
government, and 1 million for Industrial and commercial purposes. Slightly 
over half the carbaryl used nationwide in 1972 was used in the southeast 
and the north central states (about 8 million and 5 million pounds, 
respectively). [19] An estitaated 40% of the carbaryl used throughout the 
world is applied in the production of cotton. [20]
The product of the carbaryl-manufacturing process is a 98% 
concentrate. [21] Carbaryl is formulated as wettable powders, pellets, 
granules, dusts, fertilizer mixtures, and liquids. [18]
The people most likely to be occupationally exposed to carbaryl are 
those engaged in the development, manufacture, and distribution of 
insecticides, as well as agricultural crop workers, farmers, plant nursery 
workers, spray pilots, and others engaged in spraying and dusting
operations, eg, soil fumlgators and exterminators. [22] NIOSH estimates 
that 100,000 US workers are potentially exposed to carbaryl.
Historical Reports
The cholinesterase-lnhibltor physostigmine, an alkaloid extract of 
the calabar bean, has been used since the mid-19th century for ophthal­
mologic treatment and diagnostic purposes. [23] Its clinical use predates 
an understanding of cholinesterase enzyme inhibition.
In 1925, Stedman and Barger [24] elucidated the structure of
physostigmine. A year later, Stedman [25] reported on the pharmacologic
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action of substituted phenyl carbamates in mammals. He had synthesized a 
series of compounds and screened them for miotic activity by applying them 
directly to the eyes of cats.
Research and development on heterocyclic carbamates, initiated in 
1947, led to several Swiss patents on dimethylcarbamates having 
insecticidal activity. [26] Lambrech synthesized carbaryl (Sevin) in the 
United States in 1953; and in 1956, after preliminary field tests, Sevin 
was released for testing in agricultural experiment stations. [20] In 
1957, Haynes et al [26] described the Insecticidal properties and some of 
the physicochemical characteristics of carbaryl.
Union Carbide Corporation was issued US Patent No. 2,903,478 for 
carbaryl in 1959, [18] the year after commercial production and sales on an 
experimental basis were begun. [16,20]
In 1961, Carpenter et al [27] described a series of biologic and
toxicologic investigations of carbaryl conducted on experimental animals. 
In 1962, Best and Murray [28] were the first to report the results of 
investigations on occupational exposures to carbaryl. These investigations 
[27,28] are discussed further in this chapter.
Best and Murray [28] described the case of a 19-month-old infant who 
had miosis, excessive salivation, and incoordination after ingesting an 
unknown amount of carbaryl. The child responded to gastric lavage and
atropine therapy and apparently recovered completely in 12 hours. The
authors [28] received a report of this incident in a personal
communication, and it probably Is the first reported case of symptomatic 
carbaryl poisoning.
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In 1963, Hayes [21] reported that, within 20 minutes after ingesting 
a 250-mg "carefully measured oral dose" (about 2.8 mg/kg) of carbaryl, a 
man experienced epigastric pain and sweating. Atropine sulfate was 
administered, and recovery was complete within 2 hours. Hayes gave no 
further details on the incident. A later publication [29] indicated that 
the incident described in 1963 was, in fact, a purposeful ingestion by a 
scientist.
Effects on Humans
Feldmann and Maibach [30] studied the percutaneous absorption of
carbaryl by applying 14C-labeled carbaryl (4 fig/sq cm) dissolved in acetone 
to the forearm skin of six adult male volunteers. The acetone volatilized 
in seconds; the skin was not washed for 24 hours. Eight urine specimens 
were collected from each subject over 5 days as follows: four during the
first day, three collections at 4-hour intervals and the fourth 12 hours 
later; and once daily (total 24-hour specimens) on each of the next 4 days. 
The amounts of 14C radioactivity in the urine were determined by liquid 
scintillation counting and were compared with the amount of 14C 
radioactivity recovered in a similar study involving a single intravenous 
(iv) injection of one microcurie of carbaryl. After correction with the 
factor of 7.4% for incomplete urinary excretion obtained in the iv study, 
the results were expressed in percentages of the dermally applied dose. 
The results indicated that 73.9% of the 14C-carbaryl applied to the skin 
was excreted in the urine within 5 days. The absorption of carbaryl was
probably increased by the use of acetone in this study.
In a similar study of 14C-carbaryl (4 ¿tg/sq cm) dissolved in acetone,
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Maibach et al [31] showed that other parts of human skin were similar to 
that of the forearm in absorption of carbary1. Approximately 70% of the 
14C-carbaryl was excreted within 5 days after application to the skin over 
the angle of the jaw. Other pesticides were also studied. Parathlon 
absorption by the skin of the scrotum, axilla, and forehead, for example, 
was considerably greater than that from the forearm skin.
Wills et al [32] collected urine from two male volunteers who had 
been administered carbaryl in gelatin capsules at a dose of 2 mg/kg. Total 
urine samples were collected at 4-hour Intervals for the first 16 hours, 
followed by one 8-hour collection sample. Thereafter, for the next 3 days, 
total urine was collected and pooled at 24-hour intervals. Urine samples 
from control subjects had been obtained for the 24-hour period before 
carbaryl administration. Using these samples, Knaak et al [33] determined 
the metabolites of carbaryl in the urine of the two volunteers. Portions 
of all urine samples were subjected to ion-exchange chromatography, and 
fractions were analyzed by spectrophotofluorometry. Also, composite 4-day 
samples, one from each subject, were pooled for colorimetric analysis. The 
metabolites in the 24-hour urine samples, separated by chromatography, were 
1-naphthyl glucuronide, unidentified neutrals, 4-(methylcarbamoyloxy)-l- 
naphthyl glucuronide, and 1-naphthyl sulfate. In addition, another 
metabolite, 1-naphthyl methylimldocarbonate 0-glucuronide, was identified 
by fluorometry. Moreover, colorimetric analysis revealed an average 
concentration of 1-naphthol in the urine of 0.81 mg/100 ml. From this, the 
authors estimated that 37.8% of the orally administered carbaryl would be 
excreted within 4 days. Of the total determined, fluorometric analysis 
indicated that only 26-27% was excreted as metabolites during the first 24
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hours. These metabolites were identified and quantitated. They were: 1-
naphthyl glucuronide 12.9%, 1-naphthyl sulfate 8.5%, and 4- 
(methylcarbamoyloxy)-l-naphthyl glucuronide 5.1%. Fluorometric analysis 
revealed small amounts of metabolites in the urine on the second day but 
none were detected on days 3 and 4. Knaak et al [33] did not explore the 
possibility that either carbaryl or some of its metabolites may have been 
excreted in the feces, either directly or indirectly through the 
enterohepatic circulation, or by other routes.
Using similar techniques in another study, Knaak et al [34] analyzed 
24-hour urine specimens from men exposed to carbaryl dust during a 
packaging operation in a factory (the number of men, exposure periods, and 
other conditions were unspecified). Twenty-four-hour urine specimens 
obtained from the same men 72 hours after their last exposure to carbaryl 
served as controls. The urinary metabolites separated by chromatography 
were 1-naphthyl glucuronide, 1-naphthyl sulfate, and unidentified neutral 
metabolites. Concentrations of the glucuronide and sulfate in the urine 
were estimated to be 25 and 5 /Ltg/ml, respectively.
Vandekar [35] published the results of a study conducted in 1963 by 
the WHO Insecticide Testing Unit in three villages of southern Nigeria. 
The investigators used a water-dispersible carbaryl powder with 85% active 
ingredient to prepare a spray that contained 5% active ingredient which 
they expected would deposit 2 g of active ingredient on each square meter 
of surface. They studied the effects on 10 men who applied the spray as a 
residual insecticide in 16 houses over a single 6-hour period and on 95 
villagers who resided in these houses. The sprayers wore overalls, broad- 
brimmed oilskin hats, and rubber boots during the entire 6 hours of
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spraying, but wore masks for the first hour only. Clinical observations of 
all 105 individuals involved were recorded throughout the investigation. 
Plasma cholinesterase activities as well as urinary metabolites were 
determined before and after spraying. Except for a distinct rash on a 
single sprayer whose back was splashed while he was filling an applicator 
with the carbaryl spray, no adverse effects were seen in either the 
sprayers or the villagers. Plasma cholinesterase activity was determined 
electrometrically by a micromodification [36] of the method of Michel from 
blood samples taken by flngerprick and stored at 4 C until analyzed, 
usually on the same day. This method, like most others, probably 
underestimates the amount of inhibition of cholinesterase activity caused 
by carbaryl (see Biologic Evaluation in Chapter IV). A slight reduction in 
plasma cholinesterase activity was reported [35] for all 10 sprayers the 
day after the carbaryl application; however, when measured again 5 days 
after spraying, the enzyme activity was found to be within the preexposure 
range. A slight but statistically significant reduction in plasma 
cholinesterase activity was found in the 63 exposed villagers measured 1 
week after the spraying. The mean reduction was 8%, ranging from somewhat 
greater for residents 7- to 14-years-old (10.1%) and those over 30 years of 
age (10.8%), to less for residents 1- to 6-years-old (5.9%) and for those 
15- to 30-years-old (5.3%). The metabolites of carbaryl were estimated 
[35] according to the colorimetric method of Dawson et al [37] in urine 
samples usually collected between 8 AM and 10 AM. Excretory levels of 
naphthol derivatives in the urine of the sprayers were unchanged on the 
first and second days or thereafter, except for a slight increase on the 
sixth day after exposure to carbaryl. [35] The urinary excretory levels of
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naphthol derivatives for 38 villagers before and for 32 villagers a week 
after the spraying, however, were significantly different; before exposure, 
the mean was 30.5 /ug/ml, and 50.3 jug/ml afterwards.
In a comprehensive Union Carbide Corporation report submitted to 
NIOSH, Williams [13 (sec 9,10)] described an inhalation-absorption study of 
two employees. Employee A, an observer, was located near employee B who 
was emptying containers of carbaryl in a recovery operation. Employee A 
had complete body protection, except for the face, but no respiratory 
protection. Employee B, who made no special effort to avoid body contact, 
worked with and without gloves, but wore coveralls and an air-supplied 
respirator. Although observation extended intermittently over 24 days, the 
carbaryl airborne concentrations were similar on only 2 days. On the first 
such day, the airborne environmental carbaryl concentrations were 50.9 and
49.3 mg/cu m for employees A and B, respectively. The initial urinary 
naphthol concentration of employee A obtained before he began work that day 
was undetectable. After exposure to carbaryl, it rose to a maximum of 
3,619 /ng/100 ml. For employee B, the initial urinary naphthol
concentration of 1,939 jig/100 ml rose to 8,975 ¿ig/100 ml. Both maximum 
concentrations were from urine samples collected at 6:30 PM, after exposure 
had ceased. On the second day, similar environmental airborne carbaryl 
concentrations, 45.2 and 40.6 mg/cu m, were reported for employees A and B, 
respectively. The initial (second-day) urinary naphthol value for employee 
A was again undetectable, and the maximum, 2,430 ¿tg/100 ml, was in the
sample taken at 5:30 PM. On day 2, corresponding urinary naphthol 
concentrations for employee B were 1,803 /ig/100 ml initially and 2,340
¿ig/100 ml at 9:30 PM. No noticeable effects on either employee were
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observed or expressed; there were no pinpoint pupils, thought to be an 
early sign of excessive exposure to carbaryl. Methods used for air 
sampling and analysis were not identified, nor was the method for 
determining urinary 1-naphthol described.
Long [38] recounted an incident in which a worker, wearing a mask and 
goggles (skin protection not described) while loading an airplane with a 
mixture of carbaryl and sulfur, indicated he was weak and dizzy and could 
not get his breath. He experienced the same symptoms 2 days later, at 
which time chemical toxemia was the diagnosis. The attending physician 
noted that, according to the employer, four other employees had been sick 
or had had similar attacks. Long presented no further details.
Yakim [39] reported in limited detail investigations of the biologic 
effects of carbaryl in agricultural workers in the USSR. Whole blood 
cholinesterase activity was determined in men after 4- to 6-hour exposures 
to airborne concentrations of carbaryl for 3-4 days. The method used to 
determine blood cholinesterase activity was not specified. Cholinesterase 
activities decreased 11-22% in men exposed at a mean airborne carbaryl 
concentration of 2 mg/cu m while working at a loading site. Tractor 
drivers who disseminated carbaryl and were exposed at an average 
concentration of 2 mg/cu m of air had a fall of 20-24% in blood 
cholinesterase activity. Signalers exposed at 4 mg/cu m experienced a 13- 
30% decrease in cholinesterase activity. Yakim [39] indicated that the 
blood picture and results of certain tests of physiologic functions (pulse 
rate, body temperature, Aschner's reflex (oculocardiac), dermographism, and 
what was described as an orthoclinostatlc test) suggested no change In 
these workers before and after work. Pilots engaged In aerial application
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were exposed in the cabin at a mean airborne carbaryl concentration of 7 
mg/cu m, but Yakim [39] reported no data on the changes, if any, in their 
cholinesterase activity or in the blood picture or physiologic functions.
Farago [40] presented the details of a suicide attributed to carbaryl 
ingestion. The victim, a 39-year-old man described as inebriated, ingested 
about 0.5 liter of a solution of Sevin 80 (possibly 400 g of carbaryl). He 
was hospitalized 1.5 hours later, and his stomach was lavaged and 
circulation-promoting agents were administered. As his condition 
deteriorated, the patient complained of disturbed vision, and lung edema 
developed. He received atropine every half hour. One and a half hours 
after entering the hospital, he also received 250 mg of pralidoxime (PAM). 
Hayes [21] pointed out that the use of PAM is inappropriate in the 
treatment of carbaryl intoxication (see Appendix III for medical 
management). Following the administration of PAM, his condition 
deteriorated even more rapidly with attendant signs of advancing pulmonary 
edema. [40] The man died 6 hours after Ingesting the carbaryl. Autopsy 
revealed what was described as dark, livid red spots on the body surface; 
swollen, edematous brain tissue; severe pulmonary edema; and blood- 
congested viscera. Farago [40] considered the degree of kidney hyperemia 
present especially striking. Analysis of the organs showed the following 
carbaryl concentrations (in mg%): stomach flushing water, 244.6; stomach
and contents, 14.8; intestine and contents, 17.6; blood, 1.4; liver, 2.9; 
kidneys, 2.5; and urine, 3.1. At the time of death, carbaryl had not been 
completely absorbed from the gastrointestinal tract; that which had been 
absorbed apparently accumulated in the liver and kidneys. The 
cholinesterase activity in the blood, determined by an electrometric
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method, was strongly Inhibited. Thin-layer chromatography revealed one or 
two (not clear from the paper) metabolites of carbaryl in the stomach, 
three metabolites in the intestines, four in the liver and kidneys, and 
five in the urine. None of the metabolites were identified. The presence 
of a metabolite in the stomach suggests that some metabolism may also occur 
at that site in human beings.
Of the 25 cases of poisoning from organophosphate and carbamate 
compounds described by Lopez, [41] only two were attributable to carbaryl 
alone. The first was a 19-year-old man who ingested watermelon sprayed 
with 80% carbaryl, and the second was a 33-year-old man who inadvertently 
drank several milliliters of a solution of 80% carbaryl. Lopez [41] 
classified the degree of intoxication in both men as light. In addition to 
nausea, both subjects experienced signs and symptoms including vomiting, 
hyperreflexla, pallor, intestinal colic, and nasal discharge in the first 
victim; and salivation, headache, lacrimation, and tremors in the second. 
The 19-year-old and the 33-year-old patients were treated with 20 mg and 5 
mg of deoxycorticosterone and recovered completely in 18 hours and 1.5 
hours, respectively. The author hypothesized that either corticoids 
liberate cholinesterase bound to serum proteins or that further induction 
of this enzyme had been initiated by deoxycorticosterone.
In a Union Carbide Corporation medical department report dated June 
19, 1962 and provided to NIOSH, Sexton [13 (sec 7)] reported an incident at 
a carbary1-shipping facility where storage bins had become plugged, 
necessitating hand-removal of carbaryl dust from hoppers leading to the 
bins. Fourteen employees were involved, and all of the men were supposedly 
wearing dust respirators all the time while working. Between early and
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late afternoon, 7 of the 14 men reported to the medical department 
complaining of symptoms they attributed to inhalation of carbaryl dust. It 
was interpreted that the felt cartridge of the respirators had become 
clogged with dust, so that not only dust but also the vaporized carbaryl 
may have passed through the filter cartridge, resulting in exposure. The 
workers had complaints of nausea, dizziness, or both. In addition, one man 
complained of headache and another of being "overheated" and perspiring.
The seven men had worked 8-16 hours on the day they became ill. The
episode occurred on a Saturday afternoon, and company physicians were not 
notified until the following Monday morning. At that time, all 14 
employees were seen at the medical department, where urine and blood
specimens were collected. By then, none of the 14 men had any complaints.
Blood cholinesterase activities were measured by an electrometric method 
which probably underestimated the degree of cholinesterase inhibition. 
Urine was analyzed for conjugated naphthol. The mean conjugated naphthol 
content of the urine of the seven men who had complained of illness was 
1,417 ^g (range 200-3,100)/100 cc. The mean conjugated naphthol content of 
the urine of the seven asymptomatic workers was 2,443 jug (range 1,000- 
4,200)/100 cc. Mean cholinesterase activities for the ill workers were
1.097 (erythrocyte) and 3.183 (plasma) delta pH units, and for the well 
employees, 1.258 (erythrocyte) and 3.368 (plasma) delta pH units. No 
environmental data were reported. Medical personnel concluded that the 
effects were due to inhalation of carbaryl, related perhaps to respirator 
malfunction. However, the intoxications reported could have resulted from 
other than lung absorption.
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In a 1970 memorandum by Dernehl [13 (sec 13)] submitted to NIOSH by 
Union Carbide Corporation, the sequence of events in Union Carbide workers 
overexposed to carbaryl during its manufacture, formulation, and use was 
summarized as follows: headache and nausea after 3-4 hours of continuous
overexposure to airborne carbaryl dust at unstated * concentrations; 
vomiting, possibly accompanied by mild abdominal cramps, about 30 minutes 
after the onset of headache and nausea; dimness of vision; and termination 
of exposure because of the vomiting. Dernehl [13 (sec 13)] added that by 
the time affected employees were provided medical attention, usually 30-45 
minutes after becoming ill, symptoms already had begun to disappear, and 
only in rare instances did a physician consider atropine sulfate 
administration necessary. He also pointed out that it was rarely possible 
to quantitatively determine hazardous exposure levels, but that the 
employees' verbal descriptions suggested heavy concentrations well above 
those normally encountered.
Vills et al, [32] in a preliminary study, administered carbaryl in 
gelatin capsules to male volunteers 25-57 years of age (mean 36). Single 
oral doses of approximately 0.5, 1.0, and 2.0 mg/kg of carbaryl were given 
to three pairs of men, who were then observed for signs of intoxication. 
Blood plasma and whole blood cholinesterase activities were monitored by a 
pH stat method, and the subjects were questioned about symptomatic effects. 
Neither objective nor subjective changes were noted in the preliminary 
study. Wills et al [32] also administered carbaryl to another series of 
subjects. Two groups of five men each received either placebo capsules or 
capsules containing 0.06 mg/kg of carbaryl daily for 6 weeks. Two weeks 
later, two new groups of six men each started ingesting, again for six
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weeks, either placebo capsules or doses of carbaryl analyzed at 0.12 mg/kg 
by one method and by another at 0.13 mg/kg. Blood, urine, and fecal 
specimens were collected initially and weekly from all subjects throughout 
each of the 6-week study phases. The authors specifically noted that 
sulfobromophthalein (BSP) retention in the plasma before and after carbaryl 
administration did not differ, that cholinesterase activities were not 
significantly altered, and that no significant effects attributable to 
carbaryl were present in the hemograms, in the blood chemistry, or in urine 
or fecal examinations. Blood samples were examined for hematocrit, 
hemoglobin, erythrocyte count, total and differential leukocyte counts, 
blood urea nitrogen (BUN), glucose, plasma and whole blood cholinesterase 
activities, cholesterol, prothrombin time, serum glutamic oxaloacetic 
transaminase (SGOT), sodium, and potassium. Urinary specimens were 
examined for turbidity, pH, protein, glucose, erythrocytes, squamous
epithelial cells, crystals, and for the ratio of amino acid nitrogen to
creatinine. Stool specimens were examined for occult blood. The authors 
indicated that final EEG recordings for both the treated and the untreated 
groups were somewhat more synchronized than were the initial ones but 
showed none of the spiking reportedly found in the EEG of subjects exposed 
to other (organophosphate) cholinesterase inhibitors. Subjects receiving 
carbaryl at the higher dose expressed several complaints not reported by 
the corresponding placebo group. Because most of these occurred the day 
after ingestion of carbaryl had ended, they were thought to be
manifestations of withdrawal. Of the remaining complaints, the authors 
considered the two instances of difficulty in sleeping and of abdominal
cramps to be symptoms of cholinesterase inhibition. Only one subject
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reported the third complaint, an eye reaction (pupillary dilation), on one 
day; since this response usually is not caused by acetylcholinesterase 
inhibition, the authors attached no particular significance to it.
The only deviations from control levels in all the determinations 
reported were in the amino acid nitrogen to creatinine ratios, considered 
an estimate of the reabsorptive capacity of the proximal convoluted tubules 
of the kidney. [32] Wills et al [32] illustrated in charts the averages 
and ranges of these ratios for the men on both doses of carbaryl and for
their controls, but did not state the actual numerical results. Ratios of
the low-dose group (0.06 mg/kg) and their controls were determined 
Initially and at weeks 1, 2, 4, and 6 of the study. Those ratios (low 
dose) were consistently below the controls except at week 6, when they were 
equal. Determinations were similarly recorded for the high-dose (0.12 or 
0.13 mg/kg) group and their controls. Averages for six control and for six 
experimental subjects (five at the final determination) were compared. The 
ratios of the experimental group fell below those of the controls at the 
end of the first week of carbaryl ingestion, spiked upward at week 2, and
fell to a plateau (at about midpoint of the second week's increase), where
they remained until the fifth week. The next determinations on four of the 
subjects, 15 weeks after the last dose, showed that the amino acid to 
creatinine ratios had returned to the control level. The authors concluded 
that men who took carbaryl by mouth in daily doses of 0.06 or 0.12 mg/kg 
for 6 weeks suffered no subjective or objective changes clearly 
attributable to carbaryl other than a slight, reversible decrease in the 
ability of the proximal convoluted tubule of the kidney to reabsorb amino 
acids in the group on the higher dose.
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Back, [20] in a 1965 review of product development experiences with 
carbaryl, referred to "about 50 cases" of intoxication, none fatal, and 
"less than a dozen" instances of cholinesterase inhibition, apparently due 
to the carbamate. He noted that, in those instances when exposure had 
occurred among process workers, formulators, or applicators, the onset of 
illness consistently resulted in cessation of work and thus of further 
exposure. The author gave no other details.
Epidemiologic Studies
Best and Murray [28] reported observations made during a 19-month 
period in a carbary1-manufacturing plant. Involved in the survey were 59 
employees, some of whom were exposed to carbaryl for less than 1 week. A 
total of 81 samples of airborne particulates (or air samples) were 
collected on Millipore filters (AA white grid, 47-mm Millipore filter 
paper). The concentration of carbaryl was determined colorimetrically 
using the reaction with p-nitrobenzenediazonium fluoroborate. The airborne 
concentrations of carbaryl under normal and abnormal conditions in the 
production area, air separator house, stacking and shipping area, and 
bagging areas are shown in Table III-l. In addition to the work areas 
listed above, the airborne carbaryl concentrations to which the building 
services employees were exposed, while not measured, were estimated to be 
relatively high, because these employees were exposed to dusty jobs in all 
plant areas. Employees were required to wear respirators only while 
cleaning the air separator house and at times when high concentrations were 
anticipated in the bagging areas. The range of concentrations of the 81
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TABLE III-l




Concentration in mg/cu m
Range Mean
Production area 49 0.03 - 0.73 0.23
Air separator house 2 19 - 34 31
Stacking and shipping area 6 0.05 - 1.52 0.64
Bagging area (normal) 18 0.20 - 1.60 0.75
Bagging area (abnormal) 6 19 - 40 29
Adapted from Best and Murray [28]
air samples was 0.03-40 mg/cu m. Only eight of the samples equaled or 
exceeded an airborne concentration of carbaryl of 19 mg/cu m. Of these, 
two were from the air separator house (29 and 34 mg/cu m), and six were 
recorded in the bagging area under abnormal conditions, such as when flow 
system connections or bags broke, or when bags were difficult to fill 
(range 19-40 mg/cu m). The other 73 samples had carbaryl concentrations 
equal to or less than 1.6 mg/cu m.
During the first 4.5 months of the Best and Murray [28] study, urine 
specimens for 1-naphthol determination were taken early in the morning 
before work on the day after blood samples were drawn for cholinesterase 
determination. Cholinesterase activity measured by an insensitive method 
was reported to be only slightly lowered, but since 1-naphthol excretion 
was significantly high in 10 of 63 urine specimens from employees likely to
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have been most heavily exposed, it seems likely that cholinesterase 
activity might have been affected. For the next 3.5 months, 47 urine 
samples taken in the evening on days blood was drawn showed an average of
35.4 jug/100 ml which was approximately 9 ¿tg/100 ml more 1-naphthol than 
that in samples taken the next morning. During the same 3.5-month period, 
most of the cholinesterase activities fell again from 96-100% of the normal 
to 70-95% of normal range, measured by an insensitive method. Over the 
next 3 months, when carbaryl production, bagging, and shipping ceased 
entirely, the 1-naphthol urinary levels of the above employees decreased to 
an average of 10.8 jug/100 ml. With resumption of carbary1-manufacturing 
operations and of employee blood and urine sampling for the following 8 
months, 23% of 138 exposed employee blood samples, but no control blood 
samples, had some reduction in cholinesterase activity; in this case, the 
quantitative method of Fleisher and Pope [42] was used but this probably 
underestimates carbaryl-induced cholinesterase inhibition. In the 
relatively high exposure groups, blood samples from 5 of 35 workers in the 
bagging areas, 13 of 67 workers in building services, 6 of 89 workers in 
production, and 6 of 78 workers in shipping had enzyme activities measured 
by the method of Fleisher and Pope [42] that were somewhat lower than those 
from the control group of unexposed workers. With these exceptions, blood 
cholinesterase activities in the other exposed workers did not vary 
significantly from those of the controls. The authors did not specify 
either the basis for selection of the control group or the time when blood 
samples were taken. The 1-naphthol findings in the same group were much 
more impressive; 41% (of 138 specimens) had average values of more than 
1,000 ¿tg/100 ml, 2.5 times the highest control levels (150-400 jug/100 ml).
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In another study by Best and Murray, [28] the 1-naphthol urinary 
output determined during one workweek was more than doubled in one of two 
carbaryl baggers. Five other employees regularly assigned to various 
duties were monitored by 1-naphthol urine determinations twice daily for a 
single Monday-through-Friday workweek. The 1-naphthol levels in the urine 
were approximately 150% of their own control levels in two workers and 
approximately 223, 277, and 285% of their control levels in the three other 
workers at the end of the workweek. Although all of these employees had 
been similarly exposed to carbaryl dust in the previous week, they began on 
Monday of the test week usually with low values of urine 1-naphthol. The 
1-naphthol urinary levels were highest on Wednesday to Friday. In the 
study of two baggers, one, who had been on vacation the previous week, 
began on Monday with urinary levels in the normal range and never reached 
the level of the other bagger.
In summarizing their results, Best and Murray [28] stated that 
relatively large amounts of 1-naphthol were excreted in the urine by 
employees exposed at air concentrations of carbaryl ranging from 0.23 to 31 
mg/cu m but at times reported to be 0.03-40 mg/cu m. Blood cholinesterase 
activities in exposed employees were either within the normal range or were 
only slightly inhibited, but, in view of the enzyme assay methods used, 
these data are of doubtful significance. At no time did any of the 





(1) Acute toxicity (other than inhalation) and interactions 
Several investigators [27,43,44] have studied the acute oral 
toxicity of carbaryl in laboratory animals. Carpenter et al [27] 
calculated the LD50 of carbaryl based on mortality occurring within 14 days 
after administration by oral gavage of single, graded doses of the test 
material to groups of five rats weighing 90-120 g. The carbaryl was 
administered at a concentration of 50 mg/ml in 0„25% agar. The LD50's were 
510 mg/kg in rats of unspecified sex and 610 mg/kg in females. Other 
authors, [43,44] using different strains of rats or different suspending 
agents, reported slightly different LD50 values. For example, Gaines [43] 
suspended technical grade carbaryl in peanut oil for oral administration to 
rats and calculated the LD50 values of carbaryl as 850 and 500 mg/kg for 
male and female rats, respectively. Gaines [43] also reported that the 
lowest oral dose which killed a male and a female rat was 600 and 100 
mg/kg, respectively. These results suggested that the female rat was more 
sensitive to carbaryl than was the male. Coulston and Serrone [44] 
determined the oral LD50 in rats (sex not stated) to be approximately 600 
mg/kg. The same authors reported an oral LD50 for mice of 650 mg/kg and an 
estimated LD50 for dogs and monkeys at less than 500 and greater than 1,000 
mg/kg, respectively.
In a series of studies designed to assess the extent of 
cholinesterase inhibition in animals after administration of carbaryl, 
Carpenter et al [27] injected carbaryl iv as an 8% solution in 95% ethyl 
alcohol at doses of 10 and 15 mg/kg of body weight to two groups of three
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dogs. Blood samples were taken before, and at intervals of 0.5, 1, 2, 5, 
and 23 hours after, carbaryl administration. Erythrocyte and plasma 
cholinesterase activities were determined by an electrometric method which, 
like many other methods, probably underestimates the degree of inhibition. 
Ethyl alcohol administered iv at volumes approximating the amount of ethyl 
alcohol given in the 8% carbaryl solution did not affect either plasma or 
erythrocyte cholinesterase activity. Recognizing the difficulties in 
evaluating the rapid reversibility of carbaryl-inhibited cholinesterase 
activity, the investigators chose to measure the extent of inhibition after 
equilibrium between substrate and enzyme was attained in the incubation 
phase of the analysis. They conceded that the values thus attained were 
not an exact measure of cholinesterase activity, but they believed that the 
values did represent the relative picture at various time intervals after 
administration. Results of these determinations revealed no significant 
changes in either erythrocyte or plasma cholinesterase activities after 
single iv carbaryl doses of 10 and 15 mg/kg.
Carpenter et al [27] also administered carbaryl in single oral doses 
by gelatin capsule to six bitches weighing about 8 kg each. One dog 
received carbaryl at 500 mg/kg, four dogs at 375 mg/kg each, and one dog at 
250 mg/kg. The one dog given 250 mg/kg remained normal; the five dogs at 
the two highest doses showed signs of overstimulation of the 
parasympathetic nervous system. The signs the authors reported were as 
follows: the dogs were quiet for 15-30 minutes; then salivation and
respiratory rate increased; lacrimation, urination, defecation, and 
intermittent muscular twitching occurred for 30-90 minutes; and muscle 
tremors increased (one dog had a minor convulsion). All five dogs had
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constriction of pupils, profuse salivation, poor coordination, diarrhea, 
further increases in respiratory rate, and loss of bladder control after 
2.5 hours. Three hours after administration, the animals vomited mucus and 
thick saliva and had violent intestinal movements, weakness, and 
considerable muscular spasm. After 5.5 hours, all five animals became 
quieter, but lacrimation, salivation, slight pupillary constriction, poor 
coordination, intermittent muscular twitching, and occasional vomiting of 
mucus persisted. After 7 hours, the pupils were almost normal, salivation 
decreased, and coordination improved. The authors noted no adverse effects 
on the following day, except that the dog treated with 500 mg/kg of 
carbaryl was extremely weak for 24 hours and did not eat for five days. 
Cholinesterase activities were not determined in the animal receiving 500 
mg/kg. Plasma cholinesterase inhibition was found to be "insignificant" in 
the four dogs given 375 mg/kg, but some erythrocyte cholinesterase 
inhibition was verified in three of them, the maximum effect occurring 
within 2-3 hours after carbaryl administration. The maximum inhibition of 
erythrocyte cholinesterase activity during the first 3 hours for the three 
dogs was 24-33%. After 7 and 24 hours, these values varied from 12-30% and 
from 0-14%, respectively.
Carpenter et al [27] studied the effectiveness of atropine sulfate 
(an agent that blocks the cholinergic receptors, particularly at the 
parasympathetic neuroeffector junction, to prevent the action of 
acetylcholine) in combination with pyridine-2-aldoxime methiodide (PAM) (an 
agent that reactivates the phosphorylated cholinesterase enzymes after 
poisoning with organophosphate inhibitors) in blocking cholinergic effects 
produced by a single high dose of carbaryl in the dog. A single dog
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weighing 8 kg, which had received carbaryl at a dose of 375 mg/kg in a 
capsule, was treated with 40 mg of PAM and 10 mg of atropine sulfate after 
signs of poisoning appeared. This combination failed to control the 
effects of carbaryl, but subsequent doses of 5 and 10 mg of atropine 
sulfate without the PAM proved effective. The same investigators 
administered a lethal oral dose (800 mg/kg) of carbaryl followed by PAM at 
a dose of 20 mg/kg iv to five female rats with no reduction of the 
mortality rate. A similar dose of atropine sulfate prevented death in a 
similarly treated group of five female rats. Similar results were obtained 
in rabbits. All these studies appear to provide reliable evidence that the 
administration of large doses of atropine sulfate, but not of PAM, can be 
effective in treating carbaryl intoxication. The adverse effect of oxime 
cholinesterase reactivators in animals poisoned with carbaryl was confirmed 
by Natoff and Reiff [45] in rats and by Akamatsu and Kohgo [46] in mice. 
Sanderson [47] found oxime treatment ineffective in carbaryl poisoning in 
rats.
In order to study the interactions between carbaryl and other 
pesticides, Carpenter et al [27] administered single oral doses of carbaryl 
in combination with each of 24 other compounds by gavage to rats weighing 
90-120 g. The predicted LD50 for each pair of pesticides was calculated 
from the Individual LD50 and proportion of each compound present in the 
administered dose. The ratio of the predicted toxicity over the observed 
toxicity was calculated. The authors considered a ratio of two or more 
indicative of a greater than additive or potentiating effect. They 
concluded from their data that there was no evidence of carbary1-caused 
potentiation or antagonism. However, additive effects were observed with
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10 organophosphate pesticides— diazinon, EPN, guthion, malathion, methyl 
parathion, OMPA, parathion, phosdrin, systox, and trithion. In a similar 
study in rats, Keplinger and Deichmann [48] obtained values for ratios of 
predicted over observed toxicity, based on LD50 after oral administration, 
of 1.30-1.82 for 4 organophosphate pesticides— diazinon, parathion, delnav, 
and malathion— administered with carbaryl. The authors concluded that 
these ratios suggested more than an additive effect. However, it is 
doubtful that this degree of increase in toxicity as evidenced by decreases 
in LD50's is sufficiently marked to be considered a synergistic or 
potentiating effect.
(2) Inhalation toxicity
Studies involving the exposure of animals to airborne carbaryl 
are relatively limited. Carpenter et al [27] exposed six guinea pigs for 4 
hours to an airborne carbaryl wettable powder (50%) of 15 pm average 
particle size at a concentration of 390 (344-722) mg/cu m. The authors 
noted that at this concentration there was a visible dense cloud of dust. 
The animals gained weight normally during the subsequent 2-week observation 
period; however, nasal and local ocular irritation were evident. Autopsy 
disclosed healed hemorrhagic areas in the lungs. The authors provided no 
additional information.
Six guinea pigs were exposed for single 4-hour periods at a mean 
concentration of 230 mg/cu m of a "microfine" (average particle size was 5 
pm, ranging from less than 1 to 10 pm) wettable powder containing 85% 
carbaryl by weight. [27] In the 14-day postexposure observation period, 
the animals initially showed slight weight losses, but they had returned to 
their pretreatment weights by the end of the period. Another group of five
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guinea pigs survived a 4-hour exposure at a mean concentration of 332 
mg/cu m to the same dust. No other information was provided.
An unspecified number of dogs were exposed [27] to microfine wettable 
powder of carbaryl at concentrations of approximately 75 mg/cu m. Within 5 
hours, typical signs of cholinesterase inhibition were seen. Also, 
repeated exposures to the same formulation did not cause death or other 
evident injury in rats that inhaled 10 (5-20) mg/cu m for 7 hours/day, 5 
days/week, for a total of 90 exposures. In an unpublished report 
(C Carpenter, written communication, January 6, 1976), the results of the 
gross and microscopic examinations of tissues taken from rats in the 
inhalation study were described. No signs of treatment-associated gross or 
microscopic lesions were present in the rats exposed to carbaryl (Sevin 
85S) by repeated inhalation at the concentration used.
Yakim [39] reported the results of exposures of cats to airborne 
carbaryl. Three groups of four cats each were exposed for one period of 6 
hours to carbaryl dust at concentrations of 82 (80.2-83.7), 37 (31.7-42.2), 
and 20 (18.7-21.2) mg/cu m. Yakim [39] did not specify the particle size, 
method of sampling, or sex or age of the cats. No deaths occurred, 
although the highest concentration did cause signs of toxicity which 
disappeared after exposure ceased. The cholinesterase activities fell 
immediately after exposure to 39-55% and 53-71% in serum and erythrocytes, 
respectively, but returned to normal in two of three cats in 72 hours. The 
third cat showed a partial recovery of cholinesterase activity after 72 
hours. Cats exposed to a carbaryl dust at 37 mg/cu m showed 23% serum and 
41% inhibition of erythrocyte cholinesterase activity which returned to 
normal in 48 hours. Carbaryl dust at 20 mg/cu m caused reductions of
44
11-24% in serum and 15-28% in erythrocyte cholinesterase activities, but 
recovery was complete in 24 hours. The authors concluded that the single 
exposure at 20 mg/cu m represented the threshold exposure concentration. 
Three additional groups of four cats each were exposed repeatedly to 
carbaryl dust. The first group, at an airborne concentration of 16 (15.3- 
16.6) mg/cu m, showed no signs of toxicity during the 4-month (6 hours/day) 
exposure. In the second group, at a concentration of 63 (61.1-64.2) 
mg/cu m for 6 hours/day for 1 month, periodic salivation was most profuse 
during the first 2 hours of each exposure. One cat died on the 20th day; 
the surviving cats showed reductions of 31-40% in serum and 41-58% in
erythrocyte cholinesterase activities. The third group was exposed to 
carbaryl at an average concentration of 40 (37.4-43.3) mg/cu m for 6
hours/day for 2 months. Details were not given, but the author stated that 
some deterioration occurred in undefined conditioned reflexes of cats at 
this concentration, mostly after the first exposure; although erythrocyte 
cholinesterase activity dropped to 50% or less on some days, the
conditioned reflexes remained normal. The author concluded that results 
from inhalation experiments of 1-4 months suggest that 16 mg/cu m
constitutes the threshold concentration and 63 mg/cum is the toxic
concentration of carbaryl for cats. Based on his studies on cats and
humans which were discussed earlier, the author suggested that the maximum
permissible concentration in the USSR be set at 1 mg/cu m. The author did
not describe the method used to determine cholinesterase activity.
(3) Local (skin and eye) effects
Carpenter et al [27] also reported on studies investigating 
the possibility of injury to the surface of the eye following contact with
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carbaryl. They applied 0.5 ml or more of various concentrations of an 
undescribed form of carbaryl to one eye of each of five rabbits. The eyes 
were examined for any immediate local effect; any 24-hour reactions were 
recorded after application of a 5% aqueous fluorescein stain to reveal the 
presence of injured tissue. Volumes of 0.5 ml or more as a 10% suspension
of technical grade carbaryl caused only mild injury in one of five rabbit
eyes at the 24-hour examination. A 25% aqueous suspension of "microfine" 
carbaryl (a powder containing 85% active agent by weight) with an average
particle size of 5 pm caused no injury. Fifty milligrams of carbaryl dust
caused only traces of corneal necrosis.
Yakim [39] found that application of a 10% suspension of carbaryl and 
of 50 mg of powder to the eyes of rabbits caused only transient miosis and 
hyperemia. Those signs could occur after local absorption of an 
anticholinesterase agent.
Carpenter et al [27] evaluated the primary skin irritation potential 
of topically applied carbaryl. A solution of technical grade carbaryl was 
applied at a concentration of 10% in acetone at a dose of 0.01 ml to the 
clipped abdominal skin of five rabbits. The authors noted that, whereas 
most of the carbaryl went into solution, a slight turbidity remained. The 
rabbits were observed for 24 hours; no signs of irritation were noted.
Gaines [49] investigated the acute dermal toxicity of carbaryl in 
rats. He applied technical grade carbaryl dissolved in xylene to cleanly 
clipped areas of skin over the shoulders and forward parts of the backs of 
10 male and 10 female rats. The animals were at least 90 days old and 
ranged in weight from 175 to 200 g. The dermal LD50 values exceeded 4,000 
mg/kg in both sexes. Gaines [49] stated that an LD50 by the dermal route
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is much more indicative of the possibility of occupational toxicity than 
the acute oral LD50. Yakim [39] reported that, whereas no deaths occurred 
in six rabbits when a dose of 500 mg/kg of carbaryl was applied to the 
skin, serum and erythrocyte cholinesterase activities were inhibited during 
the first 24 hours after treatment. Yakim [39] also indicated that 
cholinesterase activity was normal after 72 hours and that the skin was not 
irritated. The cholinesterase activity was determined colorimetrically by 
Hestrin's method, [50] but no specific details were given on how the method 
was carried out. The original method by Hestrin [50] is not a reliable one 
for measuring cholinesterase activity in blood samples (see Chapter IV, 
Biologic Monitoring).
Carpenter et al [27] examined the skin sensitization potential of 
carbaryl. Sixteen male albino guinea pigs were treated with eight
intracutaneous injections (3/week on alternate days) of 0.1 ml of a 0.1% 
carbaryl dispersion in 3.3% propylene glycol made up in 0.75% NaCl. After 
3 weeks during which no injections were given, a similar dose was again 
administered intracutaneously, and all sites of injection were examined 24 
and 48 hours after this challenge dose. The authors reported that 4 of the 
16 showed evidence of weak sensitization.
(4) Other effects
Carpenter et al [27] fed carbaryl at 1,500 and 2,250 ppm in
the diet to two groups of 10 rats each for 96 days. The higher level
produced a decrease in the body weights of females, an increase in the
liver-to-body-weight ratio in males, and an increase in the kidney weight 
of females compared with the controls. Food intake was not affected. The 
only microscopic finding was a minor degree of diffuse, cloudy swelling of
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the kidney tubules in 4 of 10 animals fed 2,250 ppm of carbaryl. At the 
1,500-ppm dose level, an increase in kidney weights of females was the only 
deviation from control values; organ damage was not evident upon 
microscopic examination. The authors speculated that the apparent 
difference in response between sexes occurred because the dose for females, 
in mg/kg of body weight, was about 30% greater than that for males at the 
same dietary Intake.
Carpenter et al [27] reported a 2-year study in which rats received 
carbaryl mixed with feed. Five groups of 40 animals (20 males and 20 
females), 60 days old at the beginning of the study, were administered 0, 
50, 100, 200, and 400 ppm carbaryl in the diet. Before the start of the 
study, 10 of the male rats (age 54 days) were selected randomly from each 
of the 200- and 400-ppm treatment levels and from the control group for 
hematocrit determinations, which were made initially and at various 
intervals throughout the study. All surviving animals were killed between 
days 732 and 736 of the experiment. Gross and microscopic examinations 
were performed on gastrocnemius muscle, sciatic nerve, lung, kidney, liver, 
heart, spleen, pancreas, stomach, duodenum, descending colon, testis or 
ovary, fallopian tube, esophagus, trachea, thyroid, urinary bladder, and 
adrenal gland tissues. Lung infections, which accounted for 88% of all 
deaths during the study, appeared to be no more frequent among treated than 
among control rats. The other causes of death, none of which appeared to 
be dose related, were peritonitis, 6.5%; neoplasms, 3.3%; anuria, 1.1%; and 
nephritis, 1.1%. No single type of tumor or site of origin was associated 
with the inclusion of carbaryl in the diet, nor was the incidence of tumors 
in the carbaryl-fed groups different from that for control rats. In fact,
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mortality in the control group exceeded that in any of the treated groups. 
No statistically significant difference was found between the rats fed 
carbaryl and the control group in mean age at death, mean expectation of 
life at birth, or mean expectation of life after 1 year of administration. 
The mean age in days at death for both sexes at the 200- and 400-ppm diet 
levels were 630 and 656 days, respectively, and 585 days for the control 
rats. Liver and kidney weights which were calculated as percentages of 
body weights of rats killed periodically during the experiment did not 
differ from control values. None of the mean hematocrit values for the 
400-ppm diet-fed rats differed at any interval from those for the control 
group, and only a single midexperiment mean for the 200-ppm diet group was 
different from the controls. No significance was attached to this isolated 
deviation. Microscopic examination of tissues from randomly selected 
animals fed carbaryl in the diet for 180 and 270 days revealed no 
significant difference from the controls. Kidney changes of a mild, 
transitory nature observed in female rats fed 400-ppm carbaryl diet for 365 
days were characterized as a cloudy swelling of the proximal convoluted 
tubules. After 2 years of receiving 400-ppm of carbaryl in the diet, some 
rats developed renal changes consisting of cloudy swelling of the proximal 
convoluted and loop tubules of the kidney, but the incidence was not 
significant. The authors considered the cloudy swelling of the hepatic 
cords, principally located around the central veins, to be more noteworthy. 
This was a finding of statistical significance in the group of animals on 
the 400-ppm diet for 2 years. Microscopic examination of rats at the lower 
doses, ie, 50, 100, and 200 ppm, revealed no differences between the 
treated and control animals. The authors concluded that after two years
49
none of the tissues examined from the rats on the 400-ppm diet showed 
permanent degenerative changes which could be attributed to toxicity of the 
insecticide.
Aspects of the comparative toxicology of carbaryl in rats and monkeys 
were presented in an abstract by Serrone et al. [51] The authors concluded 
that monkeys tolerated much larger single oral doses of carbaryl (up to
1,000 mg/kg) than did rats or dogs. Although monkey plasma cholinesterase 
was inhibited at a dose of 600 mg/kg in a 6-month study (number of doses 
and frequency not stated), little inhibition occurred at lower doses. The 
authors also noted that electron microscopic studies of the kidneys of rats 
and monkeys treated with carbaryl disclosed a marked vacuolation of the 
epithelium in the proximal renal tubules. In a review article which 
discusses the same or similar studies, Coulston and Serrone [44] presented 
an electron photomicrograph of renal tissue from a monkey treated with
carbaryl at 600 mg/kg (length and frequency of treatment not stated) that
also demonstrated this lesion. In the abstract, [51] the authors also 
reported having observed no disturbances in urinary function other than a 
discoloration of the urine (this was also reported in swine [52]), which 
the authors thought might be caused by the presence of a metabolite of
carbaryl. It is difficult to draw any conclusions from these studies,
[44,51] since the length and frequency of treatment was not specified and 
only a single electron photomicrograph was presented.
Carpenter et al [27] administered carbaryl in gelatin capsules to 
Basenji-Cocker dogs for 1 year. A control group received no carbaryl. 
Fourteen dogs were randomly distributed by sex and litter among the treated 
and control groups. Carbaryl was administered 5 days/week at doses of
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approximately 0.45, 1.8, and 7.2 mg/kg. Hematocrit, hemoglobin,
erthyrocyte fragility, and differential leukocyte evaluations were made 
prior to the initial dose and after 3, 6, 7.5, 9, and 12 months of
administration. Except at 7.5 months, determination of BSP retention and 
serum alkaline phosphatase, urea nitrogen, and bilirubin concentrations 
were made at the same intervals. Plasma and erythrocyte cholinesterase 
determinations were also made five times during the 3-week pretreatment 
period, as controls. Twenty additional cholinesterase assays were 
performed electrometrically weekly for 9 weeks, twice during the next 
month, and about monthly thereafter. After a year of treatment, the dogs 
were anesthetized and exsanguinated. Brain, spinal cord, thorax, abdomen, 
gastrocnemius muscle, and sciatic nerve were examined. One of two bitches 
that received carbaryl at 0.45 mg/kg had shown transient hind leg weakness 
after the 189th day of administration. Carbaryl treatment was continued 
without pause and, within 21 days, the dog appeared to be normal. There 
was no statistically significant difference between treated and control 
animals with respect to mean body weight, mean blood values (hematocrit, 
hemoglobin, and differential leukocyte count), BSP retention, serum urea 
nitrogen, total serum bilirubin, and serum alkaline phosphatase values. 
Cholinesterase activity was not significantly different in the treated and 
in the control dogs; however, the method used to determine cholinesterase 
activity probably underestimated the degree of inhibition. The weights of 
livers and kidneys of the carbaryl-treated and control animals also did not 
differ. Microscopic examination revealed diffuse, cloudy swelling of the 
proximal convoluted and loop tubules of the kidney and focal sudanophilic 
"dust" in the glomeruli of dogs given carbaryl at 7.2 mg/kg. The authors
judged these to be transient conditions rather than the early stages of 
toxic degeneration, because the microscopic findings were also present in 
the control dogs, but to a lesser extent. Although considerable 
intracellular fat was observed in the proximal kidney tubules of the 
females, the authors did not regard this as indicative of toxicity, but 
rather as a variability within the normal range. Carpenter et al [27] 
concluded that tissues from the dogs killed after 1 year of carbaryl 
administered orally in doses of 7.2 mg/kg or less showed no permanent 
degenerative changes.
(b) Paralytic Effects
Grob, [53] in a review of neuromuscular pharmacology, indicated that 
the only residual effects after exposure to some organophosphate 
cholinesterase inhibitors were a few instances of paralysis. These 
disorders resembled the peripheral neuritis and demyelination (Ginger Jake 
paralysis) which occur at 14 days or more after exposure to 
triorthocresylphosphate (TOCP). Consequently, cholinesterase-inhibiting 
compounds are frequently tested for nerve-demyelination potential early in 
their development.
Carpenter et al [27] studied in chickens (Rhode Island Red hens) the 
potential of carbaryl to cause the type of paralysis referred to as Ginger 
Jake paralysis seen with TOCP. The chemicals (carbaryl and TOCP) were 
suspended in lard and single doses administered subcutaneously to chickens 
(13 carbaryl- and 10 TOCP- treated) at doses of 0.25, 0.5, 1.0, 2.0, and
3.0 g/kg (number of hens at each dose level unspecified). Five control 
hens were untreated, two hens were vehicle-treated (lard), and one 
additional hen was given undiluted TOCP at 1.0 mg/kg. Chickens that
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received 1.0 g/kg or less of carbaryl did not develop signs of leg
weakness. At 2.0 g/kg, leg weakness was observed on the first or second
day following administration; in one case, the chicken was unable to walk 
for 3 days, but none developed late paralysis (after 14 days) typical of 
TOCP-demyelinating injury. All chickens given TOCP at 3.0 g/kg showed leg 
weakness at 14 days which persisted until they died. Microscopic 
examination of tissue sections of brain, sciatic nerve, and spinal cord 
revealed no evidence of demyelinatlon at any carbaryl dose level; however, 
demyelination was present in some TOCP-treated chickens. The authors
concluded that leg weakness was evidence of a transient cholinergic effect
caused by the slow absorption of carbaryl from the subcutaneous depot. 
Evidence of slight degeneration (focal loss of striations and fatty 
infiltration of gastrocnemius muscle fibers) was present at the 3.0 g/kg 
dose of carbaryl and at all doses of TOCP. These authors concluded that
the role of carbaryl in the production of leg weakness in chickens may be
described as cholinergic rather than demyelinating.
Gaines' study [43] in chickens supports the studies of Carpenter et 
al. [27] Gaines pretreated an unspecified number of chickens with 15 mg/kg 
of atropine orally to protect against the acute effects of the subcutaneous 
administration of 800 or 1,600 mg/kg of carbaryl. The animals were then
observed for 21 days. The higher dose of carbaryl caused leg weakness
within 24 hours; all chickens recovered by day 24. As stated above, in 
TOCP poisoning paralysis develops after 14 days and continues until death.
Smalley et al [52] fed a ration containing carbaryl to 13-week-old 
Yorkshire pigs. One male and one female pig received 150 mg of 
carbaryl/kg/day for 72 and 83 days, respectively; one female and two male
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pigs received 150 mg/kg/day for 28 days followed by 300 mg/kg/day for 
either 18 (both males) or 57 (one female) additional days. Two pigs from 
the same litter served as controls. During the first 4 weeks of treatment, 
signs of carbaryl effect were limited to brown discoloration of the urine 
upon exposure to light and air. The first group (one sow and one boar) 
that received 150 mg/kg/day showed signs of toxicity on days 45 and 62 
respectively. The second group (2 boars and 1 sow), whose dose was 
increased from 150 to 300 mg/kg/day on day 29, exhibited signs of toxicity
on days 37, 39, and 41. Animals in both groups were reluctant to stand,
remaining recumbent for long periods; later, they were ataxic, 
incoordinated, and had tremors. In the first group, the boar became 
prostrate and died on day 72; the sow became prostrate on day 80 and died 
on day 83. In the second group, both males were prostrate by days 43-44
and died on day 46, while the female became prostrate on day 71 and died on
day 85. Microscopic examination of skeletal muscle revealed three 
distinctive types of myodegeneration, one type related to trauma or 
ischemia, another characterized as hyaline and vacuolar degeneration, and a 
third type associated with dystrophic calcification of mitochondria and the 
sarcotubular system. In the myelinated tracts of the cerebellum, brain 
stem, and upper spinal cord, the moderate-to-severe edema was considered by 
the authors to be caused by vascular changes characterized by endothelial 
hypertrophy, hyalinization of vessel walls, and widespread hemorrhages; 
however, no demyelination of nerve tissue was observed. In another 
publication, Smalley [54] indicated that administration of 
hydrochlorothiazide, a diuretic, reversed the signs of toxicity of carbaryl 
in chronically treated pigs. He suggested that the mechanism of this
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reversal was related to increased excretion of carbaryl in the urine. In 
the same study, two 5-mg doses of atropine given intramuscularly, 2 hours 
apart, proved effective in controlling signs of acute carbaryl intoxication 
in pigs administered single oral doses of carbaryl at 2 g/kg. One sow 
which received carbaryl in the diet at a dose of 150 mg/kg/day developed 
paresis on day 93. Atropine therapy, 5 mg (im) repeated at 8-hour 
intervals for a total of 40 mg over a 3-day period was not effective in 
controlling signs resulting from repeated administration of carbaryl. The 
author stated that the only unusual gross or microscopic lesions were in 
the striated muscle, and that these lesions resembled myopathies of toxic 
or nutritional origin. The author suggested that brown urine might be 
evidence of carbaryl poisoning, but it may have actually indicated only 
carbaryl absorption.
The sensitivity of the pig to carbaryl was compared with that of the 
dog in a study by Miller et al. [55] A single 20-mg/kg dose of carbaryl 
was injected iv into eight male miniature pigs. Four control pigs received 
the vehicle only, which consisted of peanut oil, saline, and lecithin. 
Both control and experimental pigs were killed 20 minutes after injection. 
Five male pigs had been fed carbaryl at 125 mg/kg in the diet for 6-8 weeks 
and were then killed, and five served as controls. Five male dogs received 
carbaryl at 30 mg/kg by single iv injection. Five additional dogs received 
the same vehicle as the pigs and served as controls. Both control and 
experimental dogs were killed 20 minutes after injection. Six male dogs 
received carbaryl at 125 mg/kg in the diet for 2 months, and five 
additional dogs were used as controls. All eleven were killed at the end 
of the study. The signs of carbaryl toxicity following iv injection were
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more marked in the pigs than in the dogs. Tremor, ataxia, incoordination, 
and paraplegia were observed in the pigs, but only lacrimation, salivation, 
and occasional tremors occurred in the dogs. Dietary administration failed 
to produce any overt signs of toxicity in the dog, whereas a spastic 
paresis of the posterior extremities developed in the pigs after 6-8 weeks 
on the carbaryl diet. There was a significant depression of brain 
cholinesterase of a similar degree in each species, but the method may not 
have adequately detected cholinesterase inhibition.
(c) Behavioral Effects
Santolucito and Morrison [56] examined the effect of carbaryl on the 
EEG of the rhesus monkey. Daily oral carbaryl doses of 0.01 and 1.0 mg/kg 
were given to four and three rhesus monkeys, respectively, for 18 months; 
seven monkeys served as controls. During that period, the experimental 
animals showed no obvious changes in behavior. After 18 months, a single 
15-minute EEG recording was made from each monkey while they were 
immobilized and anesthesized. There were no significant quantitative EEG 
changes, but whether this was due to anesthetic suppression is not known.
Sideroff and Santolucito [57] conducted a series of investigations on 
the effects of carbaryl on rat behavior. Two techniques, liquid 
reinforcement and electroshock avoidance, were combined and used in this 
study. Each of four groups of male rats weighing 200-250 g was composed of 
5-9 controls and an equal number of treated animals which were injected 
subcutaneously with carbaryl at 10 mg/kg, once weekly, for 2-5 weeks. The 
results of the experiments showed a statistically significant difference 
between the control and the treated animals. This led the authors to 
conclude that the carbaryl-treated rats were less motivated (fewer lever
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pressings for water) and less inhibited by aversive (electroshock) 
situations than were the control rats.
Singh [58] found that a decrease in physical activity of rats, as 
measured in an activity-wheel cage, occurred following single ip injections 
of carbaryl at 0.56 and 2.24 mg/kg. Atropine at 2 mg/kg ip did not alter 
the carbaryl effect in female rats. In male rats, the effects of the 2.24 
mg/kg dose were reversed.
(d) Reproduction Studies, Including Teratogenesis and Mutagenesis
Epstein et al [59] included carbaryl in a series of agents screened 
for dominant lethal-mutations in mice. Carbaryl was administered orally in 
daily doses of 50 and 1,000 mg/kg to 10 male mice each for 5 days. One 
mouse in the 1,000 mg/kg group died. Each of the 19 surviving males was 
then caged for mating with three untreated virgins each week for 8 
consecutive weeks. The females were killed on about the 13th day of 
gestation. At autopsy, each female was scored for\ pregnancy and for number 
of total implants, including live implants and early fetal deaths. The 
authors assessed the reduction in total implants by comparing the number of 
total implants in females mated with treated and control males. While 
these specific data for carbaryl were not discussed further in the paper, 
the authors Included carbaryl in a class of agents which did not meet "any 
screening criteria for mutagenic effects."
In addition to the dominant-lethal test, the results of several other 
studies of the mutagenic potential of carbaryl have been reported. In a 
plant study undertaken by Amer, [60] 0.5 and 0.25% saturated solutions of 
carbaryl (pure and formulated), prepared at 22 and 60 C, were applied to 
Allium cepa germinating roots for 4 and 24 hours. The pure and formulated
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solutions prepared at the higher temperature (60 C) caused abnormal forms 
of mitotic figures and a complete arrest of the process. Solutions
prepared at the lower temperature caused fewer abnormal forms of mitotic 
figures and partial arrest of the mitotic process. The formulation caused 
more severe arrest than did the pure solutions. The relevance of these 
data to humans is not clear at this time.
In another plant study, Wuu and Grant [61] using barley (Hordeum 
vulgare L) seeds and seedlings found that carbaryl at 1,000 ppm for 12 
hours on the sprouted seeds induced meiotic changes, namely, chromosomal 
aberrations of 0.55% in the C-l generation and 2.9% in the C-2 generation. 
The positive controls, treated with ethylmethanesulfonate at 1,000 ppm and 
X-rays at 5,500 R, and the untreated control sprouted seeds showed
chromosomal abnormalities of 1.57%, 3.91%, and 0.22%, respectively, in the 
C-l generation and 0.38%, 1.26%, and 0.49%, respectively, in the C-2
generation. The seedlings sprayed once with carbaryl at a concentration of 
500 ppm which showed 1.21% chromosomal abnormalities contrasted with the 
untreated control rate of 0.66%.
Brzeskij and Vaskov [62] examined the effects of carbaryl on 
mutations and fertility in Drosophila melanogaster using criteria of (1) 
deletions in X-chromosomes, (2) recessive sex-linked lethal and sublethal 
mutations caught in F2 by Moeller-5 method, and (3) male fertility by 
examining sex cells in different stages. They found no effects on
fertility of males at any stage of spermatogenesis but found a low rate of
recessive sex-linked lethal and sublethal mutations. Therefore, they 
concluded that carbaryl was a weak mutagen. Elespuru et al [63] found that 
carbaryl was not mutagenic in Hemophilus influenzae. Siebert and
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Eisenbrand [64] examined carbaryl for genetic activity in a diploid strain 
of Saccharomyces cerevisiae, heteroallelic at the gene loci ade-2 and trp- 
5. Even at a concentration of 4.97 millimolar, carbaryl did not change the 
frequency of mitotic gene conversion compared with control solvents and was 
judged genetically inactive. Uchiyama et al [65] assayed carbaryl for 
mutagenic activity by using (1) the back-mutation method with an 
auxotrophic mutant of E coli B/r WP-2 try and (2) recombination assay with 
B subtilis Marburg 17a, of recombination-capable strain, and Marburg 45T of 
recombination-lacking strain. Carbaryl did not result in mutagenic 
changes, even at the highest concentration of 10 mg/plate, with either 
method.
The preceding mutagenic studies on a mammal (mice), [59] on bacteria 
(H influenzae, [63] and E coli and .B subtilis [65]), and on yeast (S 
cervisiae) [64] indicate that carbaryl is not a mutagen under these 
experimental conditions, although experiments on an insect (Drosophila) 
indicate weak mutagenicity. [ 62] However, nitrosocarbaryl (N-nitroso-N- 
methyl-1 naphthylcarbamate) was a strong mutagen in H influenzae, [63] S 
cerevisiae, [64] and E coli and B subtilis. [65] Uchiyama et al [65] also 
pointed out that the N-methyl carbamates, including carbaryl, might be 
convertible to nitroso compounds. They speculated that since carbamates 
are widely used and since nitrite is a common constituent of human saliva, 
the stomach would then provide the acid medium necessary for nitrosation. 
Nevertheless, the significance of the formation of nitrosocarbaryl in 
relation to any effect of carbaryl on humans remains to be determined.
Smalley et al [66] investigated the teratogenic potential of carbaryl 
incorporated into the diet of pregnant beagles throughout gestation
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(averaging 62 days). Fifty-five bitches were treated with carbaryl as 
follows: 10 at 3.125 mg/kg, 10 at 6.25 mg/kg, 18 at 12.5 mg/kg, 9 at 25
mg/kg, and 8 at 50 mg/kg. Sixteen animals used as controls were maintained 
under similar conditions but received no carbaryl. After parturition, the 
bitches and pups were carefully examined. Radiographs were taken of the 
pups if skeletal abnormalities were observed or suspected. Defective pups 
were killed and necropsled after birth, the rest at weaning; abnormalities 
were characterized and recorded. At all levels of treatment, the 
percentage of pups born alive was lower than in the controls. At the 
highest carbaryl dose (50 mg/kg/day), eight animals were bred, three 
conceived, but no pups were born alive. Dystocia was present in about one 
out of three of the treated bitches; none of the control bitches had 
dystocia. The authors did not state whether the dystocia was maternal or 
fetal but, from the information given on the appearance of the reproductive 
organs, it is inferred that the dystocia was maternal. The average numbers 
of pups/litter at the two highest dose levels were 3.5 and 3.8; the control 
average was 5.4. Of the total number of pregnant beagles at all carbaryl 
doses, 21% produced pups showing evidence of embryotoxicity. At the lowest 
dose (3.125 mg/kg) and in the control group, there were no abnormal pups. 
Excluding fetal deaths and resorptions, 21 pups (11.6%) were abnormal; all 
were from dams that received the four higher doses. Teratogenic effects 
included abdominal-thoracic fissures with varying degrees of intestinal 
organ agenesis, extra phalanges, brachygnathia (shortened lower jaw), and 
failure of skeletal formation. This study [66] was listed in the Registry 
of Toxic Effects of Chemical Substances [14] as showing teratogenic effects 
and will be discussed and evaluated further (see Absorption and Metabolism
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under An-»ma1 Toxicity, Correlation of Exposure and Effect, and Chapter V, 
Basis for the Recommended Standard).
In studies [67] designed to evaluate the effects of carbaryl on 
reproduction in primates, carbaryl was administered in 1% aqueous gum 
traqacanth by stomach tube to mature female rhesus monkeys throughout the 
gestation period, as follows: 2.0 mg/kg to 4 monkeys and 20.0 mg/kg to 10
animals. Seven control monkeys received the vehicle. Monkeys at all 
treatment levels, including controls, were mated and confirmatory pregnancy 
tests performed. Two of four monkeys given carbaryl at 2.0 mg/kg were 
pregnant but both aborted. Six of 10 monkeys on the 20 mg/kg dose were 
pregnant; 3 aborted and 3 delivered normal babies. Five of seven control 
monkeys were pregnant; one aborted, and four delivered normal babies. 
Although not directly dose related, abortion rates for the treated groups—  
100% (two of two) at 2 mg/kg, 50% (three of six) at 20 mg/kg— exceeded the 
20% rate (one of five) for the control group^ It is difficult to make 
conclusions on the basis of this report since the number of monkeys used 
was too small. Abortions were reported but no terata were found; this 
agrees with Wilson [68] who has indicated that with several suspected or 
proved teratogens, the range of doses causing terata in the primate is 
small; moreover, unlike rodents, primates are more likely to respond to 
potential teratogens by aborting.
Dougherty and Coulston [69] extended the previous study [67] using 79 
female rhesus monkeys; 78 finished the study. The animals were divided 
into 4 groups of 16 each and 1 group of 15 (vehicle control). Each monkey 
of three groups was given carbaryl in a gelatin capsule at 0.2, 2.0, or 20 
mg/kg/day from day 20 through day 38 of gestation; the fourth group was
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given empty capsules; the fifth group was not treated. All monkeys were 
mated and delivered naturally with the following results: the 0.2 mg/kg 
group had 14 live births and 2 abortions; the 2.0 mg/kg group had 15 live 
births and 1 abortion; the 20.0 mg/kg group had 12 live births, 3 
abortions, and 1 was not pregnant; the vehicle control group had 13 live 
births, and 2 abortions; the untreated control group had 13 live births, 2 
abortions, and 1 stillborn. No terata were found. The authors concluded 
that carbaryl was not teratogenic, that it was not associated either with a 
high incidence of abortion or stillbirth or with abnormal gestation length 
or mean body weight, and that it did not have any adverse effect on adult 
females or surviving Infants. Microscopic examination of the tissues of 
the young monkeys which died was not performed.
Weil et al [70] reported a study of the teratogenic potential of 
dietary carbaryl in rats. After mating, pregnant rats were assigned at 
random to one of three treatment schedules: (1) carbaryl in the diet
throughout pregnancy or until weaning of the pups; (2) carbaryl in the 
diet from days 1 to 7 of pregnancy; and (3) carbaryl in the diet from days 
5 to 15 of pregnancy. Females for each of the three treatment schedules 
were randomly assigned to three groups of six rats each and administered 
20, 100, or 500 mg/kg of carbaryl. Six rats were assigned to the control 
group. Neither fertility nor gestation was affected by carbaryl in the 
diet. However, at the dose of 500 mg/kg until weaning, 2/3 of the pups 
died within 4 days after birth. The viability of pups in the other treated 
groups was not significantly affected. The mean body weights of the pups 
from control and treated dams were similar, although the adult female rats 
and their pups that received 500 mg/kg of carbaryl during pregnancy and
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nursing weighed less than did the control dams and pups at time of birth. 
No gross or teratogenic anomalies associated with carbaryl treatment were 
found in the pups weaned at 21 days of age. Six adult rats of each of the 
nine treatment groups and one control group were killed on days 19-21 of 
their pregnancies. The uteri were examined for resorption sites and for 
dead and living pups. Gross and microscopic examination revealed no 
significant abnormalities attributable to carbaryl in the 709 fetuses 
examined. The poor survival of the rat pups allowed to nurse may have been 
related to the excretion of carbaryl or its metabolites in the milk and to 
the greater sensitivity of young rats to carbaryl, or it may have been 
related to the inability of the dams treated with carbaryl at 500 mg/kg to 
successfully nurse and rear their young, as indicated by their limited body 
weight gains.
The teratogenic potential of carbaryl has also been investigated in 
various other species of animals. Robens [71] administered carbaryl to 
guinea pigs daily in gelatin capsules on days 11-20 of gestation at a dose 
of 300 mg/kg. This resulted in 38% mortality in 26 pregnant dams, as 
compared with no deaths in control guinea pigs given empty gelatin 
capsules. Fetal mortality was 17.5% in the litters of surviving treated 
dams and 9.5% in control litters. There were 11 terata among the fetuses 
of these treated dams. The changes included skeletal defects, most of 
which involved the cervical vertebrae. Carbaryl was also administered as a 
single-dose treatment of 300 mg/kg to another group of 40 guinea pigs, some 
(number not specified) of which received their single doses between days 11 
and 20 of gestation. Maternal mortality for this group was 12.5%; and 
fetal mortality was 6.5%, which was below that for the control group
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(9.5%). All nine malformed fetuses were produced in the litters of dams 
treated on days 12, 13, 14, 15, and 16. Eight of the nine had vertebral 
malformations, and two revealed organ agenesis. One of the two
malformations in control fetuses was dental, the other vertebral. The 
mortality of the adult females in all groups which produced terata, was 
greater than in the controls. Robens [71] stated that the doses required 
to produce terata in guinea pigs were at least 1,000 times the level of 
carbaryl allowed in human food. This study [71] was one of those listed in 
the Registry of Toxic Effects of Chemical Substances [14] as showing 
teratogenic effects, and will be further discussed later.
Oral administration [71] of carbaryl in gelatin capsules at doses of 
50, 100, and 200 mg/kg to four, four, and nine pregnant rabbits,
respectively, on days 5-15 of gestation produced neither terata nor dose- 
related fetal mortality, as compared to the results from 21 pregnant 
control does. The author indicated that signs of cholinesterase inhibition 
did not occur following any dose of carbaryl used in this study.
Carbaryl was administered by stomach tube to pregnant hamsters [71] 
on days 6, 7, and 8 of gestation at a dose of 125 mg/kg, or on day 7 or 8
at 250 mg/kg. Two of six hamsters treated with one dose of 250 mg/kg of
carbaryl died, none of the eight hamsters given 125 mg/kg died, and none of 
the controls. Signs of cholinesterase inhibition (salivation, diarrhea, 
and incoordination) were observed in all treated hamsters. Fetal mortality 
was 30.3% at the high dose (250 mg/kg), 10.0% at the low dose (125 mg/kg), 
and 5.5% in the controls. No anomalies were found in any of four fetuses 
examined from each litter. The results show that, among the species 
studied, [71] terata were produced only in guinea pigs and by doses which
also caused mortality and morbidity in some of the dams. Also, since only 
one level was used in the single- and multiple-dose guinea pig studies, no 
conclusions of dose-related significance can be made.
In another study by Weil et al, [72] 300 pregnant guinea pigs in 
groups of 5 or 10 were administered doses of 100, 200, or 300 mg/kg of
carbaryl by dietary inclusion, or 50, 100, or 200 mg/kg by gastric
intubation, for 1-, 2-, 3-, 5-, or 15-day intervals during days 10-24 of 
gestation and were killed prior to parturition on day 34 or 35. Two 
control groups of 10 and 30 guinea pigs were treated in the same manner as 
the dietary- and gavage-treated guinea pigs, respectively. Body-weight 
gains for all guinea pig dams treated on days 12, 13, 14, 15, and 16 were 
less than those of the control animals, and this effect was more marked in 
intubated than in diet-treated guinea pigs at the same dose. Fewer 
carbaryl-gavaged than control-gavaged pregnant guinea pigs died. Dietary 
carbaryl produced no dose-related incidence or significant numbers of 
terata, as compared with controls. Oral intubation of carbaryl at 50 mg/kg 
to pregnant guinea pigs on days 10-24 of gestation produced 15.7% fetal 
skeletal anomalies compared with 9.1% for control pups, while doses of 100 
and 200 mg/kg resulted in 5.4 and 8.3%, respectively. The authors [72] 
contrasted their results with those of Robens [71] and Shtenberg and 
Ozhovan [73] (discussed later in this section) who used gastric intubation 
as the route of administration, thereby causing greater toxicity than when 
compounds are incorporated in food. Weil et al [72] concluded that a 
carbaryl dose of 300 mg/kg in the diet or 200 mg/kg by intubation did not 
result in teratogenic effects in guinea pigs. They questioned whether the 
material used in the USSR study [73] was sufficiently pure. Argauer and
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Warthen [74] have subsequently shown contamination of samples of carbaryl 
manufactured outside the United States (see later discussion in review of 
Carcinogenesis).
Benson et al [75] investigated the teratogenic potential of carbaryl 
in mice. Carbaryl was administered in the diet at levels of 10 or 30 mg/kg 
to groups of 20 pregnant mice from day 6 of gestation until birth of the 
pups. Twenty untreated females served as controls. The treated and 
control adults did not differ in mortality, behavior, physical condition, 
resorptions, or fetal deaths. The fetuses from treated dams did not differ 
from control fetuses in mortality and weight, but nine so-called minor 
fetal abnormalities in two litters occurred at the high dose (30 mg/kg), 
compared with two for the controls. The authors concluded that, because of 
the small incidence of abnormalities (6% at 30 mg/kg vs 2.1% in controls) 
and the lack of a consistent pattern in those found, the abnormalities were 
not related to administration of carbaryl. Lack of sufficient detail in 
their report makes an analysis for an independent evaluation impractical. 
However, lack of graded response in various abnormalities reported, at 
doses of 0, 10, or 30 mg/kg, supports their conclusion.
Vashakidze [76] carried out a 3-month study on rats at oral doses of 
50, 100, and 300 mg/kg to measure the reproductive effects of what was 
described as Sevin powder. At doses of 100 and 300 mg/kg administered to 
female rats, there was a disruption in the sexual cycle reported as a 
decreased frequency or absence of estrus, proestrus and diestrus as well as 
elongation of the latter two phases. At the same doses, treated females 
Impregnated by untreated males were reported to have reduction in litter 
size and prolonged pregnancy with what was described as deformation of the
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womb. Autopsy showed embryos either dead or at various stages of 
development. The author reported that 50 mg/kg of the compound 
administered during organ differentiation, which was reported to be on the 
9th or 10th day of development, caused developmental disorders. These 
disorders were explained in the study as either the death or cessation of 
development of the embryo. At unspecified doses, males were reported to 
show decreased sperm motility and deformed spermatozoa. At 300 mg/kg, 
treated males were unable to impregnate untreated females. It is not 
possible from the study described by Vashakidze [76] to determine either 
the purity or chemical composition of the material administered to rats 
that was described by the author as Sevin powder or the method of oral 
administration. Since the study was purely descriptive with no data 
presented, the results cannot be adequately evaluated. This study, 
unevaluated, was one of those listed in the Registry of Toxic Effects of 
Chemical Substances [14] as showing teratogenic effects.
Shtenberg and Rybakova [77] administered carbaryl described as 100% 
active material orally at doses of 7, 14, and 70 mg/kg to groups of 24 rats 
of each sex for periods of up to 12 months. A group of equal size received 
no carbaryl. The method of administration, whether by dietary inclusion or 
by stomach tube, is not clear from the text description. When compared 
with control rats, growth was inhibited in those receiving 14 and 70 mg/kg 
of carbaryl, but not in those receiving 7 mg/kg. Cholinesterase activity 
in blood as measured by acetylcholine-hydrolysis time was decreased in the 
14 mg/kg and 70 mg/kg groups from the third month (first determination) 
until the end of the study. After 12 months of treatment, there was a 
dose-related decrease in spermatozoal motility at all doses. Microscopic
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examination of the testes showed edema of interstitial tissue, destruction 
of germinal epithelium, and reduction in spermatocytes and spermatids. In 
females, the estrus cycle was prolonged by an increase in length of the 
diestrus phase at the 14 mg/kg and 70 mg/kg doses. All groups of carbary1- 
treated rats showed an increase in gonadotropic hormone production in the 
hypophysis as determined by tests on immature mice. Decreased thyroid 
activity was indicated by a reduction in the absorption and excretion of 
131-1. When examined microscopically, the cortex of the adrenal glands 
also showed evidence of increased activity in the zona glomerulosa and zona 
fasciculata. The authors suggested that the primary site of action was 
probably the anterior pituitary which caused secondary changes in the 
reproductive glands; however, a direct effect of carbaryl on the
reproductive glands was not ruled out.
Collins et al [78] studied the effects of carbaryl on the
reproductive cycle in a three-generation reproduction study in rats. 
Carbaryl (technical grade, 99% purity) was administered by incorporation 
into the diet at levels of 0, 2,000, 5,000, and 10,000 ppm and was
continued throughout the study. Groups of 20 pairs of weanling rats at 
each dose plus the same number of untreated controls were mated at 100 days 
of age. Two litters (Fla and Fib) were produced from each pair. Animals 
from the first litter (Fla) were reared to weaning and then killed. Those 
from the second litter (Fib) were raised to weaning and 20 littermate pairs 
were selected to produce the next generation. The same procedure was 
followed until two litters had been produced for each of three generations 
(Fla, Fib, F2a, F2b, F3a, and F3b). All the rats of the third generation 
(first and second litters) were killed at weaning. The authors stated that
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microscopic studies of the rat tissues were not performed. The ability of 
the female rats to produce young (fertility) was decreased only at the 
10,000-ppm level. No litters resulted from the second mating of the second 
generation at this dose; therefore, no third generation was produced. The 
viability of the pups from dams treated at 5,000 and 10,000 ppm was 
significantly decreased. The average litter size and survival of offspring 
until 4 and 21 days of age were significantly decreased in a dose-related 
manner at both the 5,000-ppm and 10,000-ppm dietary levels. Mean weanling 
body weights at all carbaryl dose levels were significantly lower than 
those of control young and showed a dose-related suppression. The 
decreased fertility in rats on the highest dose was suggested by the 
authors as possibly due to an effect of carbaryl on sperm motility and the 
enzymatic activity of testes and ova, and mediated indirectly through 
effects on the hypothalamohypophyseal complex. The authors also suggested 
that the decreased survival rate of the 1- to 4-day-old pups, especially at 
the two higher doses, appeared to result from an increased susceptibility 
of the pups to metabolic damage from carbaryl treatment. Collins et al 
[78] concluded that the no-effect level for carbaryl was below 2,000 ppm.
A three-generation study of similar design was conducted in rats by 
Weil et al. [72] This study design differed from that of Collins et al 
[78] in that offspring of the first mating of the third generation (F3a), 
when killed at 21 or 90 days of age, were examined for tissue changes. The 
female rats used to produce the second litter of the third generation (F3b) 
were killed at day 18 or 19 of the second gestation period; examination of 
the uterine contents for viable or dead fetuses, resorption sites, fetal 
weight, and skeletal or soft tissue anomalies of the fetuses was performed
as in teratogenic studies. Some males of the second generation (F2a) were 
removed from treatment at 224 days of age and mated for 10 consecutive 
weeks to virgin females that had never received carbaryl, to test for 
dominant-lethal mutagenicity. The possible differences between gastric 
intubation versus dietary inclusion were also compared in this study. The 
dose levels for those rats treated by intubation were 0, 3, 7, 25, and 100 
mg/kg, while the doses given in the diet were 0, 7, 25, 100 (also 100 in 
corn oil), and 200 mg/kg. Carbaryl at a level of 100 mg/kg by oral 
intubation produced signs of cholinesterase inhibition and increased 
mortality of parents at all breeding periods; it decreased the number of 
pups born alive (Fla, F2a, F3a) and the percentage of females that produced 
litters (Fib only); it decreased the number of fetuses and of live fetuses; 
it increased the frequency of fetal resorption; it lengthened the gestation 
period of female rats yielding first generation, second litter (Fib); and 
it decreased the body weights of the original parents before the first 
mating. The lower doses (3, 7, and 25 mg/kg) of carbaryl by oral
intubation were without effect. The effects of 200 mg/kg of carbaryl
administered by inclusion in the diet were limited to an initial decrease
in body weight gain in the original rats and lengthened gestation periods 
of the first and second generations as compared with the controls. No 
signs of cholinesterase inhibition were observed at this dose level. The
authors reported that the teratogenic and dominant-lethal portions of the
study did not indicate any carbary1-related effects. The results of this 
study, and of the previously discussed guinea pig teratogenic study 
included in this paper, [72] suggested that, at equal doses, carbaryl 
administered by stomach tube can produce a more pronounced toxic effect
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than by dietary inclusion. This is probably due to the higher blood levels 
from the rapid absorption which can occur from gastric intubation.
Shtenberg and Ozhovan [73] gave carbaryl dissolved in sunflower oil 
perorally to rats (second (F2) through fifth (F5) generation) at doses of 2 
and 5 mg/kg. According to their written communication to Weil and 
coworkers, [72] this was administered by gastric intubation. A control 
group was maintained under similar conditions. The test material was 
administered to both sexes of each generation for 6 months, but the rats 
were paired for breeding after 4 months of treatment. Sperm motility and 
resistance (not defined), spermatogenesis, and duration of sperm survival 
(in a nutrient medium) were significantly reduced in male rats of both 
treated groups from the second to the fourth generation when compared with 
the controls. Microscopic examination of testicular tissue revealed What 
was described as dystrophic-atrophic changes in the nature of the 
spermiogenic epithelium. In both the third and fourth generations, the 
duration of estrus was decreased and the interestral period lengthened in 
rats after 3 months of 5 mg/kg carbaryl treatment; at 6 months, rats 
receiving 2 mg/kg carbaryl were similarly affected. Microscopic 
examination of ovarian tissue revealed what was called an atrophically 
sclerotic process in the follicles of carbaryl-treated females. The 
authors stated that the effect was seen to increase from generation to 
generation. The dose of carbaryl at which these tissue changes were seen 
was not specified. Fertility of the females (litter size) decreased 
progressively from the second through the fourth generations, the effect 
being dose related. Survival of the pups during the first month of life 
decreased as the dose of carbaryl was increased. The adverse effect on
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survival was seen to increase progressively from the third through the 
fifth generations. From the results of these studies, the authors 
concluded that carbaryl has a direct and negative influence on the 
reproductive glands.
Collins et al [78] conducted a three-generation study in Mongolian 
gerbils (Meriones unguiculatus). Carbaryl was administered in the diet at 
levels of 0, 2,000, 4,000, 6,000, and 10,000 ppm. No litters were produced 
from the second mating of the third generation (F3b) at the 10,000-ppm 
level. Adverse effects on fertility, litter size, pup viability, and 
survival to day 21 appeared sporadically in the second and third 
generations at carbaryl treatment levels of 2,000, 4,000, and 6,000 ppm, 
and in all generations at 10,000 ppm. Survival from day 4 to weaning was 
significantly decreased in all generations at doses of 4,000 ppm and above, 
while effects were seen in the second and third generations at 2,000 ppm. 
No grossly visible abnormalities were observed in any of the offspring. 
Microscopic examination (tissues not specified) revealed no changes. Mean 
weanling weights were variably lower in gerbils treated with 4,000 ppm or 
more of carbaryl.
(e) Carcinogenesis
Carpenter et al [27] investigated the lung cancer potential of 
carbaryl which was injected subcutaneously once a week into 60 male mice 
(tumor-susceptible A/Jax and C3H strains) during their third to eighth 
months of age, after which a gross examination only was made for lung 
tumors. Technical carbaryl was suspended in 0.25% agar at a concentration 
of 5.0%, and 0.2 ml was injected into each mouse, delivering a carbaryl 
dose of 10 mg/week to each mouse (or a dose of about 400 mg/kg/week in a 25
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g mouse). One control group received injections of 0.25% agar only, and 
another was untreated. The authors stated that males of the A/Jax strain 
have a high rate of spontaneous lung tumor. Under the conditions of the 
experiment, subcutaneous administration of carbaryl did not significantly 
increase the incidence of tumors, lung infection, or death in tumor- 
susceptible mice over that in the controls.
limes et al, [79] In a study of 120 compounds performed in 
conjunction with the National Cancer Institute, administered carbaryl to 
neonatal mice daily for about 18 months. The mice received the test 
material (4.64 mg/kg) by stomach tube on days 7-28 of age and thereafter in
the diet at a level stated to be equivalent to the amount ingested. A
total of 72 mice, 36 of each sex, composed the treatment group. Eleven of 
the compounds studied caused a significant elevation of tumors; 89 more
compounds, including carbaryl, gave no significant evidence of
tumorigenicity; the remaining 20 warranted, it was concluded, further 
evaluation. Further data on carbary1-treated mice were not supplied. The 
authors pointed out that there was no way to predict whether humans are 
more or less susceptible than mice to the induction of tumors by the 
compounds tested in this study. In addition, they indicated that the dose 
received by the mice was far in excess of that likely to be consumed by 
humans.
Andrianova and Alekseyev [80] administered carbaryl orally to 60 male 
mongrel rats at 30 mg/kg twice weekly for periods of up to 22 months 
(whether by incorporation into their diet or by intubation is not clear). 
Another 48 mongrel rats were treated by subcutaneous implantation of a 
paraffin capsule containing 20 mg of Sevin (carbaryl) 97.65% pure obtained
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from the Shchelkov Chemical Plant. The control group consisted of 48 male 
rats, but it was not stated whether they were sham-treated orally or had 
empty capsules implanted subcutaneously. Of the 12 surviving rats in the 
orally treated carbaryl group, 4 had tumors; there were 2 subcutaneous 
fibrosarcomas, 1 polymorphous cell sarcoma (the tumor grew into the stomach 
wall but did not affect the organs of the abdominal cavity), and 1
osteosarcoma. Of the 10 surviving rats in the subcutaneously treated 
group, 2 had subdermal tumors, both of them said to be fibrosarcomas, but
not at the implantation site. In the control group, 46 of 48 rats
survived, and only 1 had a tumor at 11 months, a fibrosarcoma at an 
unspecified location. Although the authors concluded that carbaryl could 
produce tumors in rats, the results of this study are not conclusive
because of the high mortality in the experimental group and the absence of 
information on how the controls were treated. This study [80] was listed, 
unevaluated, in the Registry of Toxic Effects of Chemical Substances [14] 
as showing carcinogenic effects. It will be further discussed and 
evaluated (see Correlation of Exposure and Effect and Chapter V, Basis for 
the Recommended Standard). As previously mentioned in the discussion of 
reproduction studies, Weil et al [72] have questioned the chemical purity 
of the carbaryl produced outside the United States. The following paper 
may partially answer the question. Argauer and Warthen [74] analyzed 
various samples of carbaryl (1-naphthyl methylcarbamate) for the presence 
of the contaminant 2-naphthyl methylcarbamate by using liquid and thin- 
layer chromatography with confirmation by spectrofluorometry. 
Contamination of carbaryl with the 2-naphthyl methylcarbamate can occur if 
the precursor 1-naphthol, used to synthesize the carbaryl, is not pure.
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The presence of the 2-naphthyl Isomer is undesirable since the compound has 
been reported to have caused cancerous tumors in rats and in mice when 
given orally or intravenously. [74] Of the four samples of carbaryl 
produced in the United States which were analyzed in this study, none 
contained a detectable amount of the 2-naphthyl contaminant. Each of the 
four samples produced in foreign countries contained measurable amounts 
(2.3 and 14 mg in the 250-mg technical samples; 1.3 and 12.4 mg in the 500- 
mg samples of 50% wettable powder) of the 2-naphthyl isomer measured as 2- 
naphthol in a previously hydrolyzed sample. In the previously cited paper 
by Carpenter et al, [27] there was no dose-related incidence of tumors or 
increase in tumors over the controls in rats given US-manufactured carbaryl 
in the diet at levels of 50, 100, 200, and 400 ppm for 2 years.
Shlmkin et al [81] synthesized N-methyl naphthyl carbamate and 
compared it to 21 other carbamates, one of which was ethyl carbamate, a 
known carcinogen, by a sensitive, pulmonary-tumor-induction bioassay method 
in Strain A/He mice from the National Cancer Institute. The compound was 
administered ip to 16 mice at 0.5 mg 3 times weekly for 4 weeks; the total 
dose to each mouse was 6.0 mg (1,190 pmoles/kg). Three control groups of 
mice (32 in each group) were Injected with water or the vehicle tricaprylin 
or were untreated. The experiments were terminated 20 weeks after the last 
injection by killing the animals. The lungs were examined microscopically 
for tumors. While several of the carbamates were actively tumorigenlc 
(ethyl carbamate, most active; methyl carbamate, inactive), the synthesized 
N-methyl naphthyl carbamate was classed as marginal. Two important points 
need to be emphasized concerning the compound described In the study of 
Shlmkin et al [81] as N-methyl naphthyl carbamate. First, there is a lack
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of information on the purity of this specially synthesized compound, and, 
secondly and more importantly, it is not clear from the structural formula 
presented whether the compound was 2-naphthyl N-methylcarbamate or 1- 
naphthyl N-methylcarbamate (carbaryl). Therefore, it is difficult to draw 
any conclusion as to the potential for carcinogenicity of carbaryl from 
this study. In a study using Ehrlich ascites tumor cells, injected 
intraperitoneally, Walker et al [82] determined that carbaryl, also 
injected ip, produced a moderate but significant inhibition of tumor growth 
in vivo in mice. The authors also found that carbaryl "reduced 
appreciably" the rates of incorporation of the isotopically labeled 
precursors, uridine-5-3H, thymidine-methyl-3H and L-leucine-14C into 
ribonucleic acid, desoxyribonucleic acid, and protein, respectively, in 
Ehrlich ascites tumor cells, in vitro.
(f) Absorption and Metabolism
Hwang and Schanker [83] studied the absorption of 14C-labeled 
carbaryl by the intestine and the lung in rats. They instilled 0.1 ml of a 
(0.025-0.05 mM 14C-labeled carbaryl) test solution into a tightly secured 
tracheal cannula (at the tracheal bifurcation) in 12 anesthetized rats. At 
the end of 2, 4, and 6 minutes, the lungs were removed, processed, and
analyzed by liquid scintillation for the recoverable 14C-labeled material. 
The entire small intestine was isolated in 15 rats and 1 ml of a 0.005-0.1 
millimolar 14C-labeled carbaryl aqueous solution was injected into the 
lumen of the small intestine. At 2, 4, 6, 8, and 10 minutes, the
intestines were removed and the unabsorbed 14C label was recovered and 
measured by liquid scintillation. By plotting the measured amounts 
recovered at the various times, it was determined that the absorption half-
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time for the lungs of rats was 2.6 minutes and for the intestine 6.4 
minutes. By varying the known concentration of the carbaryl solution, the 
investigators determined that 14C-labeled carbaryl crosses the wall of the 
rat intestine by simple diffusion. The authors indicated that absorption 
through the lung was much more rapid than through the intestine and also 
appeared to occur by a process of simple diffusion.
Casper et al [84] examined the gastric absorption of 14C-labeled 
carbaryl in the isolated (empty) stomachs (with portal circulation intact) 
of an unspecified number of rats and found about 53% and 82% of the 14C 
label in the portal blood in 22 and 67 minutes, respectively. The authors 
verified the identity of the 14C material in the portal blood using several 
analytical techniques (chromatography and infrared spectroscopy) and 
concluded that approximately 90% of the labeled material found in the 
portal blood was 14C-labeled carbaryl. They concluded that carbaryl could 
be rapidly absorbed from the stomach in the fasting rat, but that
absorption would be expected to be retarded by the presence of additional
gastric contents.
In a percutaneous absorption study, Hurwood [85] studied the carbaryl 
residues in selected tissues (liver, kidney, muscle, and omental and 
perirenal fat) of steers and in the milk of cows. Fourteen steers were 
used in the study. Six steers were sprayed once and six were sprayed three 
times, at 2-day intervals, with 2 gallons of 0.3% carbaryl as a colloidal 
dispersion in water. Two untreated steers served as controls. Two animals 
from each group were killed at 1, 3, and 7 days after application of the 
spray for tissue analysis to detect any carbaryl residue. Perirenal fat
from the steers was found to have the highest concentration in the tissues
77
examined 1 day after treatment. All tissue examined had some carbaryl 
residue 3 days after treatment. However, no detectable tissue residue was 
present in the steers' tissues after 7 days. Each of three dairy cows was 
sprayed once with 2 gallons of the 0.3% carbaryl spray, and milk samples 
were analyzed from both daily milkings for the next 5 days. Carbaryl was 
found in the greatest concentration at the first milking, 5 hours after 
spraying. It was excreted in the milk for at least 69 hours but was not 
found in milk taken 77 hours after spraying the cows.
Bukin and Filatov [86] studied the tissue distribution of carbaryl 
and its metabolites in rabbits. Carbaryl was administered in single oral 
doses ranging from 100 to 700 mg/kg. No clinical signs were observed and 
no carbaryl was found in the organs or tissues at autopsy, 24-80 hours 
after carbaryl treatment at 100, 200, or 300 mg/kg . After single doses of 
400 mg/kg, an unspecified number of rabbits were killed at various 
intervals, and tissues, bile, and urine were analyzed for carbaryl. 
Residual amounts of carbaryl determined by paper chromatography are listed 
in Table XIII-3. At doses of 600 and 700 mg/kg, residual carbaryl ranged 
from 0.075 to 1.2 mg/kg in all organs and tissues examined; the time of 
examination was not reported however. The high dose (700 mg/kg) was fatal 
to all rabbits. These results suggest rapid excretion and little long-term 
retention of carbaryl in rabbits.
Carpenter et al, [27] in their 1961 report on the effects of carbaryl 
in mammals, established that approximately 31.3 ± 1.6% of the 1-naphthol 
portion of an orally administered dose of 0.015 g of carbaryl to each of 18 
rats was recovered from their urine in 48 hours as a conjugated form, 
probably as the glucuronlde.
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In a study by Knaak et al, [34] carbaryl labeled with carbon-14 at 
various moieties, including the naphthyl (naphthyl-labeled), methyl 
(methyl-labeled) and carbonyl (carbonyl-labeled) moieties, was administered 
by gavage to three groups of four rats each. One group received 20.0 mg/kg 
each of methyl-labeled carbaryl; another group of four received 20.0 mg/kg 
each of naphthyl-labeled carbaryl; and the third group received 9.0 mg/kg 
of carbonyl-labeled carbaryl. The average total amount of labeled carbaryl 
which was detected and measured by a scintillation spectrometer from all 
sources— urine, feces, expired air (carbon dioxide), and carcasses— waB 94% 
over a 7-day period. However, the authors stated that the excretion of 
carbaryl was essentially complete by the end of 3 days. Ninety-five 
percent of the naphthyl-labeled compound was detected in urine and feces; 
99% of the carbonyl-labeled compound was found in urine, feces, and 
respiratory carbon dioxide; and approximately 91% of the methyl-labeled 
carbaryl was detected in urine, feces, carbon dioxide, and carcasses of the 
rats.
In the same publication, [34] the authors reported on administration 
of carbaryl ip to three groups of three 150-g male rats as naphthyl- 
labeled, methyl-labeled, or carbonyl-labeled carbaryl. Each rat was 
administered 3.0 mg of the appropriate labeled material in 300 mg of 
polyethylene glycol 400. The naphthyl- and methyl-labeled carbaryl were 
also administered ip at the same doses to three 200-g guinea pigs of 
unstated sex. From 24-hour pooled specimens of rat urine, 73, 47, and 48% 
of the naphthyl-, methyl- and carbonyl-labeled compounds, respectively, 
were recovered as carbaryl equivalents. Guinea pig urine, also 24-hour 
pooled specimens, yielded 85% of the total amount of naphthyl- and methyl-
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labeled carbaryl administered. The urinary metabolites of the rat and 
guinea pig were identified from chromatographs. From those determinations, 
the authors showed that carbaryl, in the rat and guinea pig, is transformed 
into a series of eight or more metabolites. The major metabolites in this 
series were two glucuronides, the 4 (methyl carbamoyloxy)-l-naphthyl 
glucuronide also known as 4-hydroxycarbaryl glucuronide and the 1-naphthyl 
methylimidocarbonate-O-glucuronide. Hydrolyzed products were also present; 
the glucuronide and the sulfate of 1-naphthol were detected in both rat and 
guinea pig urine after administration of the naphthyl-labeled carbaryl. 
The 1-naphthyl methylcarbamate N-glucuronide was present in guinea pig 
urine only after administration of either naphthyl- or methyl-labeled 
carbaryl. Table XIII-4 lists the metabolites found in rat and guinea pig 
urine with those of other mammals for comparison. Unidentified neutrals 
and other unidentified metabolites were found in excretions of both rats 
(one group, A) and guinea pigs (two groups, A and B). The investigators 
also found evidence that carbaryl could have been conjugated directly with 
glucuronic acid to form 1-naphthyl methylcarbamate N-glucuronide and 1- 
naphthyl methylimidocarbonate-O-glucuronide.
The in vitro metabolism of carbaryl by rat and guinea pig liver 
preparations was investigated in the same study. [34] Naphthyl-labeled 
carbaryl was incubated with fortified liver homogenates or microsomal 
preparations obtained by differential centrifugation. Metabolites formed 
by both rat and guinea pig liver preparations included 1-naphthyl 
glucuronide, 4-hydroxycarbaryl, 4-hydroxycarbaryl glucuronide, and 
unidentified water-soluble neutrals. The formation from carbaryl of 1- 
naphthyl, 1-naphthyl methylimidocarbonate-O-glucuronide, and 4-hydroxy-l-
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naphthyl methylcarbamate was observed with rat, but not with guinea pig, 
liver preparations. These studies indicate a metabolic profile similar to 
that seen in the urinary excretion studies with carbaryl.
The metabolism of carbaryl in the dog was reported by Knaak and 
Sullivan. [87] Two forms of carbaryl, labeled with carbon-14 at either the 
naphthyl or methyl moiety, were separately and sequentially administered 7 
days apart, in gelatin capsules to three female beagles weighing 9 kg each 
in doses of 25 mg/kg. Urine and feces were collected daily for 7 days and 
analyzed for 14C by liquid scintillation counting techniques. Although 
similar techniques for detection were used, those metabolites found in rats 
and in most other mammals were not present in dog urine (Table XIII-4). 
The beagles did not seem to be able to excrete unconjugated 1-naphthol or 
hydroxylate carbaryl. However, it probably can form naphthyl glucuronide 
and sulfate, and it does seem to be able to conjugate carbaryl directly. 
The only other metabolite found in dog urine was 1-naphthyl 
methylimidocarbonate-o-glucuronide. The dog also differs from the rat in 
the route and quantity of excretion. Almost half the total carbaryl 
equivalents excreted by the dog were found in the feces and were accounted 
for by the naphthyl label, whereas only about 10% were found in the rat 
feces. [34] Rat urine yielded about 68% [34] and dog urine about 23% [87] 
of the dose as the methyl label.
Knaak et al, [33] using techniques similar to those they used in 
studies of other mammals, [34,87] examined fecal and urinary metabolites in 
two young female swine weighing 14.5 and 18 kg. [33] One animal was given 
methyl-labeled carbaryl and the other naphthyl-labeled carbaryl at doses of 
25 mg/kg in gelatin capsules. Urine and feces were collected over a 5-day
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period. The pigs excreted 83.4 and 1.6% of the naphthyl label in urine and 
feces, respectively, and 7 0 and 1.0% of the methyl label in urine and 
feces, respectively. Two major metabolites, 1-naphthyl
methylimidocarbonate-o-glucuronide and 4(methylcarbamoyloxy)-1-naphthyl
glucuronide, were identified. In addition, several unidentified 
metabolites and 1-naphthyl glucuronide from the naphthyl label were 
obtained. Swine metabolites are listed with others in Table XIII-4. In
the same report, [33] the metabolism of carbaryl in sheep was described.
One 42-kg ewe was given a dose of 25 mg/kg of naphthyl-labeled carbaryl 
orally in gelatin capsules; 2 weeks later a similar procedure was used to 
administer methyl-labeled carbaryl. Three major metabolites excreted were
1-naphthyl methylimidocarbonate-o-glucuronide, 4 (methylcarbamoyloxy)-1-
naphthyl glucuronide, and 1-naphthyl sulfate. The two metabolites having 
only the naphthyl label were 1-naphthyl glucuronide and the sulfate. The 
sheep metabolites are listed with others in Table XIII-4.
One female rhesus monkey weighing 4.6 kg was orally administered
labeled carbaryl at a dose of 300 mg/kg, in two phases. [33] In the first 
phase, the naphthyl-labeled form was ingested, and, in the second phase 4 
days later, the methyl-labeled form of carbaryl was administered. The 
monkey excreted in the urine two major metabolites: 1-naphthyl
methylimidocarbonate-o-glucuronide and 4 (methylcarbamoyloxy)-1-naphthyl
glucuronide. Small quantities of the sulfate-conjugated naphthyl and
4-hydroxycarbaryl were excreted in monkey urine. The monkey metabolites 
are listed in Table XIII-4.
In Effects on Humans, the results of studies by Knaak et al [33] on 
the urinary metabolites of carbaryl in two men were discussed. The men,
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weighing approximately 81 and 86 kg, ingested carbaryl in gelatin capsules 
at doses of 2 mg/kg. Urine was collected before administration, for 
control determinations, and for 4 days after administration. Only 26-27% 
of the dose was accounted for in the composite 4-day urine collected from 
the two men. The following were identified from the urine specimens: 1-
naphthyl glucuronide and sulfate, and conjugates of glucuronic and sulfuric 
acids, 4-(methylcarbamoyloxy)-l-naphthyl glucuronide. The human 
metabolites are presented in Table XIII-4 for comparison with six other 
mammals.
In view of the possible relevance of the metabolism of carbaryl with 
respect to its teratogenic potential in various mammalian species, it is 
important to identify those species that metabolize the compound similarly 
or dissimilarly to humans. The results of the preceding studies on the 
metabolism of carbaryl in human beings, rats, guinea pigs, sheep, monkeys, 
swine, and dogs [33,34,87] show that the similarity of metabolic products 
allows these species, with the exception of the dog, to be divided into two 
groups: in the first, humans, rats, guinea pigs, and sheep, and in the 
second, monkeys and swine. Low doses of carbaryl were reported [66] to 
cause teratogenic effects in the beagle dog. (See previous discussion of 
reproduction studies.) However, unlike humans, the beagle does not excrete 
1-naphthol nor does it hydroxylate carbaryl. Carbaryl was not found to be 
a teratogen in monkeys [67,69] and rats, [70] but in one study carbaryl 
produced terata in guinea pigs at very high doses, [71] while in another 
study of the same species using moderately high doses carbaryl was not 
found to be teratogenic. [72] Present studies show that the metabolism of 
carbaryl in the dog differs from that in humans, monkeys, rats, and guinea
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pigs, so it is unwarranted now to extrapolate from dogs to humans regarding 
the teratogenic potential of carbaryl.
The excreted metabolites identified in rats, humans, and guinea pigs 
[34]; in monkeys, swine, sheep, and humans [33]; and in the dog [87] have 
been summarized in Table XIII-4 so that the metabolic pathways of carbaryl 
in several species may be compared.
Correlation of Exposure and Effect
Carbaryl, a methyl carbamate compound, has anticholinesterase 
properties. [5] Therefore, regardless of its route of entry, once 
absorbed, it can induce signs and symptoms of toxicity by causing an 
increase of acetylcholine at its sites of action in the central, autonomic, 
and peripheral nervous systems. This increase in acetylcholine is a
consequence of the inhibition of acetylcholinesterase, the enzyme which 
hydrolyzes acetylcholine. [2,5] The relationship of the inhibition of 
cholinesterase in plasma and erythrocytes to the inhibition of 
acetylcholine in the nervous system and at other sites of action has not 
been clearly established.
Evaluation of the available information suggests that carbaryl may be 
absorbed after oral ingestion, [40,41] during exposure to airborne
concentrations, [28] or upon direct dermal contact. [30,31] The signs and 
symptoms observed as a consequence of exposure to carbaryl in the workplace 
are clearly manifestations of excessive cholinergic stimulation, and thus 
Inhalation or dermal exposure resulted in the following signs and symptoms: 
nausea and dizziness, headache, perspiration [13 (sec 7)]; headache,
nausea, vomiting, mild abdominal cramping, dimness of vision [13 (sec 13)];
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skin rash [35]; and weakness, dizziness, and difficulty in breathing. [38] 
Oral ingestion, usually unrelated to occupational exposure, has resulted in 
the following signs and symptoms, most of which are also due to excessive 
cholinergic stimulation: miosis, excessive salivation, and incoordination
[28]; epigastric pain, sweating [21]; disturbed vision, and pulmonary edema 
[40]; nausea, vomiting, hyperreflexia, pallor, intestinal colic, nasal 
discharge, salivation, headache, lacrimation, and tremors [41]; difficulty 
in sleeping, and abdominal cramping. [32] Overexposure to carbaryl in the 
workplace environment apparently results in a rapid onset of symptoms which 
causes voluntary cessation of work and termination of exposure. [13 (sec 
13),20] In addition, employees who have been overexposed to carbaryl in 
the workplace apparently recover rapidly. [13 (sec 7,13)]
Animal studies have indicated that absorption of carbaryl by the 
lungs, [83] intestine, [83] and stomach [84] is fairly rapid. The 
characteristics of the urinary metabolites encountered in both humans 
[33,34] and animal species [33,34,87] would indicate that the liver is the 
primary site for metabolizing carbaryl after its absorption by various 
routes. Support for this hypothesis is found from in vitro studies [34] 
using carbaryl incubated with rat and guinea pig liver preparations which 
resulted in the formation of metabolites almost identical to those observed 
in the urine of animals treated with carbaryl.
Several studies by Knaak and coworkers [33,34,87] compared metabolic 
processes of carbaryl in seven mammals, namely rat, guinea pig, dog, swine, 
sheep, monkey, and human. Table XIII-4 lists the various metabolites and 
the means by which they were detected. It was concluded [87] that the dog 
(beagle) probably conjugates carbaryl and excretes much of the degradation
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products in the feces, unlike most of the other species, in which the urine 
is the major excretory route. Most of the other mammals hydrolyze and 
hydroxylate, as well as conjugate, carbaryl before excretion. From the 
studies of Knaak and coworkers, [33,34,87] humans, rats, guinea pigs, and 
sheep metabolize carbaryl in one manner, monkeys and swine in another, and 
dogs in a third. One metabolite which appeared in the urine of all 
species, except the dog, was conjugated 1-naphthol [33,34,87] which might 
be useful in assessing carbaryl exposure. [13 (sec 7,9,10),28,32-35]
Best and Murray [28] observed 59 employees during a 19-month period 
in a carbaryl-manufacturing plant where airborne concentrations of carbaryl 
ranged from 0.03 to 40 mg/cu m. Their report indicated that relatively 
large quantities of 1-naphthol were excreted in urine, that blood 
cholinesterase activity was either within the normal range or slightly 
inhibited, and that at no time did any of the employees studied have 
clinical or subjective evidence of increased acetylcholine activity. 
However, the methods used to determine cholinesterase activity in this 
study probably underestimated the degree of cholinesterase inhibition.
Williams [13 (sec 10)] reported only limited data suggesting that 
airborne concentrations of carbaryl around 50 mg/cu m during an approximate 
8-hour workday did not produce symptoms of toxicity if the workers were 
provided either respiratory or dermal protective equipment. The report of 
Yakim [39] indicated that reductions in blood cholinesterase activity 
occurred following 4- to 6-hour exposures of workers for 3-4 days to an 
average airborne carbaryl concentration of 2 or 4 mg/cu m. He did not 
adequately describe how he measured the airborne concentrations or the 
method used to determine cholinesterase activity. At these concentrations
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and durations of exposure, no symptomatic changes due to anticholinesterase 
activity were reported by the author. It is apparent from the literature 
reviewed that the airborne carbaryl concentration at which significant 
signs and symptoms may first appear in humans has yet to be determined. 
Vandekar [35] observed no adverse effects when sprayers and 95 villagers in 
Nigeria were exposed to carbaryl from an application of a 5% solution in 
their dwellings.
Several inhalation studies [27,39] on animals exposed to airborne 
carbaryl have been conducted. Carbaryl at a concentration of 390 mg/cu m 
has been shown to produce nasal and ocular irritation in guinea pigs upon 
4-hour exposure. [27] Exposure concentrations of 63 mg/cu m in cats [39] 
and 75 mg/cu m in dogs [27] produced signs of cholinesterase inhibition 
within 2-5 hours of exposure. Rats exposed to carbaryl dust in air at an 
average concentration of 10 mg/cu m (5-20 mg/cu m) for 7 hours/day, 5 
days/week, for 90 days did not show any grossly visible changes, and all 
the animals survived. [27] Microscopic examination of several tissues 
including lung taken from these animals revealed no carbary1-associated 
lesions. Yakim [39] exposed four cats at an airborne carbaryl 
concentration of 63 mg/cu m for 6 hours/day for a month. Cholinergic 
stimulation, indicated by periodic salivation, was observed during the 
first 2 hours of exposure each day. Exposure at an average concentration 
of 40 mg/cu m for 6 hours/day for 2 months produced some deterioration in 
conditioned reflexes of the cats. No further information was given. No 
signs of toxicity were observed upon exposure of cats for 4 months (6 
hours/day) at a concentration of 16 mg/cu m, while at 40 mg/cu m 
erythrocyte cholinesterase activity dropped to 50% or less. The method for
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determining cholinesterase activity was not disclosed. [39] The above 
studies [27,39] indicate that typical signs of cholinergic stimulation are 
evident at airborne concentrations of 63 and 75 mg/cu m in the cat and dog, 
respectively, while exposure at 16 mg/cu m appears to constitute a no­
effect level with respect to toxic manifestations of cholinesterase 
inhibition in the cat. [39]
Dermal absorption of carbaryl has been investigated in both humans 
and experimental animals. In two dermal absorption studies on humans, 
[30,31] approximately 74 and 70% of 14C-labeled carbaryl were recovered 
from urine within 5 days after application of carbaryl in acetone to the 
skin of the forearm and of the face near the angle of the jaw, 
respectively. In another study [13 (sec 9,10)] comparing absorption after 
inhalation and dermal exposure in humans, two employees in a plant 
manufacturing carbaryl were exposed at approximately the same airborne 
concentrations on each of 2 days. Employee A was protected from skin 
contact but not from inhalation of carbaryl; employee B was protected from 
airborne carbaryl but not from carbaryl contact on his arms and hands. 
Measurement of 1-naphthol (a carbaryl metabolite) in control and 
postexposure urine revealed that the concentration of urinary 1-naphthol 
excreted by employee A was over 3,600 and 2,400 /¿g/100 ml and by employee B 
over 7,000 and more than 500 pg/100 ml, on days 1 and 2, respectively, thus 
indicating that, under similar exposures, lungs and skin readily absorb 
carbaryl. No topical reactions have been reported in humans except for a 
single case [35] of a rash of uncertain cause associated with carbaryl 
exposure, and no dermal irritation has been reported in carbary1-treated 
experimental animals when carbaryl was directly applied. [27,39] A slight
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degree of local eye Injury and necrosis has been found In rabbits when 
carbaryl was applied directly to the eye, and guinea pigs were weakly 
sensitized in a skin-sensitivity test. [27] In addition, miosis and 
conjunctival hyperemia, which are signs of anticholinesterase activity, 
also have been observed in rabbits' eyes treated locally. [39] In cattle 
sprayed with carbaryl, the compound was present in all body tissues 
examined 1 and 3 days, but not 7 days, after exposure. [85] The 
concentration of carbaryl in the milk of cows was highest 5 hours after 
skin exposure but fell to an undetectable level 77 hours after spray 
application. No detectable carbaryl residue was found in meat of steers 7 
days after spraying.
A few studies on the effects of carbaryl administered orally to 
humans have been reported. A report [40] of one case of suicide attributed 
to carbaryl has been found. This Incident is clouded by the fact that the 
subject was treated with an oxime (PAH), which is usually recommended for 
treatment of poisonings due to excessive absorption of organophosphate 
anticholinesterase agents, but which has had an adverse effect on animals 
poisoned with carbaryl. [45,46]
A single oral dose of 250 mg of carbaryl (approximately 2.8 mg/kg) 
produced early symptoms including sweating and epigastric pain in an adult 
male [21] who Intentionally swallowed the chemical. [29] A rapid recovery 
followed treatment with atropine. [21] Best and Murray [28] described a 
case in which an unknown amount of carbaryl was ingested by a 19-month-old 
Infant who then had typical signs of anticholinesterase intoxication 
including miosis, excessive salivation, and Incoordination. Recovery was 
complete after atropine treatment. Lopez [41] described light intoxication
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in a young man who ate watermelon which had been sprayed with 80% carbaryl, 
and in another person who drank several milliliters of a solution of 80% 
carbaryl. Symptoms reported by the author in the men were nausea,
vomiting, hyperreflexia, pallor, intestinal colic, nasal discharge, 
salivation, headache, lacrimation, and tremors.
Daily oral carbaryl doses of 0.12 mg/kg in gelatin capsules
administered to 6 volunteers for 6 weeks caused no changes except an 
apparently slight decrease in the ability of the proximal convoluted 
tubules of the kidney to reabsorb amino acids as assessed by the urinary 
amino acid nitrogen to creatinine ratio. [32] This functional, but 
reversible, alteration was reported to be present only in the group of 
volunteers who ingested 0.12 mg/kg/day, and not in the group receiving 0.06 
mg/kg/day, in which the urinary amino acid nitrogen to creatine ratios were 
lower than the controls. Repeated oral administration of carbaryl produced 
mild renal changes in rhesus monkeys, [44,51] rats, and dogs. [27] The 
oral doses administered to experimental animals were considerably higher, 
viz, 600 mg/kg in the monkey at an unstated length and frequency, 7.2 mg/kg 
in the dog for 1 year, and 400 ppm in the diet of rats for 2 years, than
the dose required to produce the changes in human renal function reported
by Wills et al. [32] Furthermore, the renal changes in rats were not 
significant after 2 years of administration; in the dogs, the same cloudy 
swelling of the renal tubules was found in the experimental and, to a 
lesser extent, in the control groups. [27] Doses of 0.12 mg/kg of carbaryl 
administered to man were reported by the authors to be responsible for 
reversible renal tubular dysfunction. [32] Since calculation of the ratios 
was carried out on only 5 subjects and that differences apparent from the
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graphic illustration of the data are not striking, the results presented in 
this study are difficult to interpret. As discussed earlier, it is 
difficult to draw conclusions from the vacuoles seen in a single electron 
photomicrograph of the monkey kidney tissue studies. [44,51] The long-term 
administration of carbaryl to rats and dogs [27] resulted in some cases in 
an incidence of renal damage only slightly greater in test animals than in 
the controls. Considering all the present data, the evidence for renal 
dysfunction is at best suggestive but not conclusive.
In order to study the paralytic effects of carbaryl, Carpenter et al 
[27] administered the compound at very high doses to chickens (0.25-3 
g/kg). There was leg weakness at doses greater than 1 g/kg, attributed by 
the authors to transient cholinergic effects, but no microscopic evidence 
of demyelination. Another study In chickens by Gaines [43] lends support 
to the conclusion of Carpenter et al. [27] Smalley et al [52] showed that 
repeated administration of large doses of carbaryl to swine (150-300 mg/kg) 
produced ataxia and prostration without demyelination, and, in another 
study [55] at a dose of 125 mg/kg, the compound failed to produce paralysis 
in dogs but did produce paraplegia and spastic paresis in miniature pigs. 
[55] Carbaryl did not cause any demyelination in the chicken, the animal 
of choice for detecting this form of paralysis, and, since no data have 
been found concerning demyelinating paralytic effects of carbaryl in 
humans, it is concluded that, based on available evidence, carbaryl is not 
likely to cause chronic neurotoxicity, ie, Ginger Jake paralysis.
The effects of carbaryl on the developing fetus have been 
investigated in several studies. [66,67,69-71] Smalley et al [66] 
described reduced viability of pups and dystocia, probably maternal, in
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beagle dams given oral doses of carbaryl ranging from 3.25 to 50 mg/kg 
throughout gestation. Litter size was reduced as compared to controls in 
the 25 and 50 mg/kg dose groups. Teratogenic effects were seen at doses 
ranging from 6.25 to 50 mg/kg. In a study [67] on primates, the abortion 
rate was increased at carbaryl doses as low as 2 mg/kg given orally. This 
effect was not dose related, since a dose of 20 mg/kg produced only half as 
many abortions (3 out of 6) as the 2 mg/kg dose (2 of 2). In addition, the 
small number of pregnant animals in each group (2 and 6, respectively) and 
in the control group (5 animals) prevents reliable conclusions based on a 
statistical evaluation. [67] A later report by Dougherty and Coulston [69] 
describes another monkey study using 79 animals. These Investigators 
observed no signs of toxicity in adult females, no increase in abortions 
over controls, and no fetal abnormalities in monkeys given carbaryl (range 
0.2-20 mg/kg/day) during days 20-38 of gestation.
Robens [71] found that fetal deaths and terata occurred in guinea 
pigs administered carbaryl at a dose of 300 mg/kg during various intervals 
of gestation. This dose was also lethal to some dams, and the author 
indicated that this dose, which produced terata and maternal deaths in 
guinea pigs, was at least 1,000 times the level of carbaryl allowed in 
human food. The high mortality rate in the pregnant dams at this high 
dosage makes a conclusion of teratogenicity in this study difficult since 
another study by Weil et al [72] in the same species reported no carbary1- 
related teratogenicity at dietary and intubation levels of 300 and 200 
mg/kg, respectively. Doses of 50, 100, and 200 mg/kg of carbaryl given to 
pregnant rabbits [71] produced no adverse effects on dams or offspring. In 
hamsters [71] given carbaryl at doses of 125 and 250 mg/kg during
92
gestation, fetal mortality was higher than in controls, but no terata were 
found. Rats were administered carbaryl in the diet at doses of 20, 100,
and 500 mg/kg at various intervals throughout pregnancy or until weaning of 
the pups. [70] No teratogenic effects that could be attributed to carbaryl 
were observed at any dose level. As discussed earlier, the dog differs 
markedly from several other species, including humans, in its metabolism of 
carbaryl. This difference could account for the teratogenic effects 
observed in the study by Smalley et al. [66] The lack of carbary1-related 
teratogenicity in other species does not now warrant the conclusion that 
carbaryl should be classified as a teratogen in humans.
Effects of carbaryl on various aspects of the reproductive cycle of 
rodents have been observed at doses given either in the diet or by oral 
intubation, ranging from 2 to 20 mg/kg and from 2,000 to 10,000 ppm.
[72.73.78] Effects seen in rats with doses as low as 2 and 5 mg/kg 
included decreased spermatogenesis, sperm motility, and duration of estrus. 
[73] Decreased litter size and reduced survival of the pups have been 
observed with varying frequencies in rats and gerbils at all doses studied
[73.78] except in a three-generation reproduction study of rats conducted 
by Weil et al [72] in which adverse effects on viability of pups and litter 
size, as well as decreased fertility and lengthened gestation period, were 
seen only at doses of 100 mg/kg given by oral intubation, and not at lower 
doses. In the same study, [72] lengthened gestation periods in rats 
administered carbaryl in the diet were seen only at a dose of 200 mg/kg. 
Collins et al [78] studied rat parents and offspring in a three-generation 
reproduction study. Doses of 2,000, 5,000, and 10,000 ppm carbaryl in the 
diet showed that, at the highest dose and to a lesser extent at the next
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lower dose, the viability of the pups, survival of offspring, and litter 
size decreased from the first generation on. The lowest dose (2,000 ppm) 
affected only body weight gain of the parents and weanlings. In a similar 
three-generation reproduction study on gerbils given carbaryl in the diet 
(2,000, 4,000, 6,000, and 10,000 ppm), Collins et al [78] reported that no
litters were produced in the F3b generation at 10,000 ppm, and that there 
was a decrease in fertility, pup viability, litter size, and survival of 
pups from day 4 to weaning which appeared sporadically at all doses. 
Collins et al [78] suggested that the effect of carbaryl on reproduction
was due to an indirect effect on the testes and ova mediated through the
hypothalamohypophyseal complex. Carbaryl given to rats by gastric 
intubation at doses of 2 and 5 mg/kg produced adverse effects on fertility 
and survival of the pups during the first month of life. [73] The same 
doses produced a decrease in spermatogenesis and a decreased duration of 
estrus. In addition, microscopic changes of an adverse nature were noted 
in ovarian follicles and spermiogenic epithelium of the testes after 
carbaryl treatment.
In another study, Shtenberg and Rybakova [77] administered carbaryl 
orally to rats of both sexes at doses of 7, 14, and 70 mg/kg for up to 12
months. Growth of rats was inhibited at 14 and 70 mg/kg, and sperm
motility in males also decreased in a dose-related manner after 12 months 
of treatment. Degenerative changes in the testes, including edema of 
interstitial tissue and destruction of germinal epithelium, were noted in 
carbary1-treated male rats. In females, the estrus cycle was prolonged at 
the 14 and 70 mg/kg doses. From the above studies, [72,73,77,78] it may be 
concluded that oral administration of carbaryl to rodents has an effect on
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several aspects of their reproduction. However, it is difficult to relate 
these effects from oral administration at high doses to rodents to those 
encountered by inhalation and dermal absorption in humans, at lower doses 
in the workplace environment.
From the results of a screening experiment for dominant-lethal 
mutagenic effects, [59] in which mice received carbaryl at doses up to
1,000 mg/kg for 5 days, there is no evidence that carbaryl is a dominant- 
lethal mutagen in mice. More recent studies on bacteria [63,65] and on 
yeast [64] indicate that carbaryl is not a mutagen; however, experiments on 
an insect indicates that it is a weak mutagen. [62] Nitrosocarbaryl in 
several microbiologic studies [63-65] proved to be a strong mutagen. The 
significance of this finding in terms of its relevance to humans exposed to 
carbaryl remains to be determined.
Shimkin et al [81] synthesized N-methyl naphthylcarbamate and 
compared it in mice to 21 other carbamates using a pulmonary tumor 
bioassay. While some of the carbamates were positive, the synthesized 
compound was classed as marginal. Shimkin et al [81] classified the 
synthesized N-methyl naphthylcarbamate as a marginal tumorigen in mice; 
however, the lack of information on the purity of the compound and the 
structural formula written in the study leave doubt as to whether 2- 
naphthyl or 1-naphthyl N-methyl carbamate (carbaryl) was tested and make 
the results of the study difficult, if not impossible, to interpret.
Oral administration of carbaryl to mice (4.6 mg/kg/day for 18 months) 
revealed no significant evidence of tumorigenicity. [79] Subcutaneous 
injection of carbaryl, approximately 400 mg/kg/week, into tumor-susceptible 
mice for 5 months did not Increase the incidence of tumors over that in the
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control animals. [27] No dose-related incidence of tumors or increase in 
tumors over the controls was established by Carpenter et al [27] in rats 
given carbaryl in the diet at levels of 50, 100, 200, and 400 ppm for a 
period of 2 years. Andrianova and Alekseyev [80] found tumors in mongrel 
rats given carbaryl orally (30 mg/kg twice weekly) or by subcutaneous 
Implantation (paraffin capsules containing 20 mg of carbaryl) for 22 
months. The results of this study are not conclusive because of the high 
mortality in the experimental group, the absence of sufficient control and 
other background data, and the fact that the carbaryl used in these 
experiments was probably contaminated. An evaluation of the carcinogenic 
studies [27,79-81] does not now warrant a conclusion that carbaryl is a 
carcinogen.
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IV. ENVIRONMENTAL DATA AND BIOLOGIC EVALUATION
Environmental Data
Airborne concentrations of carbaryl and the potential for respiratory 
and dermal exposures have been examined in the workplace. The three major 
types of possible occupational exposure— the manufacture of technical 
carbaryl, the production of formulations of carbaryl, and the use of 
carbaryl for application purposes— have been considered.
Best and Murray [28] reported air concentrations at various sites In 
a carbaryl-manufacturing plant. The air samples were collected on membrane 
filters and analyzed by a colorimetric method for determining the airborne 
concentration of carbaryl. The mean carbaryl concentration of 49 air
samples in the production area was 0.23 (range 0.03-0.73) mg/cu m of air.
In the bagging area, 18 air samples with a mean of 0.75 (range 0.20-1.60) 
mg/cu m were collected under "normal conditions." Under abnormal 
conditions (described in Chapter III), the carbaryl concentration ranged 
from 19.0 to 40.0 mg/cu m, with an average of 29 mg/cu m for six samples. 
"Stackers" (handlers of bags for shipment) were exposed at a mean air 
* concentration of 0.64 (range 0.05-1.52) mg/cu m based on six samples 
collected. In the air separator house, only two airborne concentrations of 
carbaryl were measured, and these were in the range of 29.0-34.0 mg/cu m 
with an average of 31.0 mg/cu m. Union Carbide Corporation [13 (sec 9,10)] 
also supplied information on individual air concentration samples from the 
shipping department of the same plant. These air samples, collected and
analyzed in the same manner as that used by Best and Murray, [28] were
obtained sporadically over a 2.5-year period. Mean values, presented
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below, are calculations from the original data. A total of 96 air samples 
from the bagging operation had a mean carbaryl airborne concentration of 
2.96 mg/cu m, with a range of 0.32-13.33 mg/cu m. Near an instrument 
panel, the mean airborne concentration was 2.76 (range 0.12-10.51) mg/cu m 
based on 44 samples. In the shipping department office, the mean carbaryl 
airborne concentration was 0.33 (range 0.04-0.83) mg/cu m from 43 samples, 
which was comparable to the mean airborne concentration in the outside 
loading area of 0.37 (range 0.04-0.74, 8 samples) mg/cu m. Mean airborne 
carbaryl concentrations in railroad cars and trailer trucks, presumably 
loaded with bags of carbaryl, were 0.54 (range 0.10-1.22, 24 samples) and 
0.64 (range 0.26-1.62, 9 samples) mg/cu m, respectively.
Comer et al [88] investigated potential dermal and respiratory 
exposures to carbaryl in formulating-plant workers and orchard spray 
workers. The subjects included baggers and mixers at three plants 
formulating 4 and 5% carbaryl dust and spray workers operating tractor- 
drawn airblast equipment for applying 0.045-0.06% carbaryl spray, 
apparently from a wettable powder, to fruit trees. Dermal contamination by 
carbaryl sprays and dusts was determined by attaching absorbent cellulose 
pads and layered gauze pads, respectively, to various areas of the workers' 
bodies and clothing. Respiratory exposures were estimated from the 
contamination on special filter pads inserted in the filter cartridges of 
respirators worn by the subjects. The filter pads were shielded to prevent 
direct impingement of droplets or particles onto the pads except for those 
carried by respiratory action. A total of 480 dermal and 73 respirator-pad 
samples were analyzed spectrofluorometrically for carbaryl during different 
exposure situations including 48 for formulating-plant workers and 32 for
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orchard spray workers. In addition, the authors measured the urinary 
excretion of 1-naphthol in 102 urine samples from the formulating-plant 
workers, using a spectrofluorometric method. Mean values for potential 
carbaryl exposure among the formulating-plant workers were calculated to be 
73.9 (range 0.80-1,209) mg/hour of work activity by the dermal route and
1.1 (range 0.03-4.1) mg/hour by the respiratory route. For the orchard 
workers, the mean values were 59.0 (range 1.7-212) and 0.09 (range 0.01-
1.08) mg/hour by the dermal and respiratory routes, respectively. The 
authors found that, in the bagging and mixing sections of formulating 
plants, the areas with greatest potential of dermal exposure were the front 
of the chest and neck, the forearms and hands, and the face. Among spray 
applicators, the areas of greatest potential exposure were the shoulders 
and the back of the neck. The authors further calculated that the mean 
potential for both dermal and respiratory exposures of formulating workers 
would be 75 mg/hour, or 600 mg over an 8-hour workday. The authors did not 
report the airborne concentrations of carbaryl dust to which the workers in 
the formulating plants or orchards were exposed. In the 102 urinary 
specimens analyzed during and after exposure, 1-naphthol concentrations 
were 0.2-65.0 ppm (20-6,500 pg/100 ml), with a mean value of 8.9 ppm (890 
pg/100 ml). The authors stated that carbaryl exposure at the beginning of 
the workday was followed by peak excretory levels of 1-naphthol by late 
afternoon and evening, followed by a drop to lower levels at the start of 
the next workday. The rate of excretion of 1-naphthol varied from 0.004 to 
3.4 mg/hour, with a mean value of 0.5 mg/hour. The authors Indicated that 
this was equivalent to the excretion of approximately 0.7 mg/hour of 
carbaryl, or an absorption of 5.6 mg of carbaryl during an 8-hour period.
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When this absorption value of carbaryl (5.6 mg/8 hours) was compared to the 
total potential dermal and respiratory exposure value (600 mg/8 hours) for 
the formulating-plant workers, it was suggested that absorption from dermal 
contact with carbaryl dust was probably not very complete. The authors 
concluded that dermal absorption of carbaryl from dry formulations in 
formulating plants may be only a small fraction of the total potential 
calculated exposure.
Jegier [89] measured respiratory and dermal exposures to carbaryl 
(Sevin 50 WP, 0.5-8.0 lb/100 gal water) for tractor operators engaged in 
orchard-spraying operations. Air samples were collected from the tractor 
operators' breathing zones, and results of the analyses for carbaryl were 
used to calculate respiratory exposures which were determined by a filter- 
pad method. Filter pads were attached to double-unit respirators and 
absorbent materials were strapped to the forehead and wrists of observers 
riding beside the tractor drivers to estimate respiratory and dermal 
exposures, respectively. The airborne concentrations of carbaryl in seven 
breathing-zone samples ranged from 0.18 to 0.81 mg/cu m, with a mean of 
0.60 mg/cu m. Calculated mean respiratory exposure based on the measured 
air concentrations and an assumed lung ventilation rate of 444 liters/hour 
was in close agreement with the mean respiratory exposure of 0.29 (range 
0.24-0.53) mg/hour as determined by the filter-pad technique. The mean 
dermal exposure was estimated at 25.3 (range 18.5-30.3) mg/hour.
Simpson [90] measured dermal and respiratory exposure of workers 
spraying carbaryl in an orchard. Filter papers were pinned to the 
operators' clothing and cotton absorbent pads were inserted into the 
cartridges of respirators. These were analyzed for carbaryl to determine
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dermal and respiratory exposures. Simpson [90] estimated the mean 
respiratory exposure rate to carbaryl at 482 (range 10-1,080) pg/hour. The 
mean dermal exposure rates, in jug/100 sq cm/hour, were: hat (or head),
1,150; arm, 1,134; chest, 1,122; shoulder, 957; back, 774; wrist, 734; and 
thigh, 587.
Kale and Dangwal [91] investigated the air concentrations of carbaryl 
and other pesticides in several agricultural settings. Air samples were 
collected with a midget impinger containing either distilled water or 
alcohol. The authors stated that the samples were collected as close as 
possible to a worker's breathing level and in a manner to avoid interfering 
with his work. In the first instance, a 50% wettable powder of carbaryl 
was applied to mango trees with a hand pump sprayer under medium air- 
movement conditions; only traces of carbaryl were detected. In the second 
agricultural application, 10% carbaryl dust was applied to cotton with a 
rotary hand duster in medium wind conditions; again, only traces of 
carbaryl were present. In a third farming operation, similar to the second 
but with high air movement, carbaryl concentrations were 0.1-0.8 mg/cu m of 
air. During the application in medium wind of 10% carbaryl dust by rotary 
hand duster to wheat approximately 30 cm high, airborne concentrations of 
carbaryl were 0.8-1.6 mg/cu m. Neither the collecting medium nor the 
analytical procedure for determining carbaryl was identified by the 
authors, nor did they mention any biologic evaluation of the workers.
Control of Exposure
Engineering design and work practices for carbaryl should have, as 
their main objectives, controlling airborne concentrations and minimizing
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skin and eye contact. The environmental data previously presented suggest 
that concentrations of airborne carbaryl are significantly lower, and 
therefore there is potentially less absorption in agricultural occupations 
than in manufacturing and formulating operations.
In manufacturing and formulating plants and in other locations where 
suitable and practical, closed systems, properly operated and maintained, 
should be used to achieve reduced airborne concentration and to minimize 
skin contact. Where closed systems are not feasible, well-designed local 
exhaust ventilation should be provided. Guidance for design can be found 
in Industrial Ventilation— A Manual of Recommended Practice, [92] or more 
recent revisions, and in Fundamentals Governing the Design and Operation of 
Local Exhaust Systems, Z9.2-1971. [93] Exhaust air should not be
recirculated and should be filtered to prevent pollution of the outdoor 
air. Neither respiratory protective equipment nor personal protective 
clothing is an acceptable substitute for proper engineering controls, but 
both should be available for emergency purposes and for nonroutine 
maintenance and repair situations.
Tests performed by Union Carbide Corporation [13 (sec 16)] have shown 
that dust clouds of technical carbaryl and formulations of carbaryl can be 
ignited in closed spaces, and that explosions could occur. According to 
this manufacturer, carbaryl also may have an electrostatic potential that 
could produce a spark. Thus, it is recommended that equipment in confined 
spaces always be adequately grounded. Union Carbide Corporation reported 
that the minimum concentration of technical grade carbaryl dust to produce 
explosive mixtures is 20.3 g/cu m.
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Sampling and Analysis
In 1962, Best and Murray [28] reported measurements of airborne 
concentrations of carbaryl dust in a manufacturing plant, based on a 
sampling method using cellulose ester membrane filters (AA white grid). 
During subsequent determinations of airborne carbaryl dust concentrations 
in this plant, 0.8-pm membrane filters composed of a copolymer of 
acrylonitrile and polyvinyl chloride were used for carbaryl collection. 
[13 (sec 11)]
Popendorf et al [94] used membrane-filter air samplers (with a 
sampling rate of 3 ± 0.25 liters/minute) in the measurement of
concentrations of foliar pesticide residues likely to become airborne in
work situations. Although the use of carbaryl was not included in this
report, it appears that this sampling procedure, when coupled with an 
appropriate analytical procedure, may be useful for evaluating airborne 
carbaryl concentrations.
Air sampling specific for carbaryl was reported in a study by
Klisenko [95] in 1965. He used FPP-KhA filters (no other identification of 
material) to collect carbaryl in air for a period of 4-5 minutes at a 
sampling rate of 5 liters/minute. The reagent diazobenzenesulfonic acid 
was used to develop color with carbaryl in the methanol extract for
subsequent colorimetric determination. The sensitivity was 1 mg carbaryl 
in 4 ml of final solution. The author did not report the efficiency of the 
sampling method.
In the same study, Klisenko [95] investigated carbaryl analysis by 
ultraviolet spectrophotometry, still using diazobenzenesulfonic acid as the 
coupling reagent. He found appreciable interference at 281 run from
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methanolic extracts of the FPP-KhA filters. To avoid such interference in 
the ultraviolet range, carbaryl in the air was absorbed at a sampling rate 
of 0.5 liter/minute in 5 ml of methanol in a scrubber with a porous disc. 
No information regarding carbaryl collection efficiency was given. The 
sensitivity was reported to be 0.1 fig of carbaryl in 2.5 ml of solution.
In 1971, Kale and Dangwal [91] used midget impingers (with a
collecting medium such as distilled water or alcohol) for air sampling of 
several different types of pesticides, including carbaryl, at spraying or 
dusting sites. The absorbing solution selected for carbaryl collection was 
not identified, and no information was presented on collection efficiency 
or sampling details such as flowrate and sampling time. Also, the authors
did not mention the analytical procedure used for the carbaryl
determinations.
Reports of the filter collection methods, [13 (sec 11),28,95] as well 
as the scrubber methods, including midget impingers, [91,95] did not 
specify carbaryl collection efficiencies. Since carbaryl formulations 
include wettable powders, dusts, and granules, [13 (sec 18)] the membrane 
filter collection technique would be expected to provide an effective 
collection method for airborne particulate carbaryl.
Most reported environmental exposure data for airborne carbaryl dust 
levels have been based on the membrane-fliter collection method. [13 (sec 
11),28] Membrane filters which have been used for particulate collection 
are polymeric (plastic) [96] or glass-fiber filters. [97] Because they are 
highly efficient, involve no fragile glassware such as impingers, and 
require no liquids, membrane filters are better suited to personal 
monitoring than are sampling techniques utilizing glassware and liquids.
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The membrane filter method is recommended as the air sampling method of 
choice.
The sampling method recommended in Appendix I involves the use of a 
glass-fiber membrane filter (Type A), 37 mm in diameter, mounted in a two- 
piece cassette filter holder and held in place by a backup pad. [97] 
Details of membrane filter sampling and airflow calibration procedures are 
given in Appendix I.
The analytical procedures usually employed for determining carbaryl 
concentrations are based on quantifying 1-naphthol [13 (sec 11),28,98-101] 
derived from the alkaline hydrolysis of carbaryl. In 1962, Best and Murray 
[28] presented a colorimetric method to quantitatively determine 1- 
naphthol. This method involved measurement of the intensity of a blue dye 
formed by the reaction between p-nitrobenzenediazonium fluoroborate and 1- 
naphthol. This method may be used to determine either the free urinary 1- 
naphthol concentration or the total urinary 1-naphthol concentration. In 
the former case, the metabolite is extracted from the urine, and in the 
latter case, the naphthol conjugates are first hydrolyzed to 1-naphthol. 
This method was modified by Johnson [98] in 1964 with regard to sample 
preparation of food products and was adopted the same year by the 
Association of Official Analytical Chemists (AOAC) [99] as the recommended 
method for the quantitative determination of carbaryl. Except for the 
incorporation of a further optional modification in sample preparation by 
Benson and Finocchiaro [100] In 1965, this method remains the official AOAC 
analytical method. [101]
Another analytical approach was Investigated by Frei et al. [102] 
When carbaryl was hydrolyzed to 1-naphthol and the latter determined
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fluorometrically on thin-layer chromatograms, a visual detection limit of
0.006 fig/spot and an instrumental detection limit of 0.001 jug/spot were 
reported. This procedure was developed for carbaryl residue analysis but 
was not applied to air-sample analysis.
Early attempts to use gas-liquid chromatography for the quantitative 
determination of carbaryl indicated that, under the conditions commonly 
used for such analyses, carbaryl underwent thermal decomposition to 1- 
naphthol. [103,104] Such analytical techniques, therefore, were not 
applicable to the analysis of samples which might contain 1-naphthol or 
carbaryl analogs that in turn might generate 1-naphthol upon thermal 
decomposition. Two approaches to overcoming the problem of thermal 
decomposition of carbaryl have been investigated.
The first approach was to prepare thermally stable derivatives of 
carbaryl. Fishbein and Zielinski [103] prepared trimethylsilyl carbaryl by 
the reaction of carbaryl with excess hexamethyldisilazane and 
trimethylchlorosilane in pyridine. The reaction mixture was analyzed for 
the trimethylsilyl derivative of carbaryl using 6-ft x 6-mm ID glass 
columns containing various solid supports and stationary liquid phases in a 
gas chromatograph equipped with a flame ionization detector. The authors 
did not specify the sensitivity of the method. Khalifa and Mumma [105] 
prepared trlfluoroacetyl and heptafluorobutyryl derivatives of carbaryl, 
which were thermally stable under the conditions selected, for analysis by 
a gas chromatograph equipped with a 63N1 electron capture detector. The 
authors did not report the specific conditions used for derivatization, nor 
did they present evidence that derivative formation was quantitative. 
Tilden and Van Middelem [106] described a gas-liquid chromatographic method
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in which the carbaryl was quantitatively hydrolyzed to yield methylamine 
through acid hydrolysis. The resulting methylamine was quantitatively 
converted to 4-bromo-N-methylbenzamide by reaction with 4-bromobenzoyl 
chloride. Analysis of the 4-bromo-N-methylbenzamide was performed using a 
gas chromatograph equipped with a 63Ni electron capture detector and a 6-ft 
x 4-mm glass column containing 3% Carbowax 20M on Chromosorb W. The lower 
limit of detection of pure carbaryl was 20 pg by this method. The use of 
derivatization for carbaryl analysis has been applied primarily to residue 
analysis, where the carbaryl is usually extracted in an organic solvent and 
high sensitivity is required because of the small sample sizes. Reports in 
which such methods have been applied to air samples have not been found, 
but the time-consuming stepwise handling of samples required by these 
methods Is a distinct disadvantage.
A second approach to overcoming the problem of thermal decomposition 
of carbaryl during analysis by gas-liquid chromatography was to design the 
system so that decomposition is minimized or eliminated. Thus, Riva and 
Carisano [107] indicated that the recovery of undecomposed carbaryl was 
better than 90% for a 300-ng sample if the 0.5% SE-30 on 100-120 mesh Gas- 
Chrom P column was sllanized by repeated injections of hexamethyldisilazane 
before sample injection. Presumably the silane treatment prevents the 
adsorption of carbaryl on active sites of the solid support and glass 
column where decomposition occurs. Lewis and Paris [108] indicated that by 
using a short column (0.3 m) and low column temperatures, thermal 
decomposition could be prevented. Using a gas chromatograph equipped with 
such a column containing 3% SE-30 on Gas-Chrom Q and a 63Ni electron 
capture detector, they were able to analyze for carbaryl in quantities as
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small as 0.2-0.5 ng/injection volume. Again, both these methods were
devised for residue analysis, and no information on their application to 
air sampling and analysis has been found. As a result of the lack of
quantitative information on the sensitivity, accuracy, and precision of gas 
chromatographic methods as applied to analysis of air samples for carbaryl, 
such methods are not now recommended.
The p-nitrobenzenediazonium fluoroborate colorimetric method has been 
selected as the analytical method. This method has been used for many
years by Union Carbide Corporation [13 (sec 11)] and others, [28,98-101] 
and has shown the required sensitivity for evaluation of personal exposures 
to carbaryl in accordance with the TWA environmental limit [97] discussed 
in Chapter V of this document. The principle of the method is that
alcoholic potassium hydroxide is used to hydrolyze the carbaryl to 1- 
naphthol, which is determined colorimetrically after reaction with p-
nitrobenzenediazonlum fluoroborate. The presence of 1-naphthol in the air 
sample leads to erroneously high values for determination of the airborne 
concentrations of carbaryl. In addition, other substances such as phenols 
and aromatic amines that form derivatives with p-nitrobenzenediazonium 
fluoroborate or that absorb around 475 nm, will interfere if present in the 
air sample. Details of this method are presented In Appendix II.
When both 1-naphthol and carbaryl are in the air sample, gas
chromatographic methods will probably allow separation of the two
compounds, however, details for such methods are not worked out. When they
are developed, our recommendations will be reconsidered. Since carbaryl is 
metabolized by humans to 1-naphthol, the recommended analytical method may 
be superior in detecting toxicity because of its lack of specificity.
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Biologic Evaluation
Evaluation of the available literature cited in Chapter III would 
indicate that there are two possible means of determination of carbaryl 
exposure in the workplace environment. These are the measurement of 1- 
naphthol in the urine and determination of cholinesterase activity in the 
blood. The urinary concentration of 1-naphthol, one of the principal 
metabolites of carbaryl, which is excreted in the urine as the sulfate or 
glucuronide, [33,34] has been used as an indication of exposure to carbaryl 
in the workplace. [28] Comer et al [88] reported that the highest 
concentrations of urinary naphthol occurred usually after the daily 
exposure had ended. Because of the possible occurrence of carbaryl in food
[109] and because 1-naphthol itself may be encountered during the 
manufacturing process, [15,16] many individuals exposed to carbaryl in the 
workplace might normally have small amounts of 1-napthol in the urine from 
sources other than airborne carbaryl. Although there is evidence that 
urinary 1-naphthol levels increase on exposure of humans to airborne 
carbaryl, [13 (sec 9,10),28,88] no definite quantitative relationship has 
been established between exposure to airborne carbaryl and total urinary 1- 
naphthol excretion. Therefore, measurement of urinary 1-naphthol as an 
Indicator of carbaryl exposure is not now recommended.
Since the basis for the acute toxicity of anticholinesterase agents 
is the inhibition of the enzyme acetylcholinesterase, [7] the measurement 
of this enzyme activity would appear to be a useful biologic monitoring 
technique. The rapid regeneration of the carbamylated enzyme [5,110] 
probably makes the degree of inhibition by carbaryl at any given time 
elusive. The enzyme activity when analyzed in the sample tends to be higher
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than was the actual case when the blood sample was obtained, and thus the 
degree of inhibition may be interpreted as less than actually occurred.
[110] The California Department of Health [111] has recommended that,
because of the reversibility of the complex of enzyme and carbamate, blood
samples should be drawn and analyzed within 4 hours after exposure when 
carbamate poisoning is suspected.
Biologic monitoring of cholinesterase activity in blood, plasma, 
serum, or erythrocytes is not recommended as a means of assessing 
occupational exposure to carbaryl because (1) the rapid reversibility of
carbaryl-induced cholinesterase inhibition makes cholinesterase 
determination impractical in occupational situations where blood samples 
cannot be analyzed immediately, and (2) occupational exposure to carbaryl 
results in a rapid onset of symptoms, self-termination from further 
exposure, and rapid recovery.
Although monitoring of cholinesterase activity is not specifically 
proposed as a requirement for carbaryl exposure, it can, properly 
performed, give useful information in exposures to carbaryl as well as to 
other cholinesterase-inhibiting compounds such as the organophosphate 
pesticides. For those who plan to carry out these measurements, it should 
be pointed out that individual variation due to disease states and genetic 
makeup may influence the results. A decrease in the activity of serum
cholinesterase has been found in liver disease, [112] pregnancy, [113] and 
malignant neoplasms. [114] In patients suffering from pulmonary 
tuberculosis, plasma cholinesterase activity was also decreased. [115] 
Familial reduction in pseudocholinesterase levels was reported by Lehmann 
and Ryan [116] and by Kalow, [117] and later was found to be related to the
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presence of an atypical gene. [118] Between 1 in 3,370 and 1 in 10,500 
individuals tested in a healthy Canadian population was found to be 
homozygotic for this atypical gene [117] and thus could be expected to have 
a genetically determined deficiency in plasma cholinesterase. Erythrocyte 
cholinesterase activity was inhibited in certain pulmonary and 
extrapulmonary cancers [115] and in paroxysmal nocturnal hemoglobinuria. 
[119] Familial symptomatic reduction in erythrocyte cholinesterase
activities also has been reported. [120] For those situations where 
measurements of cholinesterase activity is applicable, an assessment of 
cholinesterase methodology is presented below.
Measurement of cholinesterase (true or pseudo-) activity depends 
basically on two principles. The first involves measurement of the product 
formed as a result of hydrolysis of the substrate by the enzyme; this 
product can be estimated directly or indirectly by various techniques. The 
second principle involves measurement of the disappearance of the
substrate, which also can be measured directly or indirectly by various 
techniques.
In early assays for cholinesterase, acetylcholine was usually used as 
a substrate and changes were measured as the ester was hydrolyzed. This 
change has been determined manometrically, [121,122] by changes in color of 
acid-base indicators, [123] and by pH measurement. [8]
Manometric methods for the analysis of cholinesterase are precise, 
but they are inherently tedious and time-consuming. These methods are
based on the measurement of the amount of carbon dioxide released when
acetic acid is allowed to react with bicarbonate ion. Both erythrocyte and 
plasma cholinesterase activities have been assayed manometrically. [7,124]
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However, Winteringham and Disney [125] believed that since dilution of the 
enzyme was necessary to achieve sensitivity when using conventional 
manometric methods, these methods were inappropriate for measurements in 
cases of carbamate exposure. Such dilution decreased the percentage of 
enzyme bound to the carbamate substrate by enhancing the dissociation of 
the complex. [125]
A photometric method based on the change in color of an acid-base 
Indicator has been adapted to measure cholinesterase activity in the 
presence of a large amount of serum by using a calibration based on the 
ratio of final to initial absorbance, [123] thereby eliminating the errors 
from the effects of dye binding with protein in the serum. This method is 
not applicable to hemolytic serum. Turbidity and extraneous colors 
interfere with the method. An automated method used by Winter [126] has 
not proved adequate for the assay of erythrocyte cholinesterase [127]; the 
automated micro determination of cholinesterase, as described by Levine et 
al, [127] involved a 1:4 dilution of plasma and serum and a 1:10 dilution 
of erythrocytes. Thus, these automated methods [126,127] have limitations 
resulting from dilution in determining carbaryl-induced cholinesterase 
inhibition. The principle of colorimetric or electrometric measurement of 
the acetic acid liberated from the hydrolysis of acetylcholine by 
cholinesterase has led to several useful field screening procedures for 
cholinesterase activity. Such field methods have poor precision (± 25%)
and are adequate only for screening purposes. [128-131]
The electrometric method of Michel, [8] developed primarily to 
shorten the time required for analysis, was well suited to determinations 
of both erythrocyte and plasma cholinesterase activities. This method has
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been used to measure erythrocyte and plasma cholinesterase activities in 
humans exposed to organophosphate cholinesterase inhibitors. [132] This 
method makes use of electrodes to measure changes in pH (expressed as delta 
pH/unit time) resulting from the production of acetic acid when 
cholinesterase hydrolyzes acetylcholine. However, when this method, [8] or 
modifications thereof, [132] are applied to the evaluation of carbamate
exposures, problems are anticipated as a result of diluting the samples
during the assay process.
More recently, Winteringham and Disney [133] devised a radiometric 
assay of acetylcholinesterase. In this method, a drop of 14C-labeled 
acetylcholine, used as the substrate, was mixed with the diluted blood 
sample on a slide. The enzymatic hydrolysis was stopped by adding a drop
of acid inhibitor after a measured time period. The amount of unhydrolyzed
14C-labeled substrate was then measured with a Geiger-Muller tube after 
removal of volatile 14C-acetate by drying in hot air. This activity was 
then compared to that contained in a previously inactivated sample 
containing a measured amount of 14C-labeled substrate. By this method, the 
enzyme activity can be determined at low substrate concentrations and with 
minimal dilution.
Potter [134] modified the radiometric method to use both 14C- and 
tritium-labeled acetylcholine; the reaction product (labeled acetate) was 
quantified by liquid scintillation spectrometry after separation from the 
labeled acetylcholine by an extraction procedure. The advantage of the 
radiometric method is that the biologic fluids require no dilution, thereby 
preventing greater dissociation of the enzyme-carbamate complex. In a 
critical review of the measurement of cholinesterase activity, Wills [7]
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suggested that the radiometric modification described by Potter [134] might 
be particularly appropriate for reversible inhibitors such as the 
carbamates. However, the WHO Expert Committee on Insecticides [29] did not 
recommend the radiometric method for general use. The expense, the 
necessity for complicated apparatus, and the difficulty in calculating the 
results were cited as disadvantages.
The basic principle of titrimetric techniques involves titration with 
standard alkali of the acid released during hydrolysis of the choline ester 
at a constant pH and use of either an indicator or a potentiometer. [110] 
According to Witter, [110] acetylcholine, acetyl-beta-methylcholine, or 
butyrylcholine can be used as the substrate in this method. Noting that 
the continually changing color in the reaction mixture was often difficult 
to match with the indicator standard, Witter [110] suggested that this 
difficulty was due to the color of the blood or the plasma, or to other 
factors such as the presence of activators or inhibitors. However, the 
author indicated that this difficulty was obviated if a potentiometer was 
used to measure the pH. Jensen-Holm et al [135] used an automatic titrator 
for measuring the cholinesterase activity in blood and other biologic 
material. The authors claimed that the method had the advantage of 
following the course of acid liberation (and therefore of cholinesterase 
activity) during the whole period of the determination. However, the 
method was subject to serious error due to nonspecific acid liberation in 
the organ homogenates before addition of substrate; but this error very 
rarely occurred in fresh blood. Another automatic titrimetric technique, 
[13 (sec 12)] in which cholinesterase activity of erythrocytes or plasma 
was determined in refrigerated equipment, was developed to retard the rapid
reversibility of the inhibition of cholinesterase activity by carbaryl. 
However, no data were reported on the samples analyzed.
Measurements of the production of acid by the addition of base to 
maintain a constant pH as hydrolysis of substrate occurs are referred to as 
pH-stat methods [7,136] and are automated versions of the method of Hall 
and Lucas. [137] Such methods have been used less frequently than the 
delta-pH methods in determining cholinesterase activity in plasma and 
erythrocytes. According to Crane et al, [138] they are slightly less 
precise than the delta-pH methods. Since these methods involve the
addition of a base to neutralize the acid, they effectively increase the 
dilution of the sample and may therefore cause dissociation of the
carbamate-enzyme complex. Therefore, pH-stat methods are of limited use in 
measuring carbaryl-induced cholinesterase inhibition.
Hestrin [50] reported on the stoichiometric reaction of acetylcholine 
with alkaline hydroxylamine to form acetohydroxamic acid which forms a red- 
purple complex with ferric chloride. Hestrin's work led to the development 
of other methods using the same principle for measuring serum 
cholinesterase activity by determining the amount of unhydrolyzed 
acetylcholine. [139,140] However, Hestrin's method [50] is not specific 
for acetylcholine; esters of other short-chain carboxylic acids, lactones, 
and anhydrides also react with hydroxylamine with resultant formation of 
hydroxamic acid.
Meyer and Wilbrandt [141] adapted a histochemical principle to the 
measurement of plasma and erythrocyte cholinesterase in blood based on the 
measurement of free SH-groups produced by the hydrolysis of esters of
thiocholine by the active enzyme. Techniques using thiocholine esters have
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been used to measure Cholinesterase activity in plasma, serum, and 
erythrocytes, and have been adapted to automatic analytical equipment. [7] 
This measurement can be accomplished iodometrically, [141] 
colorimetrically, [142] or spectrophotometrically. [143] Ellman et al
[143] were able to determine Cholinesterase activity in blood, 
erythrocytes, and tissue homogenates, using the spectrophotometric method. 
The authors claimed several advantages for this method: it operates in the
visible region of the spectrum, thus permitting spurious changes to be
observed directly; it is extremely sensitive; and it requires no special 
handling of tissue homogenates. The colorimetric method of Gary and Routh 
[142] is a very rapid micro method, with only a 3-minute incubation period 
necessary, and has been used to determine serum and plasma Cholinesterase 
activities. However, the application of these methods [141-143] to 
measuring carbaryl-induced Cholinesterase inhibition is limited by the 
dilution required in the sample preparation.
Cranmer and Peoples [144] described a method for the determination of
Cholinesterase activity that involved the incubation of erythrocytes or 
plasma with 3,3'-dimethylbutyl acetate as a substrate. The reaction 
product, 3,3'-dimethylbutanol, was extracted into carbon disulfide and 
determined by gas-liquid chromatography. According to the authors, their 
method has been applied only to strong Inhibitors of Cholinesterase and not 
to reversible inhibitors. Therefore, its validity for assaying carbamate 
inhibition estimation has not been demonstrated.
Baum [145] described a method of measuring Cholinesterase activity 
using a liquid membrane electrode having a high selectivity for 
acetylcholine. This method permitted a continuous determination of the
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rate of change of substrate concentration in the presence of active enzyme. 
When the acetylcholine concentration fell below 0.1 /uM, interference from 
sodium in the saline buffer solutions used became serious. No information 
was given on the applicability of this method for determining 
cholinesterase activity in whole blood or erythrocyte samples.
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V. DEVELOPMENT OF A STANDARD
Basis for Previous Standards
In 1964, the American Conference of Governmental Industrial 
Hygienists (ACGIH) [146] proposed a tentative threshold limit value (TLV) 
for carbaryl of 5 mg/cu m of air. This was adopted as a recommended TLV by
the ACGIH in 1966 [147] and has not been changed since then. The ACGIH
limit for carbaryl continues to be 5 mg/cu m of air. [148]
According to the most recent (1971) ACGIH Documentation, [149] the 
TLV of 5 mg/cu m for carbaryl was recommended to provide a safety factor 
for protection against systemic effects. Cholinesterase inhibition was 
considered by the Threshold Limits Committee to be the basis of the toxic 
action of carbaryl; no other types of toxicity were mentioned. The TLV was 
based on the work of Best and Murray, [28] who indicated that 31 mg/cu m of 
carbaryl could be tolerated. However, the 31 mg/cu m was an average of 
only two air samples. Neither the duration of exposure nor the number of 
workers exposed at that concentration was specified by Best and Murray. 
[28] This exposure (31 mg/cu m) was calculated by the ACGIH to be
equivalent to inhalation of 310 mg/man/day.
The documentation referred to the work of Carpenter et al, [27] who 
reported that airborne concentrations of 10 (5-20) mg/cu m of Sevin 85S 
produced neither mortality nor grossly visible injury in rats exposed 7 
hours/day, 5 days/week, for 90 exposures. The ACGIH calculated that man in 
such an atmosphere would inhale about 100 mg of carbaryl a day.
Standards for carbaryl in foreign countries are those of the Federal 
Republic of Germany (5 mg/cu m as an 8-hour TWA) [150] and of the USSR (1
118
mg/cu m as a ceiling). [151] The basis of the USSR standard is inferred to 
represent a tenfold margin of safety derived from a threshold concentration 
obtained in long-term animal studies. [39] In addition, this concentration 
(1 mg/cu m) was stated as being somewhat below the concentration which 
caused a slight fall in cholinesterase activities of workers. [39]
The present United States federal standard for occupational exposure 
to carbaryl is an 8-hour TWA limit of 5 mg/cu m of air (29 CFR 1910.1000, 
published in the Federal Register 40:23072, May 28, 1975). This standard 
is based on the ACGIH TLV recommendation.
Basis for the Recommended Standard
The absorption of airborne carbaryl during workplace exposure is 
considered to be primarily through the routes of Inhalation and dermal 
contact and, to a lesser extent, by ingestion. The airborne concentration 
at which carbaryl will Induce some or no signs or symptoms of poisoning in 
humans has not been reported. The airborne concentrations of carbaryl 
present when 7 of 14 men engaged in hand-removal of carbaryl from a plugged 
storage bin became ill were not determined. [13 (sec 7)] Although these 
workers were supposedly wearing respirators, the protective devices were 
ineffective against inhalation of carbaryl dust. The complete recovery of 
the workers in less than 36 hours without medical intervention suggests a 
rapid reversibility of carbaryl intoxication once exposure is halted.
Best and Murray [28] reported that signs and symptoms of carbaryl 
Intoxication were not detected among 59 workers exposed to airborne 
concentrations ranging from 0.03 to 40 mg/cu m. Workers exposed at high 
concentrations of carbaryl usually wore respirators, and those exposed at
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lower concentrations did not routinely wear respirators. Significant 
inhibition of cholinesterase activity was not reported; however, the 
methods used were not adequately sensitive.
In a short-term Inhalation-absorption study, [13 (sec 9,10)] two 
workers who wore either a respirator or skin protection equipment, but not 
both, were exposed to airborne carbaryl at a concentration of approximately 
50 mg/cu m during 2 workdays. No apparent adverse effects were observed.
A report from Russia [39] involving agricultural workers' exposure to 
carbaryl indicated that exposure at 2 mg carbaryl/ cu m in the air, 4-6
hours/day, for 3-4 days produced some inhibition of cholinesterase activity
(11-24%). However, clinical assessment showed no additional evidence of 
changes induced by cholinesterase inhibition. The method used for 
determining cholinesterase activity was not specified.
Several species of animals have been experimentally exposed to 
airborne carbaryl. [27,39] There were no deaths reported in guinea pigs 
exposed to carbaryl for 4 hours at concentrations of 230, 322, and 390 
mg/cu m, but nasal and local ocular irritation were noted in those animals 
exposed at the highest concentration. [27] Signs of cholinesterase 
inhibition were noted in dogs within 5 hours of exposure to carbaryl at 75 
mg/cu m. [27] Neither deaths nor carbary1-associated lesions (C Carpenter, 
written communication, January 1976) were reported in rats exposed to 
carbaryl at an average concentration of 10 mg/cu m (5-20 mg/cu m) for 7 
hours/day, 5 days/week, for 90 days. [27] Three groups of four cats each 
were exposed to carbaryl at 16, 40, and 63 mg/cu m, 6 hours/day, for
varying periods up to 4 months. [39] At 16 mg/cu m, there were no signs of
toxicity after 4 months' exposure; at 40 mg/cu m, there was a loss of
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unspecified conditioned reflexes and a 50% decrease in erythrocyte 
cholinesterase activity during 2 months' exposure; at 63 mg/cu m, the cats 
exposed to carbaryl for one month showed periodic salivation, with 31-40% 
and 41-58% decreases in serum and erythrocyte cholinesterase activities, 
respectively. The author concluded that 16 mg/cu m was the threshold 
concentration for carbaryl in cats. If humans and lower animals do not 
differ signifcantly in their susceptibility to inhaled carbaryl, the 
results of Inhalation studies in several animal species [27,39] would 
indicate that 16 mg/cu m can be considered the no-adverse-effect level with 
respect to toxic manifestations of cholinesterase inhibition in humans. 
This assumption is supported by the work of Best and Murray, [28] who noted 
no symptoms of carbaryl intoxication in humans exposed to the insecticide 
at airborne concentrations ranging from 0.03 to 40 mg/cu m. It is also not 
in conflict with the results of Yakim [39] who reported reductions in blood 
cholinesterase activity (measured by an unspecified method) following 4- to 
6-hour exposures of workers to carbaryl at average airborne concentrations 
of 2-4 mg/cu m, since no clinical evidence of anticholinesterase activity
was observed at these concentrations.
Few oral Ingestion studies on the effects of carbaryl in humans have 
been found. A suicide attributed to the ingestion of an apparently large 
dose (possibly 400 g) of carbaryl was reported. [40] The significance of 
this report cannot be determined since the patient was treated with an
oxime, a useful antidote for cholinesterase Inhibition caused by
organophosphates, but not useful in cases of carbaryl poisoning. [21]
Single oral doses of up to 2 mg/kg of carbaryl taken by male 
volunteers produced no signs or symptoms of intoxication. [32] A higher
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single oral dose of 250 mg of carbaryl (approximately 2.8 mg/kg) caused 
immediate symptoms including epigastric pain and sweating in an adult male 
who intentionally swallowed the chemical. [21] Recovery, after atropine 
sulfate administration, was complete within a few hours. Male volunteers
receiving daily oral doses of 0.12 mg/kg for 6 weeks reportedly exhibited a
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slight decrease in the ability of the proximal convoluted tubules of the 
kidney to reabsorb amino acids as indicated by an increase in the urinary 
amino acid nitrogen to creatinine ratios. [32] The increase in urinary 
amino acid nitrogen to creatinine ratio is at best a rough measure of the 
reabsorptive capacity of the proximal renal tubule.
Increased amino acid nitrogen to creatinine ratios seen in humans 
administered 0.12 mg/kg carbaryl orally, once daily for 6 weeks, were 
reversible and no increase in the ratios was seen in subjects administered 
carbaryl at 0.06 mg/kg for the same period of time. [32] These results are 
difficult to interpret because they were derived from only five subjects 
given the higher dose. Moreover, determination of ratios was absent and 
any graphically illustrated data were unimpressive.
Dietary administration of carbaryl to rats for 2 years at 400 ppm and 
to dogs for 1 year at 7.2 mg/kg resulted in a transient cloudy swelling of 
the proximal renal tubules in both species. [27] The incidence of renal 
changes seen in the rats was not significant, and similar changes were 
noted in treated as well as in control dogs. Marked vacuolization of the 
proximal tubular epithelium of the kidney in a monkey administered 600 
mg/kg of carbaryl for an unspecified period of time was reported. [44,51] 
It is difficult to draw any conclusion from these studies, [44,51] since 
only a single electron photomicrograph was presented and the length and
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frequency of treatment was not specified. Without other confirming renal 
tubular function tests in significant numbers of occupationally exposed 
subjects or animals exposed at various concentrations of airborne carbaryl, 
the results of the studies previously discussed [27,32,44,51] do not
confirm carbary1-related renal dysfunction in humans. However, sufficient 
suspicion of carbary1-related renal effects is established by these studies 
to warrant a recommendation for surveillance of kidney function in workers. 
The possibility of effects of carbaryl on the kidney needs further
investigation.
No data were found which concerns the effect of carbaryl on any phase 
of human reproduction. It was reported that carbaryl was not teratogenic 
in the monkey, [67,69] mouse, [75] rat, [70] rabbit, [71] hamster, [71] or 
guinea pig, [72] but was teratogenic in the beagle dog [66] and in the
guinea pig. [71] Two studies on rhesus monkeys, performed in the same
laboratory, were available. The first study [67] made use of 21 mated 
females, 7 of which were controls. The monkeys were administered carbaryl 
at oral doses of 2.0 mg/kg (4 animals) and 20.0 mg/kg (10 animals) 
throughout gestation. No fetal abnormalities were found; however, the 
abortion rate was high but not dose related. There was a 50% abortion rate 
(three of six pregnant animals) at the high dose, 100% (two of two pregnant 
animals) at the low dose, and 20% (one of five) in the controls. The small 
number of animals used in this study precludes any reliable evaluation of 
these results. The second study [69] involved 79 monkeys, 48 test and 31 
controls. The doses of carbaryl were 0.2, 2.0, and 20.0 mg/kg administered 
orally from days 20 to 38 of gestation. Abortions occurred in 2 of 16 at 
the lowest dose, in 1 of 16 at the mid-dose, in 3 of 15 at the highest
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dose, in 2 of 15 in vehicle-treated controls, and in 2 of 15 in the 
untreated controls. It was concluded that carbaryl was not associated with 
the producing of terata, abortion, stillbirths, or of any other adverse 
reproductive effects.
Beagle dogs, [66] unlike monkeys, did show reproductive and
teratologic abnormalities when administered carbaryl. Oral doses were 
3.125, 6.25, 12.5, 25, and 50 mg/kg throughout gestation. Dystocia
occurred in 1/3 of treated animals, while decreased numbers of live births 
occurred at all dose levels, as compared to control dams. There were 
abnormalities in pups at all dose levels except at 3.125 mg/kg. The 
litters were smaller than those of the controls in the 25 mg/kg and 50 
mg/kg dose groups.
The teratogenic potential of carbaryl was investigated in several 
other species. Weil et al [70] administered carbaryl in the diet to rats 
at doses of 20, 100, and 500 mg/kg at various intervals throughout
pregnancy or until weaning of the pups. No teratogenic effects
attributable to carbaryl were observed at any dose. Carbaryl was
administered in gelatin capsules to guinea pigs and rabbits. [71] A dose 
of 300 mg/kg given either once or daily during days 11-20 of gestation 
produced a higher incidence of terata in treated guinea pigs than in 
controls. This dose also induced a high mortality rate in the dams. There 
was no evidence from rabbits receiving carbaryl at 50, 100, or 200 mg/kg 
during days 5-15 of gestation of terata when compared to results from 
pregnant controls. Robens [71] also administered carbaryl by gastric
intubation to hamsters at doses of 125 and 250 mg/kg during days 6-8 of
*
gestation. No teratogenic effects were observed at either dose; however,
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30% fetal mortality was observed at the high dose, 10% at the low dose, and 
5.5% in the control group. Dietary or gastric administration to guinea 
pigs of carbaryl doses ranging from 50 to 300 mg/kg on days 10-24 of 
gestation produced no significant increase in the incidence of terata as 
compared to controls. [72] Mice receiving carbaryl in the diet at 10 or 30 
mg/kg from day 6 of gestation to delivery showed no evidence of carbary1- 
related terata. [75]
It may be concluded from the above studies [66,67,69-72,75] that
carbaryl in doses as low as 6.25 mg/kg is teratogenic in only one species,
ie, the beagle dog. [66] The positive findings in the beagle dog and in
the guinea pig are not persuasive. In the one study using guinea pigs,
[71] terata were produced only at doses which resulted in mortality and 
morbidity in some of the dams. In another study in the same species, [72] 
carbaryl administered by gastric intubation or dietary inclusion was found 
not to be teratogenic. Although carbaryl was found to be teratogenic in 
the beagle dog at relatively low doses, [66] the dog metabolizes carbaryl 
differently than the rat, guinea pig, monkey, and, more importantly, 
humans. [33,34,87] The dog, unlike humans, neither excretes 1-naphthol nor 
hydroxylates carbaryl. In view of the apparent differences between dog and 
humans with respect to the metabolism of carbaryl, and the fact that 
carbaryl was reported not to be teratogenic in the rat [70] and guinea pig,
[72] animals that metabolize carbaryl similarly to humans, a standard based 
on teratogenic effects is not recommended. This recommendation will be 
reconsidered if results from future research warrant a change.
Reproductive effects of carbaryl in rats have been reported by 
Shtenberg and Ozhovan [73] in a five-generation reproduction study. Doses
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as low as 2 and 5 mg/kg, administered by gastric intubation, produced
adverse effects including a decrease in spermatogenesis, a decrease in 
sperm motility, an increase in the duration of the estrus, a decrease in 
fertility of females, and a decrease in the survival of pups during the 
first month of life. In addition, degenerative changes of ovarian and 
testicular tissue were observed in the rats receiving carbaryl.
Shtenberg and Rybakova [77] administered carbaryl orally to rats of 
both sexes at doses of 7, 14, and 70 mg/kg for up to 12 months. Growth of 
the rats was inhibited at 14 and 70 mg/kg, while sperm motility in males 
also decreased in a dose-related manner after 12 months of treatment. 
Degenerative changes in the testes, including edema of interstitial tissue 
and destruction of germinal epithelium, were noted in carbaryl-treated male 
rats. In females, the estrus cycle was prolonged at the 14 and 70 mg/kg
doses. In a three-generation reproduction study on gerbils given carbaryl 
in the diet (2,000, 4,000, 6,000, and 10,000 ppm), Collins et al [78]
reported that no litters were produced at 10,000 ppm in the F3b generation, 
and that there was a decrease in fertility, pup viability, litter size, and 
survival of pups (to day 4 and to weaning) which appeared sporadically at 
all dose levels.
In a similar three-generation reproduction study, Collins et al [78] 
reported that doses of 5,000 and 10,000 ppm carbaryl in the diet reduced 
survival of offspring, viability of the pups, and litter size in rats from 
the first generation on. At 2,000 ppm, only body weight gain of the 
parents and weanling weight were affected. In contrast, Weil et al [72] 
did not see any effect when carbaryl was administered by dietary inclusion
to rats in a dose range of 7-100 mg/kg. An increased duration of the
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gestation period was the only effect seen at 200 mg/kg in the diet. 
Administration of carbary1 by gastric intubation to rats in a dose range of 
3-100 mg/kg showed effects only at the highest dose which included 
decreased pup viability and litter size, as well as decreased fertility and 
lengthened gestation period in the females.
The above studies [72,73,77,78] indicate that carbaryl has an effect 
on several aspects of reproduction in rodents administered carbaryl. 
Because of the uncertainty in extrapolating reproductive effects seen in 
animals administered carbaryl orally to those that may be encountered from 
pulmonary and dermal absorption during occupational exposure, a standard 
based on these effects is not now recommended. The effects of airborne 
carbaryl on reproduction is clearly an area for future research.
Mutagenic studies have been carried out in mammalian (mouse) [59] and 
bacterial systems (E coli, H influenzae, and B subtilis) [63,65] and on 
yeast (S cervisiae). [64] These studies indicate that, under the
experimental conditions used, carbaryl did not demonstrate any mutagenic
effects. Experiments on an insect (Drosophila) [62] showed only weak
mutagenicity. These studies do not warrant a conclusion that carbaryl is a 
mutagen. Microbiologic studies on bacterial systems [63,65] and yeast
cells [64] indicated that nitrosocarbaryl is a strong mutagen. However,
there are no available data indicating that carbaryl is converted by the
human body to nitrosocarbaryl. In addition, the reaction would most likely 
occur at low pH, ie, in the stomach, so it would be applicable to ingested, 
but perhaps not to inhaled, carbaryl. Thus, from present evidence, it does 
not seem likely that carbaryl will cause mutations in exposed workers.
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The carcinogenic potential of carbaryl has been investigated in mice. 
[27] Male mice received 10 mg carbaryl subcutaneously once weekly during 
their 3rd to 8th months of life. There was no increased incidence of 
tumors over that observed in controls. Innes et al [79] administered 
carbaryl to mice (4.64 mg/kg) by stomach tube on days 7-28 of age and then 
in the diet, at a level stated to be equivalent to the amount ingested, for 
the duration of the experiment, which lasted approximately 18 months. 
Carbaryl gave no significant evidence of tumorigenicity in this experiment.
Rats were administered carbaryl (50-400 ppm) in the diet for a period 
of 2 years [27]; there was no dose-related increase in the incidence of 
tumors over that in controls. In a USSR study, [80] rats received carbaryl 
at 30 mg/kg twice weekly by the oral route for up to 22 months. A second 
group of rats were treated with carbaryl (20 mg) by subcutaneous 
implantation in a paraffin capsule for the same duration. Only 12 of 60 
animals receiving carbaryl by the oral route survived, and 4 had cancerous 
tumors. Only 10 of 48 rats survived treatment with carbaryl subcutaneously 
and 2 had subdermal fibrosarcomas, neither being at the implantation site. 
Only one tumor was observed in the control group, in 46 of 48 rats which 
survived. The high and unexplained death rates in test animals, though the 
authors suggested little carbaryl toxicity, and the unusual incidence of 
fibrosarcomas in test and control rats in the absence of a local cause such 
as implantation, makes this study difficult or impossible to interpret. In 
addition, there is reason to suspect that the sample used was contaminated 
by the 2-naphthyl derivative.
Shimkin et al [81] administered N-methyl naphthyl carbamate of their 
own formulation ip to mice, 0.5 mg 3 times/week for a total dose of 6
128
mg/mouse over a 12-week period and observed the animals for the development 
of pulmonary tumors. When compared to other carbamates which were actively 
tumorigenic in this study, the synthesized compound was classed as giving a 
marginal response. No information was given as to the purity of the
compound synthesized and, more importantly, it is not clear from the 
structural formula shown in the publication [81] whether 2-naphthyl-N- 
methylcarbamate or 1-naphthyl-N-methylcarbamate (carbaryl) was synthesized. 
Consequently, the tumorigenic results reported in the study are impossible
to interpret as being carbaryl related. The studies described previously
[27,79-81] do not warrant a conclusion that carbaryl is a carcinogen.
Future research may clarify the apparent discrepancies in the USSR study 
[80] and thereby support or refute the implications of the study by Innes 
et al. [79]
The neuromuscular degenerative potential of carbaryl was investigated 
in pigs by Smalley et al. [52] Microscopic examination showed skeletal 
myodegeneration and vasogenic edema of the CNS but not demyelination after 
1-3 months of large oral doses (150-300 mg/kg daily) of carbaryl. The 
toxic effects noted at these doses included tremors, ataxia, 
incoordination, prostration, and eventual death. [52] Reports of 
neuromuscular changes such as these have not been found for other species 
of experimental animals. Carpenter et al [27] administered carbaryl to 
chickens at very high single subcutaneous doses, 0.25-3 g/kg, and found 
that leg weakness occurred in 1-2 days at doses higher than 1 g/kg. There 
was no microscopic evidence of demyelination in tissue sections of the 
sciatic nerve, spinal cord, and brain. The authors concluded that leg 
weakness was the only evidence of a transient cholinergic effect in the
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chicken. The results of another study in chickens by Gaines [43] lends 
support to the conclusions of Carpenter et al [27] that carbaryl does not 
cause demyelination. Male dogs treated with 30 mg/kg of carbaryl iv were 
found to have less marked signs of intoxication including leg weakness than 
male pigs treated iv with 20 mg/kg carbaryl. [55] Dietary administration 
of 125 mg/kg of carbaryl failed to produce overt signs of toxicity in dogs, 
but did produce spastic paresis of the posterior extremities in pigs. [55] 
The results obtained with chickens [43,116] and dogs [55] show that 
apparently only very high doses of carbaryl will produce neuromuscular 
effects, eg, leg weakness, in these species, probably as a consequence of 
cholinesterase inhibition. Since no demyelination occurred in the swine 
[52] nor in the chicken, [27] which is the animal of choice for 
demonstrating demyelinating effects, it may be concluded that carbaryl is 
unlikely to produce demyelinating paralytic effects in humans.
The potential for dermal penetration by carbaryl in humans has been 
established experimentally by Feldmann and Maibach [30,31] and suggested 
indirectly by Union Carbide Corporation. [13 (sec 9,10)] In addition, 
absorption of carbaryl occurs through the skin of animals as indicated by 
death in rats [49] and inhibition of cholinesterase activity in rabbits 
[39] after dermal application of carbaryl at high doses to these species. 
However, the quantitative dermal absorption of carbaryl by humans during 
occupational exposure has not been accurately determined. Adverse local 
ocular effects have not been reported in humans, but minor eye irritation 
has been demonstrated in animals after local application of carbaryl. [39] 
It is therefore concluded that dermal and eye exposure are factors to be 
considered in the workplace environment. Appropriate work practices to
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prevent or limit such contact are thus recommended.
Overexposure to carbaryl in the workplace environment apparently 
results in a rapid onset of symptoms which leads to voluntary cessation of 
work and termination of exposure. [13 (sec 13),20] Moreover, employees who 
have been overexposed to carbaryl in the workplace apparently recover 
rapidly. [13 (sec 7,13)] Because of a possible additive effect on the 
inhibition of the enzyme cholinesterase, workers occupationally exposed to 
both carbaryl and other anticholinesterase agents probably are at a greater 
risk than those exposed only to carbaryl. Those workers who have a
congenital deficiency in cholinesterase enzymes or who routinely take 
anticholinesterase drugs should be cautioned that they are at a greater 
risk of intoxication by carbaryl.
The current ACGIH [149] recommended standard of 5.0 mg/cu m was based 
on the study by Best and Murray, [28] which suggested that over a period of 
19 months, workers could tolerate airborne carbaryl concentrations up to 31 
mg/cu m. At no time were there any signs or symptoms indicative of
anticholinesterase activity, although absorption of carbaryl was verified 
by measurement of urinary 1-naphthol levels. To provide a safety factor 
for protection against systemic effects, a Threshold Limit Value of 5.0
mg/cu m was recommended. While available data to derive a safe limit are
insufficient, there is no significant evidence indicating that the limit 
should be changed. In the absence of these needed data, it is proposed 
that the present workplace environmental limit of 5.0 mg carbaryl/cu m as a 
TWA concentration be continued.
Available data do not indicate that exposure of workers at this 
concentration will result in intoxication, and some data suggest that this
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limit offers a good margin of safety. However, pertinent investigations, 
including epidemiologic studies of workers exposed to carbary1, are needed 
to validate this recommended limit or, if appropriate, to provide a basis 
for a better limit.
Sampling and analysis methods were reviewed in Chapter IV. Airborne 
particulate carbaryl should be collected on a glass-fiber membrane filter 
mounted with a backup pad in a two-piece closed-face cassette. This 
sampling method, chosen because it is the best now available, has been 
shown to provide the required degree of collection efficiency for airborne 
particulate carbaryl. A colorimetric method was selected for analysis of 
carbaryl because it is reliable, sensitive, and simple to carry out. The 
selected method is not entirely specific for carbaryl analysis and several 
compounds including 1-naphthol can interfere with the precision of the 
method if they are present in the air sample to be analyzed.
Work practices are discussed in Chapter VI. In operations involving 
the handling or use of carbaryl formulations, the potential for skin and 
eye contamination with subsequent absorption is great, and therefore 
protective clothing and equipment should be worn whenever required to 
prevent absorption through the skin or contamination of the eye. To 
minimize percutaneous absorption, employees exposed to carbaryl should wear 
freshly laundered work clothes before the work shift. They should also 
shower or bathe and change clothing after the workday. Storage, handling, 
and eating of food in carbaryl exposure areas should be prohibited to 
prevent food contamination, and therefore ingestion of carbaryl by 
employees.
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The neurotransmitter function of acetylcholine in the nervous system 
and the inactivation of acetylcholine by cholinesterase has been discussed 
in Chapter III. The inhibition of cholinesterase by carbaryl in the 
nervous system warrants a requirement for preplacement physical 
examinations directed towards the cardiorespiratory system, the CNS, and 
the eyes. In addition, such examinations must be made on a yearly basis or 
at some other interval determined by the responsible physician for 
employees subject to occupational exposure to carbaryl. It is recommended 
that preplacement erythrocyte cholinesterase determinations be performed if 
one of the methods described as suitable in Chapter IV can be used. Such a 
preplacement determination can serve as a useful comparison in the event of 
overexposure. Since the kidney is the primary organ for excretion of 
carbaryl and its metabolites, it is proposed that medical surveillance 
include a complete urinalysis including microscopic examination.
No information has been found regarding the passage of carbaryl into 
human milk. As discussed in Chapter III, carbaryl has been found in the 
milk of dairy animals after their exposure to the insecticide. It seems 
reasonable to assume that carbaryl may be excreted in human milk, and 
therefore nursing mothers must be counseled to minimize exposure to 
carbaryl wherever possible. Research to confirm or refute this assumption 
should be performed.
It is recognized that many workers are exposed to small amounts of 
carbaryl or are working in situations where, regardless of amounts used, 
there is only negligible contact with the material. Under these 
conditions, it should not be necessary to comply with many of the 
provisions of this recommended standard, which has been prepared primarily
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to protect workers' health under more hazardous circumstances. Concern for 
workers' health requires that protective measures be instituted below the 
enforceable limit to ensure that exposures stay below that limit. For 
these reasons, an action level of carbaryl has been defined as occupational 
exposure above half the recommended TWA environmental limit, thereby 
delineating those work situations which do not require the expenditure of 
health resources for environmental and medical monitoring and associated 
recordkeeping. This level has been chosen on the basis of professional 
judgment rather than on quantitative data that delineate nonhazardous areas 
from areas in which a hazard may exist. However, because of nonrespiratory 
hazards such as those resulting from skin or eye contact, it is recommended 
that appropriate work practices and protective measures be required 
regardless of the TWA concentrations. Similarly, food storage, handling, 




Occupational exposures to carbaryl may occur among people engaged in 
the manufacture, formulation, or application of the insecticide. 
Potentially exposed applicators include agricultural workers, spray pilots, 
and exterminators. [22] Even though absorption of pesticides by the oral 
and respiratory routes may be more rapid and more complete than by the 
percutaneous route, the amount of absorption by ingestion and inhalation is 
probably too small a fraction of the total potential exposure to be 
considered the main factor in most cases of intoxication of workers in the 
field. [152] Studies also showed that considerably more insecticide was 
deposited on exposed skin surfaces than that reaching the respiratory 
tract. [89,90] The average potential respiratory exposure tended to be 
higher in agricultural dusting operations than in agricultural spraying 
operations, while the potential dermal exposure was about the same in both 
spray and dust applications. [153] Absorption of carbaryl into the body 
has occurred by three routes of entry: dermal, [30,31] respiratory, [13
(sec 7,9,10)] and oral. [32-34,40] Simpson [90] summarized the relative 
importance of the dermal and respiratory routes of absorption of carbaryl 
by orchard spray applicators by stating that, although inhalation exposure 
is considerably less than dermal exposure, it has an additive effect. 
Inhalation would be an important factor only if the worker already had 
experienced sufficient percutaneous absorption approaching a level of 
absorption at which symptoms occur. [90] Employees occupationally exposed 
simultaneously to carbaryl and other anticholinesterase agents are at a 
greater risk because of a possible additive effect on the inhibition of the
135
enzyme cholinesterase. However, available evidence indicates that the 
effect would not be potentiated. [48,116] Those employees who have a 
congenital deficiency in cholinesterase enzymes or who routinely take 
anticholinesterase drugs should likewise be cautioned against additive 
effects.
Because the potential for skin contamination, with subsequent 
absorption of carbaryl through the skin, is great during many handling 
operations involving carbaryl formulations, [88] use of appropriate 
personal protective equipment is necessary during such operations to 
minimize skin exposure. The specific protective equipment required depends 
on the degree of potential exposure and the body areas that may be exposed. 
Workers should use all personal protective equipment and exercise all 
precautions specified on the label of the carbaryl formulation being used.
Protective clothing should be worn wherever required to prevent skin 
contact with carbaryl. In agricultural situations, personal protective 
clothing and respiratiors may be the only practical ways to minimize worker 
exposure. The areas of highest potential exposure for formulating-plant 
workers have been found to be the hands, forearms, and front of the body; 
[88] for spray operators, the areas of highest potential exposure have been 
reported to be the shoulders and back of the neck, [88] the head, arm, 
chest, shoulders, and back. [90] Hats and other special clothing covering 
these areas should be used. Long-sleeved coveralls and gloves are 
recommended for all exposure situations. Fresh clothing should be worn 
daily. In addition, workers should be advised to shower or bathe after the 
workday.
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In agricultural situations, because of possible bodily contamination 
by contact with sprayed foliage, as established for other insecticides, 
[154] immediate entry into sprayed areas should be avoided if possible. 
Johnson and Stansbury [155] established the half-life of carbaryl on 
various growing crops to be 2-4 days, and the half-life in soil to be 
approximately 8 days.
All personnel exposed to carbaryl should wear freshly laundered 
coveralls or work uniforms (long pants and long-sleeved shirts). [156] 
Work clothes should be laundered separately from household laundry. If the 
coveralls or uniform might become wet by mist or spray, use of a waterproof 
raincoat will provide the best protection for the upper back, shoulders, 
and forearms, [152] but this may cause discomfort or even heat stress in a 
hot environment. [157] Under such conditions, wearing long-sleeved 
clothing such as water-repellant or waterproof clothing that will not be 
easily penetrated by the insecticide should provide a significant measure 
of protection. [152]
Protection of the lower trunk and legs from contamination is 
important where the potential exists for liquid spillage, soaking by 
continued contact with sprays or sprayed foliage, or penetration of 
clothing through excessive contact with carbaryl. Waterproof trousers will 
provide the best protection for the lower trunk and leg areas. [152] Even 
though the coveralls or uniform is covered by waterproof protective 
clothing, daily bathing after work [152] and daily changes to freshly 
laundered clothing [152,157,158] are important for minimizing percutaneous 
absorption.
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The head and neck should be protected from contact with carbaryl. 
[156] Therefore, some type of protective headgear, such as waterproof 
rainhats and washable safety hardhats and caps, should be worn. Waterproof 
or water-repellant parkas also may be used to protect the head and neck at 
the same time. [156] Personnel potentially exposed to downward drifts of 
carbaryl [152] should wear wide-brimmed, water-repellant, or waterproof 
hats to obtain additional protection for the head and neck areas. [152]
Workers handling concentrated wettable powders, concentrated liquids, 
or finely divided dust formulations should wear protective gloves of 
natural rubber [156,158] or of neoprene, [159] although the permeability of 
natural rubber or neoprene to carbaryl remains to be determined. Contact 
of wet skin with carbaryl should be avoided to minimize absorption.
If an employee might come in contact with concentrated formulations, 
his hands often will be the body area receiving the highest exposure. 
Unlined rubber gauntlet gloves, which cover the wrist area not normally 
protected by the sleeve, provide the best protection. [152] These gloves 
can be turned wrong side out for proper cleansing of the inside surface.
Use of waterproof footwear is necessary to minimize exposure when the 
carbaryl formulation may wet the feet. [152] Footwear should be washed and 
dried thoroughly, inside and out, as frequently as necessary to remove 
carbaryl contamination. [156]
Safety goggles should be used to minimize eye exposure when spray or 
dust drift may be encountered, [156] but a face shield is superior to 
goggles when liquid pesticide is handled. [157] Use of eye protection by 
pilots applying carbaryl by aircraft is particularly important. Although 
reports of miosis following eye exposure to carbaryl were not found, Upholt
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et al [160] showed that eye exposure of pilots to the cholinesterase 
inhibitor tetraethylpyrophosphate (TEPP) induced miosis. Infrequent 
unilateral eye contamination of pilots applying TEPP was found to result in 
incoordination and reduced ability to judge distance. [160] Although TEPP 
is a highly toxic organophosphate insecticide and carbaryl is a 
considerably less toxic carbamate insecticide, carbaryl is also a 
cholinesterase inhibitor. Therefore, the possibility of the development of 
these effects after unilateral eye contamination should be considered. The 
accompanying incoordination could present a significant safety hazard to 
pilots. [160] It is therefore recommended that pilots engaged in aerial
spraying of carbaryl wear goggles.
Respiratory protection as specified in Chapter I must be used 
whenever airborne concentrations of carbaryl cannot be controlled by either 
engineering or administrative controls to the workplace environmental limit 
recommended in this standard. High levels of airborne carbaryl in industry 
may be present in uncontrolled atmospheres. [13 (sec 10),28]
To minimize absorption of carbaryl through ingestion, employees must 
not store and use food, beverages, tobacco, or other materials that may be 
placed in the mouth in the exposure areas. Washing of hands before eating 
and smoking to further minimize the potential for Ingestion is a good 
practice and should be required.
The employer is responsible for proper disposal of surplus pesticides 
and pesticide containers. [161,162] Disposal activities should be directed 
toward minimizing the potential for exposure of personnel to carbaryl and 
toward minimizing adverse environmental effects. Spills of carbaryl, 
generally in dry, solid forms, should be vacuumed or shoveled into suitable
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containers for subsequent reuse or for transfer to a waste disposal 
facility. [13 (sec 16)] Liquid spills should be covered with large amounts 
of absorbent clay and shoveled into disposable containers and the process 
repeated until the contaminated area is dry. The area is then scoured with 
hydrated lime and water and the slurry is then blotted with absorbent. 
[159] The Environmental Protection Agency has established regulations 
defining prohibited procedures pertinent to the disposal of surplus 
pesticides and containers (40 CFR 165, published in the Federal Register 
39:36867-70, October 15, 1974). Specifically, open dumping is prohibited, 
and water dumping is generally prohibited. Open burning is also 
prohibited, except for small quantities of combustible containers, not to 
exceed 50 pounds or the quantity emptied in a single workday, whichever is 
less. Such open burning may be performed only where it is consistent with 
federal, state, or local ordinances. "Open burning" means the combustion 
of a pesticide, pesticide container, or pesticide-related waste in any 
fashion other than by incineration in a pesticide incinerator (40 CFR 165, 
published in the Federal Register 39:36867-70, October 15, 1974).
Applicable local, state, and federal regulations should be consulted; if 
such regulations do not exist, suggested precautions include incineration 
and burial. Incineration or burial should be performed in a manner not 
contributing to air or water pollution.
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VII. RESEARCH NEEDS
Further research is required to assess the effects of long-term
occupational exposure to carbaryl, primarily as airborne dust. There is a 
need for epidemiologic studies of populations exposed to carbaryl, alone 
and in combination with other materials, in industry and in agriculture.
Animal studies which focus directly on exposures simulating those of 
industrial and agricultural workers, including qualitative studies of the 
effects of exposure to known airborne concentrations, are also important to 
clarify mechanisms.
The toxicity of carbaryl by various routes of exposure should be
correlated with possible variations in absorption, metabolism, and products 
excreted. Investigation into the validity of urinary 1-naphthol as an 
Indicator of carbaryl exposure is particularly important, since 
cholinesterase inhibition by carbaryl is readily reversible, and hence of 
less value in detecting exposure than would otherwise be the case. The
suggestion that carbaryl can cause tubular or other renal dysfunction 
suggested by the amino acid nitrogen to creatinine ratio reported by Wills 
et al [32] should be studied further to determine whether carbaryl is 
directly responsible for this effect and the mechanism involved. Since 
carbaryl is metabolized to 1 -naphthol in humans and is excreted in the 
urine, more information is needed on the toxicity of 1-naphthol and its
effect on renal function.
The excretion of carbaryl and its metabolites in milk and its effects 
on the nursing young should be evaluated in various species. Information
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is needed to clarify if carbaryl is excreted in human milk and its effect 
on the infant.
Further research is needed to support or refute conclusions arrived 
at in this document about the lack of applicability of available data 
obtained from experimental animals, on fetal deformities from carbaryl. 
The mechanism of development of such effects in animals in which fetal 
abnormalities have been observed, eg, whether they are a sequel of an anti­
cholinesterase action or whether they result from toxic action of carbaryl 
metabolites in such species, should be elucidated. But of even more 
Importance is the development of a national surveillance system that can 
relate incidences and nature of spontaneous abortions, fetal abnormalities, 
or developmental defects in children to the occupations and therefore to 
the exposures of the parents to chemical and physical agents. This would 
have applicability not only to carbaryl but also to many other occupational 
hazards.
Research is also needed for clarifying present conflicts in data on 
mutagenic or carcinogenic effects of carbaryl on mammals. Since 
nitrosocarbaryl has been shown to be mutagenic in yeast [64] and bacteria, 
[63,65] the possibility that this compound may be formed in the mammalian 
body if carbaryl is present should be investigated.
Improved sampling and analytical methods for carbaryl are needed. 
Materials impervious to all carbaryl formulations should be identified for 
use in protective clothing.
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IX. APPENDIX I 
AIR SAMPLING METHOD
The sampling method for airborne carbaryl presented in Appendix I is 
adapted from a validated NIOSH method. [97]
General Requirements
To evaluate conformance with the standard, collect breathing-zone 
samples representative of the individual worker's exposure. Record the
following on all sampling data sheets:
(a) The date and time of sample collection.
(b) Sampling duration.
(c) Volumetric flowrate of sampling.
(d) Worker's name and job title and description of work station.
(e) Temperature and atmospheric pressure.
(f) Other pertinent information.
Air Sampling
(a) Collect breathing-zone samples as close as practicable to the 
employee's face, without interfering with the employee's freedom of 
movement, to characterize the exposure from each job or specific operation 
dealing with manufacture, formulation, or application of carbaryl.
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Collect eight 1-hour breathing-zone samples representative of worker 
exposure in each operation. Sampling flowrates should be checked 
frequently. When filters become clogged so that airflow is too restricted,
change the filters and initiate the collection of new samples.
(b) Collect samples using a portable sampling pump whose flow can 
be determined to an accuracy of ± 5% at 1.5 liters/minute. Connect the 
pump to the filter unit, which consists of a glass-fiber filter (Type A, 37 
mm in diameter) mounted in a polystyrene 37-mm, two-piece cassette holder 
and supported by a backup pad. Use only membrane filters which are free of 
organic binders. Do not use Tenite filter holders.
(c) Operate the sampler at a known flowrate of 1.5 liters/minute,
and record the total sampling time. A sample size of 90 liters is
recommended.
(d) Remove the glass-fiber filter from the cassette filter holder
within 1 hour of sampling and place it in a clean screwcap bottle. Handle
the filter only with clean tweezers. The bottle caps should be lined with
Teflon for proper seal. These bottles (a 45-mm tissue-sample holder is
satisfactory for shipping) are also used to contain the solution during 
analysis.
(e) With each batch of 10 samples, submit 1 filter from the same 
lot used for sample collection, subjecting it to exactly the same handling 
as the samples except that no air is drawn through it. Label this as a 
blank.
(f) Take the screwcap bottles which contain the samples and ship 
them in suitable containers designed to prevent damage while in transit.
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Calibration of Sampling Trains
The accurate calibration of a sampling pump is essential for the 
correct interpretation of the volume indicated. The frequency of 
calibration is dependent on the use, care, and handling to which the pump 
is subjected. In addition, pumps should be recalibrated if they have been 
subjected to misuse or if they have just been repaired or received from a 
manufacturer. If the pump receives hard usage, more frequent calibration 
may be necessary. Regardless of use, maintenance and calibration should be 
performed on a regular schedule and records of these kept.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration is dependent on the 
type of instrument used as a reference. The choice of calibration 
instrument will depend largely upon where the calibration is to be 
performed. For laboratory testing, a 1- or 2-liter buret or wet-test meter 
is recommended, although other standard calibrating instruments, such as 
spirometer, Marriott's bottle, or dry-gas meter, can be used.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be 
used. The calibration setup for personal sampling pumps with a glass-fiber 
membrane filter is shown in Figure XIII-1. Since the flowrate given by a 
pump is dependent on the pressure drop of the sampling device, in this case 
a membrane filter, the pump must be calibrated while operating with a 
representative filter and backup pad in line.
(a) While the pump is running, check the voltage of the pump 
battery with a voltmeter to assure adequate voltage for calibration.
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Charge the battery if necessary.
(b) Place the glass-fiber membrane filter with backup pad in the 
filter cassette.
(c) Assemble the sampling train as shown in Figure XIII-1.
(d) Turn the pump on and moisten the inside of the soapbubble 
meter by immersing the buret in the soap solution and drawing bubbles up 
the inside until they are able to travel the entire buret length without 
bursting.
(e) Adjust the pump rotameter to provide a flowrate of 1.5 
liters/minute.
(f) Start a soapbubble up the buret and measure with a stopwatch 
the time it takes the bubble to pass through a minimum of 1.0 liter.
(g) Repeat the procedure in (f) above at least three times,
average the results, and calculate the flowrate by dividing the volume 
between the preselected marks by the time required for the soapbubble to 
traverse the distance.
(h) Record the following calibration data: volume measured,
elapsed time, air temperature, atmospheric pressure, serial number of the 
pump, date, and name of the person performing the calibration.
(i) Corrections to the flowrate may be necessary if the
atmospheric pressure or temperature at the time of sample collection 
differs significantly from those conditions under which calibration was 
performed. Corrected flowrates may be calibrated using the following 
formula:
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q (sampling) - q (indicated) x / P (sampling) x T (calibration)V P (calibration) T (sampling)
where:
q * volumetric flow rate (liters/minute)
P = atmospheric pressure (torr or pounds/square inch) 
T ■ temperature (degrees Kelvin or Rankine)
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X. APPENDIX II 
ANALYTICAL METHOD FOR CARBARYL
The analytical method for carbaryl presented in Appendix II is a 
validated NIOSH method. [97]
Principle of the Method
A known volume of air is drawn through a glass-fiber membrane filter 
to trap the carbaryl particles present. Alcoholic potassium hydroxide is 
used to extract and hydrolyze the carbaryl trapped in the filter. An 
aliquot is then reacted with p-nitrobenzenediazonium fluoroborate to form a 
colored complex. The amount of complex formed is determined with a 
spectrophotometer to give a quantitative measurement of carbaryl. [97]
Range and Sensitivity
This method has been validated over the range of 1.96-13.43 mg/cu m, 
at 24 C and 763 mmHg. The probable range of the method is 0.1-18 mg/cu m, 
based on the range of standards used to prepare the standard curve. For 
samples of higher concentration where the absorbance is greater than the 
limits of the standard curve, the samples may be diluted with methanolic 
potassium hydroxide (prior to removal of an aliquot to use for color 
development) to extend the upper limit of the range. A concentration of 




The presence of any background 1-naphthol will exaggerate the
analytical reading. Other substances such as phenols and aromatic amines
which form derivatives with p-nitrobenzenediazonium fluoroborate or those 
which have significant absorbance around 475 nm will interfere if present 
in the air sample.
Precision and Accuracy
The coefficient of variation (Cv) for the total analytical and 
sampling method in the range of 1.96-13.43 mg/cu m was 0.057. This value 
corresponds to a 0.28 mg/cu m standard deviation at the recommended 
environmental limit of 5 mg/cu m.
A collection efficiency of 1.00 was determined for the collection 
medium. Thus, no correction for collection efficiency is necessary, and it 
is assumed that no bias is introduced in the sample collection step. There
is also no apparent bias in the sampling and analytical method. Thus, Cv
is a satisfactory measure of both accuracy and precision of the sampling 
and analytical method.
Apparatus
(a) 25-ml volumetric flasks.
(b) Screwcap bottles (45-mm tissue-sample holders with Teflon-
lined caps).
(c) Assorted micropipets to deliver between 3 and 35 microliters.
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(d) 10-ml glass syringe attached to a stainless steel Luer-Lok 
fitted filter folder for 13-mm Teflon filters.
(e) 10- and 25-ml glass-stoppered graduated cylinders.
(f) Mechanical wrist-action shaker.
(g) Spectrophotometer cell with 1-cm path length.
(h) Spectrophotometer.
Reagents
(a) Carbaryl, analytical grade.
(b) Potassium hydroxide, 0.1 M in absolute methanol.
(c) p-Nitrobenzenediazonium fluoroborate: Dissolve 25 mg in 5 ml
of absolute methanol. Add 20 ml of glacial acetic acid to this solution. 
Prepare fresh daily.
(d) Glacial acetic acid.
(e) Carbaryl Standard Solution: Dissolve 460 mg of carbaryl in 10
ml of methylene chloride.
Analysis of Samples
(a) Analyze each filter separately.
(b) Add 20 ml of 0.1 M methanolic potassium hydroxide to the 
screwcap bottle containing the filter.
(c) Place the bottle on a mechanical wrist-action shaker for 5 
minutes.
(d) Transfer 2 ml of the solution to a clean screwcap bottle.
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(e) Add 17 ml of glacial acetic acid and immediately cover the 
bottle with a Teflon-lined screwcap. Mix by swirling.
(f) Add 1 ml of p-nitrobenzenediazonium fluoroborate solution. 
The color will develop in 3-5 minutes. The sample should be analyzed 
within 20 minutes.
(g) The solution will contain glass fibers from the filter. Use 
the 10-ml syringe fitted with a filter holder containing a Teflon filter to 
transfer the solution from the bottle to the 1-cm cell. The solution is 
poured into the barrel of the syringe and forced through the filter into 
the cell by moving the plunger down the barrel.
(h) Adjust the baseline of the spectrophotometer to zero with 
distilled water in both cells.
(i) Read the absorbance of the sample at 475 nm against a blank 
prepared in the same fashion as the samples.
Calibration and Standards
(a) Pipet 20 ml of 0.1 M methanolic potassium hydroxide into each 
of six 25-ml volumetric flasks.
(b) Carefully pipet 3, 8, 15, 25, and 35 microliters of the
standard solution into the flasks. Process one flask as a blank.
(c) After 5 minutes, pipet 2 ml of each solution into a clean 25- 
ml volumetric flask.
(d) Add 17 ml of glacial acetic acid and mix.
(e) Add 1 ml of p-nitrobenzenediazonium fluoroborate solution and
mix.
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(f) Allow the solution to react for 20 minutes.
(g) Adjust the baseline of the spectrophotometer to zero by 
reading distilled water in both cells.
(h) With the wavelength set at 475 nm, read the absorbance of the 
sample against the absorbance of the blank.
(1) Construct a calibration curve by plotting absorbance against
micrograms of carbaryl in the standard.
Calculations
(a) Determine from the calibration curve the micrograms of 
carbaryl present in each sample.
(b) The concentration of carbaryl in the air sampled can be 
expressed in mg/cu m (mg/cu m - pg/liter):
Carbaryl, mg/cu m - ________ jug in sample_______
air volume sampled (liters)
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XI. APPENDIX III 
SUGGESTED MEDICAL MANAGEMENT OF SYMPTOMATIC CARBARYL INTOXICATION
Carbaryl intoxication can generally be treated successfully with 
measures directed toward alleviation of symptoms.
If more aggressive treatment should be considered necessary, atropine 
sulfate can be administered. Pralidoxime chloride (PAM) and other oximes 
should not be used in carbaryl poisoning. In his Clinical Handbook on 
Economic Poisons, [21] Hayes pointed out that, depending on the severity of 
the case, all methods used for treating organophosphorus compounds may be 
useful in the management of carbaryl intoxication, with the specific 
exception of pralidoxime (PAM) which should not be used.
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XII. APPENDIX IV 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are Inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
Information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor'8 trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a
single component product must have the name of the material repeated in
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or if not available, from other sources of publications such as 
the American Conference of Governmental Industrial Hygienlsts or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity
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or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
Include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury 
(nmHg); vapor density of gas or vapor (air * 1); solubility in water, in 
parts/hundred parts of water by weight; specific gravity (water = 1); 
percent volatiles (Indicated if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Bolling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This Information is 
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate 
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the
product, including flashpoint and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to
cleanup detail. Specific neutralizing chemicals or procedures should be
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill" or "incineration." Warnings such as "comply with
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of
construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on 
any aspect of safety or health not covered in other sections should be 
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous material. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M AN U FACTU R ER  S NAME
REG U LAR  TELEPHONE NO. 





M ATER IAL  OR COMPONENT % HAZARD DATA
III PHYSICAL DATA
BOILING POINT, 760 MM HG MELTING  POINT
SPECIFIC G R AV ITY  (H^O*!) VAPOR PRESSURE
VAPOR DENSITY (AIR-1) SOLUBILITY IN H20. % BY WT
% VO LATILES  BY VOL EVAPORATION RATE (BUTYL AC E TA TE M I
APPEARANCE AND ODOR
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IV FIRE AND EXPLOSION DATA
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EXTINGUISHING
MEDIA






V HEALTH HAZARD INFORMATION
HEALTH  HAZARD  DATA






EFFECTS OF OVEREXPOSURE 
ACUTE OVEREXPOSURE
CHRONIC OVEREXPOSURE








CONDITIONS CONTRIBUTING TO  INSTABILITY
INCOMPA1 (BILITY
HAZARDOUS DECOMPOSITION PRODUCTS
CONDITIONS CONTRIBUTING TO HAZARDOUS POLYM ERIZATION
VII SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN  IF M ATER IAL  IS RELEASED  OR SPILLED 
NEUTRALIZING  CHEMICALS
WASTE DISPOSAL METHOD
VIII SPECIAL PROTECTION INFORMATION
VENTILATION  REQUIREMENTS
SPECIFIC PERSONAL PROTECTIVE EQUIPMENT 
RESPIRATO RY (SPECIFY IN DETAIL)
EYE
GLOVES











XIII. TABLES AND FIGURE
TABLE XIII-1
PHYSICAL PROPERTIES OF CARBARYL
Appearance White, crystalline solid
Empirical formula C12H1102N
Formula weight 201.22
Flashpoint, open cup 
(Cleveland)
193 C
Melting point 142 C
Specific gravity 1.232 at 20 C
Vapor pressure 0.000041 mmHg at 25 C, 




0.02 oz/cu ft (20.3 g/cu m)
Solubility in water 40 ppm at 30 C
Solubility in organic Moderately soluble in acetone,
solvents N,N-dimethyl formamide, isophorone 
and cyclohexanone
Stability Stable to light, heat, and 
acids; hydrolyzed in alkalies
Adapted from Kirk-Othmer, [11] Merck Index, [12] Union Carbide Corporation, 
[13 (sec 16)] and HH Moorefield (written communication, February 1976)
176
TABLE XIII-2 























CONCENTRATIONS (MG/KG) OF CARBARYL 
IN RABBIT TISSUES AND EXCRETORY FLUIDS AFTER 
SINGLE ORAL DOSES OF 400 MG/KG OF CARBARYL
Sample Hours after Administration
0.5 1 2.5 4 18 24 48
Brain 0.0075 0 0.03 0.054 0 0.215 0.03
Medulla oblongata 0.015 - 0.03 0.09 - - 0
Cerebellum 0.021 - 0.03 - - - 0
Kidneys 0.03 0.75 0.75 0.18 1.125 0 0
Spleen 0.075 0.075 - 0.036 0 0 0
Liver 0.225 0.975 0.15 0.036 0.15 0 0.075
Heart 0.3 0 0.03 0.018 0 0 0
Lungs 0.003 0 0 0.015 0 0 0
Lumbar muscles 0.03 0.03 0 0.012 0 0 0
Femoral muscles 0.03 0 0 0 0 0 0
Bile 3.75 0.075 4.5 0.18 1.5 1.5 1.5
Urine 1.5 1.125 11.25 1.8 0 0.75 0
Testes 0.075 0 0 0.09 - 0 0
Kidney fat 1.25 0.6 0.036 0 0.03
Adapted from Bukin and Filatov [86]
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TABLE XIII-4
CARBARYL METABOLITES FROM MAMMALIAN* URINE
Metabolites Labeled Forms of Carbaryl**




Unidentified neutrals R G M P S D R G M P S D R R Ho Hi
1-Naphthyl methylcarbamate
N-glucuronide G G R
Unidentified metabolite (A) R G D R G M D R R Ho
1-Naphthyl methylimido-
carbonate-o-glucuronide R G M P S D R G M P S D R R Ho
Unidentified metabolite (B) G D G D
4-(Methylcarbamoyloxy)-
1-naphthyl glucuronide R G M P S R G M P S R R Ho
1-Naphthyl glucuronide R G P S R Ho Hi
4-(Methylcarbamoyloxy)-
1-naphthyl sulfate R G M S R G M S R R
1-Naphthyl sulfate R G M S R Ho Hi
Unidentified metabolite (C) S
Unidentified metabolite (D) S S
*Rat (R), guinea pig (G), monkey (M), swine (P), sheep (S), dog (D), 
and human (H)
**Analysis by radiometric techniques; rats and guinea pigs treated ip, 
all others orally
***Analysis by fluorometric techniques; rats treated orally, humans 
orally (o) and by Inhalation (1)
Vdapted from Knaak et al [33,34] and Knaak and Sullivan [87]
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TABLE XIII-5 
EFFECTS OF CARBARYL EXPOSURE ON HUMANS
Routes of Exposure Concentration






59 workers 0.03 - 40 mg/cu m 
16 mo (hourly expo­
sure not stated)
8 mo (hourly expo­
sure not stated)
Agricul­ 2 - 4
tural 4 - 6






Whole blood ChE* ac- 28
tlvltles Inhibited but 
within normal range; 
urinary 1-naphthol
1,000 Mg/100 ml** 
or higher in 41% of 
samples (conc low on 
Mon, rising during 
workweek, in sub­
study of 7 workers)












Rash in 1 splashed 35
worker; plasma ChE 
slightly inhibited on 
d 1, normal on d 5 
after application in 
all 10
Plasma ChE activity 35
still Inhibited 1 wk 
after spraying
1 man 40.6 - 49.3 mg/cu m Urinary 1-naphthol 13
(with res- for 2 d 2,340 and 8,975 (sec 9,












2,340 and 3,619 (sec 9,
pg/100 ml 10)
Weakness, dizziness, 38
shortness of breath 
on day of exposure 
and 2 d later
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TABLE XIII-5 (CONTINUED)
EFFECTS OF CARBARYL EXPOSURE ON HUMANS
Routes of Exposure Concentration Refer-









8 - 16 hr
Urinary 1-naphthol 
2,443 pg/100 ml
for 7 asymptomatic 
workers; 1,417 for 
7 symptomatic work­
ers, all with dizzi­
ness, nausea, 1 with 











glucuronide and 1- 
naphthyl sulfate 
higher during expo­
sure than 72 hr after 
exposure
34




Recovery in urine, 








4 Mg/sq cm 
14C-carbaryl 







Recovery in urine, 31
70% of dose over 
5 d
Recovery in urine, 33
26-27% of dose in 32





No change in plasma 32
or whole blood ChE; 
no toxic symptoms
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Oral 5 men 0.06 mg/kg/d 
6 wk
Urinary rise of 
aa/cr***
32
II 5 men 0.12 mg/kg/d 
6 wk
Urinary rise of 
aa/cr***
32




in 2 hr with atro­
pine therapy
21






covery in 12 hr with 
atropine therapy
28









ery in 18 hr with 
deoxycorticosterone
41





ery in 1.5 hr with 
deoxycorticosterone
41
ft 1 man 80% solution 
0.5 liter
Whole blood ChE 
strongly inhibited; 
death in 6 hr; 







**Normal ränge, 150-400 ¿tg/100 ml urlne 
***Amino acld nltrogen to creatinlne ratlo
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TABLE XIII-6
















390 mg/cu m (dust) 
4 hr
230 mg/cu m (dust)
4 hr
10 mg/cu m (dust) 
7 hr/d
5 d/wk for 
90 d
75 mg/cu m (dust) 
(duration unknown)
82 mg/cu m (dust)
6 hr
37 mg/cu m (dust) 
6 hr
20 mg/cu m (dust) 
6 hr
63 mg/cu m (dust) 
6 hr/d for 
1 mo
40 mg/cu m (dust) 
6 hr/d for 
2 mo
16 mg/cu m (dust) 
6 hr/d for 
4 mo
Nasal and eye irrita­
tion; hemorrhagic 
areas in lungs
Slight initial weight 
loss; recovery by d 14
No effects
Typical signs of ChE** 
inhibition within 5 hr
Signs of toxicity 
observed; ChE in­
hibited, normal after 
72 hr
ChE inhibited, normal 
after 48 hr





cyte) ; 1 death at d 20



































0.5 ml of 
10% suspension 






in water, or 
50 mg powder
0.01 ml of 










Mild irritation in 
eye after 24 hr





0.1 ml (0.1% in 
propylene glycol) 
8 alternate days 










Inhibition of serum 
and erythrocyte ChE 
in 1st 24 hr
LD50 greater than 


















EFFECTS OF CARBARYL EXPOSURE ON ANIMALS
Routes of Exposure Concentration Refer-




















in 0.25% agar 
5 mo
No increases in tu­
mors , inf ect ions, or 
mortality compared to 
control animals
27
0.25 - 3 g/kg Leg weakness observed
(suspended in lard) at 2 g/kg; no effects
at doses of 1 g/kg or 
less




10 and 15 mg/kg 
in ethyl alcohol
5 30 mg/kg
8 M 20 mg/kg
26 F 300 mg/kg/d in 
gelatin capsule 
d 11 - 20 of
gestation
Leg weakness; recov­




No change in erythro­








38%; fetal mortality 
17.5% in survivors' 
litters (9.5% in con­











EFFECTS OF CARBARYL EXPOSURE ON ANIMALS
Routes of Exposure Concentration Refer-
Exposure Species No. and Duration* Effects ence
Oral Guinea 40 F 300 mg/kg in 
pigs capsule
(preg- single dose




ity 6.5% (controls 
9.5%); 9 malformed 
fetuses in litters of 
treated
71




d 10 - 24 of
gestation
than controls; no 
significant increase 











d 10 - 24 of
gestation
17 F 50, 100, 200 mg/kg
in capsules on 
d 5 - 15 of
gestation
18 F 500 mg/kg/d in diet
during various 
intervals of 
gestation or until 
weaning of pups




gestation or until 
weaning of pups
72
150 F 50, 100, 200 mg/kg Increased fetal anom- 72
alies at 50 mg/kg 
only (15.7% vs 9.1% 
in controls)
No terata or dose- 71
related mortality 
compared to controls
Weight gain of off- 70
spring reduced; 2/3 
mortality of pups 
within 4 d after birth
No effect on viabil- 70 











Oral Rats - F 610 mg/kg (gavage) LD50 27
If If - 510 mg/kg (gavage) LD50 27
II II - M 850 mg/kg (gavage) LD50 43
II II - M 600 mg/kg (gavage) Lowest lethal dose 43
ft It - F 500 mg/kg (gavage) LD50 43
II If - F 100 mg/kg (gavage) Lowest lethal dose 43
tl tl 10 M,F 2,250 ppm 
in diet 
96 d
Cloudy swelling of 
kidney tubules in 4
27







50, 100, 200 ppm 
in diet, 2 yr
14 and 70 
mg/kg/d 
12 mo
hepatic cords; cloudy 
swelling of kidney 
tubules present after








renal cortex activity; 
growth inhibition; 
blood ChE inhibited 
after 3 mo; testicu­






































200 mg/kg/d in diet 
3 generations














Death in 1 of 10 at 59
1,000 mg/kg; no evi­
dence for dominant 
lethal mutagenicity 
after mating
Weight below controls 78
for all treated wean­
lings; average litter 
size and survival of 
offspring decreased 
at 5,000- and 10,000- 
ppm levels
Initial decrease in 72
weight gain in F0; 
lengthened gestation 
period in FI and F2 
compared to controls
No effects compared 72
to controls in all 
generations
Increased fetal mor- 72
tality; sporadic ad­
verse effects on litter 
size, adult survival 
time, fetal resorption 
in all generations
No effects compared 72











Oral Rats - F 2 and 5 Fertility decreasing 73
progressively, dose- 
related (F2 to F4); 
reduced estrus time 



















Sperm motility, sper- 73 
matogenesis, duration 
of sperm survival 
reduced compared to 
controls
Decreased fertility, 78 
litter size, pup via­
bility in all genera­
tions; at and above
4,000 ppm, weanling 
weights less than 
controls
Hamsters 6 F 250 mg/kg/d (gavage) Signs of ChE inhibi- 71
(preg- d 7 - 8 tion; salivation,
nant) of gestation diarrhea, incoordina­
tion; 2 deaths; fetal 
mortality 30.3% (con­
trol 5.5%), no terato­
logic defects in fetuses
" 8 F 125 mg/kg/d (gavage) Fetal mortality 10% 71
d 6 - 8 (control 5.5%), no




EFFECTS OF CARBARYL EXPOSURE ON ANIMALS
Routes of Exposure Concentration Refer-









20 F 30 mg/kg/d in diet 
from d 6 
of gestation 
to delivery
20 F 10 mg/kg/d in diet 







18 mo (from d 
7 of age)












16 20 mg/kg/d in
capsules 
d 20 - 38
of gestation
16 2 mg/kg/d in
capsules 
d 20 - 38
of gestation
Minor abnormalities 75
in 9 fetuses (con­
trols , 2)
No effects compared 75
to controls
No significant in- 79
crease in tumors 
compared to controls
Dystocia in 1/3 of 66
dams, none in controls;
11.6% terata at doses 
of 6.25 mg/kg or more
Abortions 3 in 6 67
pregnancies (1 abor­
tion In 5 pregnancies 
for 7 controls)
Abortions 2 in 2 67
pregnancies
Abortions 3 in 15 69
pregnancies, no
terata



























150 mg/kg/d in 
diet for 28 d, 
300 mg/kg/d 
until death
5 M 125 mg/kg/d in diet 
6 - 8 wk
Abortions 2 In 16 69
pregnancies, no 
terata (4 abortions,
1 stillborn in 31 
pregnancies for 31 
controls; no terata)
First signs of toxi- 52




cerebral edema; death 
on d 72 (M) and 83 (F)
First signs of toxi- 52





edema; death on d 46 
(2 M) and 85 (F)
Spastic paresis of 55
posterior extremities

















FIGURE XIII-1 CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP WITH FILTER CASSETTE
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